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ABSTRACT
I. SYNTHESIS, FUNCTIONALIZATION AND METAL COMPLEXATION OF
POLYAMINE MACROCYCLES
II. SYNTHESIS AND DYNAMIC NMR STUDIES OF BICYCLIC UREAS
by
Daniel C. Hill 
University of New Hampshire, September, 1995
Part I: The syntheses and characterizations of novel bicyclic 
tetraamines (shown below) have been accomplished.
M N X - ( C H 2) m m,n = 0
[  J J m = 1 , n = 0
N N Y  = (CH2) n m,n = 1
L J BY
R = H, CH3, or CH2Ph
The complexation of bicyclic tetraam ines (R = CH3) with Li+ and Na+ 
have been studied by NMR spectroscopy. These tetraamines are 
strong bases and selective Li+ binders. The parent “cross-bridged 
cyclam” (R = H; X = Y  = CH2 ) was functionalized with a variety of
xxx
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^\A0H K -^O H
o
y v CN STr
Several of the ligands were investigated as possible 
radiopharm aceutical (99mTc) imaging agent precursors.
Syntheses of non-adjacent selectively functionalized  
tetraazacycloalkanes have also been developed.
'n  NH X = (CH2) m
p ^ m,n = 0
n  /  v  //•>! | \ m,n ~ 1
HN Y = (CH2) n
R, R' =  CH2Ph 
R = Me, R' = CH2Ph
X X X I
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Part II: Synthesis and dynamic NMR studies of intramolecular 
transamidation of bicyclic urea 1 9  9 have been carried out.
1 9 9
Bicyclic urea 1 9 9  exhibited dynamic exchange broadening indicative 
of an enantiomerization process in D2O at pD > 8 . Below pD 8  
bicyclic urea converts to guanidinium salt 2  16 .
2 1 6
Semiempirical methods (AM1, PM3) were used to study possible 
interm ediates of the transam idation reaction.
x x x ii
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PART I: SYNTHESIS, FUNCTIONALIZATION AND METAL COMPLEXATION
OF POLYAMINE MACROCYCLES 
Volume I 
Part 1
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Chapter I
A Brief Introduction to Macrocyclic Chemistry
l. in tro d u c tio n
To date, host/guest chemistry has been extensively reviewed,-! 
and several books on the subject have been written .2 Two major 
contributors to this field are Lehn3 and Cram* who established the 
fundamental terminology and concepts in this field. The field of 
“Host/Guest Chemistry” is more frequently being referred to as 
“Supramolecular Chemistry” meaning “beyond the molecule” as 
described by Lehn.s In this chapter the fundamentals of host/guest 
chemistry will be introduced and briefly reviewed.
Pharmaceutical applications are among the more prevalent 
uses for macrocyclic hosts. This is due to the fact that some 
macrocyclic compounds are able to transport ions across a lipophilic 
membrane. Macrocyclic hosts can encapsulate a metal ion and reveal 
only a lipophilic exterior to the environment. The first antibiotic 
capable of this action was Valinomycin, which was isolated in
2
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1 9 5 5 6 a and later synthesized in 1 9 6 3 .6b
II.Background
Host/guest chemistry is the study of receptor molecules 
(hosts) having convergent binding sites which include or complex 
with other chemical species (guests) having divergent binding sites. 
The intermolecular forces between the host and guest are 
electrostatic in nature. These forces can be classified as hydrogen 
bonding, metal ion to ligand interactions, 7r-acid to 7r-base 
interactions, and van der W aals attractive forces.
A. General Types of Hosts
Coronands are defined as multidentate macrocyclic ligands 
containing heteroatoms such as nitrogen, oxygen, sulfur or 
phosphorus.? Crown ether 18 and aza-crown 29 are examples of 
coronands.
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Structural modifications, such as the incorporation of rigid groups, 
can often change the basicity and donor ability of the heteroatoms 
as in crown ether 3.5
Podands are open chain compounds that can coordinate to metal 
ions much like coronands. For example tripodand 4 1 0 , is s tructurally  
less rigid, and as a result generally forms weaker complexes with 
metal cations than coronands. The lack of preorganization exhibited 
by 4 makes it a weaker complexer of alkali metal cations when 
compared to macrocyclic ligands 1 - 3. This is an example of the 
“m acrocyclic e ffe c t.”
4
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Podandocoronands including “lariat ethers”i 1 are coronands 
with attached coordinating arms. The incorporation of ligating arms 
can produce a three dimensional cavity suitable for a metal ion. 
Crown ethers with side arms containing donor atoms are referred to 
as “lariat ethers.” An example of an N-functionalized lariat aza- 
crown ether containing two sidearms (5 ) is shown below.
The donor arms in 5 can complex with metal cations and therefore 
increase complex stability when compared to aza-crowns without 
coordinating arms. The cooperative ring-side arm interaction as 
described by Gatto et a !.12  is responsible for the increased binding
5
5
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strength of lariat ethers over crown ethers. Gokehs and coworkers 
dem onstrated that lariat ether 5 complexes Na+ and K+ ions in a 
three dimensional fashion as indicated by the X-ray crystal 
structures. An example of a podandocoronand synthesized by W e i t h *  
and coworkers (6 ) is shown below.
H O  O H  H O  O H
H O  O H  H O  O H
6
Cryptands are formed by the bridging of monocyclic coronands 
to generate a bicyclic structure or “crypt.” Conventional cryptands 
contain two bridgehead nitrogen atoms which are joined by three 
polyoxyethylene chains. The three dimensional cavity generated by 
this bicyclic system is well adapted for the encapsulation of metal 
ions. Cryptand 7 was synthesized by Lehn and coworkers and has 
been studied with respect to metal cation complexation.i s
6
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M*c 7
B. Macrocyclic Polvamine Hosts
1. Historical
The first exam ple of a saturated tetraaza macrocycle (cyc lam , 
8 ) was reported in 1937 by Van A lp h e n .16 The synthesis of this 
tetraaza macrocycle was improved by Stetter and M e y e r i7 a  in  1961 
and further improved in 1972 by B a r e f ie ld . i^ b  Ongoing research in 
the area of macrocyclic polyamines ligands has resulted in the 
synthesis and study of a wide variety of polyamines. Some examples 
of macrocyclic polyamines containing 3-5 nitrogen atoms arranged 
within a saturated hydrocarbon ring system are shown below (8 - 1  2 ).
1 1 1 2
8
7
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F o r  m a n y  y e a rs  fo llo w in g  th e  firs t re p o rt o f th e  s y n th e s is  of 8  
little  re s e a rc h  on  th is  c o m p o u n d  w a s  d o n e , until th e  d is c o v e ry  o f its  
c o o rd in a tio n  c h e m is try . W h e n  c o m p a re d  to  th e ir  a c y c lic  a n a lo g s ,  
c y c la m  tra n s it io n  m e ta l c o m p le x e s  a re  m o re  s ta b le  a n d  le s s  
s u s c e p tib le  to w a rd s  d is s o c ia tio n . T h e  in e rtn e s s  a n d  u n iq u e  p h y s ic a l 
p ro p e r t ie s  o f c y c la m  c o m p le x e s  o f tra n s itio n  m e ta l io n s  in g e n e ra l  
m a d e  th e m  e x c e lle n t c a n d id a te s  fo r fu r th e r  s tu d y . C o ( l l )  a n d  N i( l l)  
c o m p le x e s  o f a z a m a c ro c y c le s  w e re  firs t re p o r te d  b y  C u r t is .1 8 , 1 9  
T h e  k in e tic s  a n d  m e c h a n is m  o f c o m p le x a tio n  o f c y c la m  w ith  
N i( l l ) ,2 0 b .c  C o ( l l ) ,2 i  Z n ( l l ) ,2 2  C u (ll ) ,2 3  T c (V ),2 4 a ,b  a n d  R e (V )2 4 c  h a v e
been studied in recent years. Recently, the cyclam complex with 
Ni(ll) was reduced to the Ni(l) complex by pulse radiolysis and laser 
flash photolysis.20a in this example, the reduction was carried out 
by solvated electrons, hydrogen atoms, and carbon dioxide radical 
anions and was shown to proceed by an inner-sphere mechanism. The  
coordination chemistry of macrocyclic polyamines has been  
extensively researched and reviewed.25
A wide variety of macrocyclic polyamine ligands have been 
synthesized and studied with respect to their coordination ability. 
Some of these polyamine macrocycles were studied with respect to
8
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their redox b e h a v io r6 and basicity.2 7
2. Factors Which Influence Complex Stability.
Varying the size of the macrocyclic ring in tetraam ines  
changes metal cation complexation selectivity. In general, smaller 
ions complex more effectively with smaller macrocyclic ring sizes 
and larger ions complex most effectively with larger metal ions. 
This concept of s ize -mat ch  s e l e c t i v i t y  was developed to describe 
the nature of crown ether metal c o m p le x e s .3 .4 ,5 ,2 5 c ,2 8  For instance, 
the complexation selectivities observed for crown ethers can be 
interpreted in terms of the ionic radius of the metal cation and the 
size of the macrocyclic cavity. For crown ethers, experimental 
evidence based on the determination of formation constants (in 
water) has shown K+ fits best in 18-crown-6 and therefore forms 
the most stable complex when compared to Li+, Na+, Rb+, and Cs+.
Polyamines, however, do not necessarily exhibit this simple 
size match relationship. The selectivity is more likely due to the 
flexibility of the macrocycle, and not the simple size-match  
relationship described above. Polyamine and crown ether 
macrocycles are flexible, and as a result, can form a number of
9
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different complexing conformations each varying slightly in the size  
of the macrocyclic cavity. H a n c o c k 9 demonstrated that polyamine 
macrocycles can adopt a variety of conformations according to 
Molecular Mechanics (M M ) calculationsso and thermodynamic 
s tu d ies .s i
For example, metal comlexes of cyclam (8 ) can adopt at least 
three configurations. Each of these configurations has a different 
metal ion size preference (Figure 1.1).
Figure 1.1
In the case of a metal complexes of cyclam, configuration c (trans I) 
is favored for larger ions whereas configuration a (trans III) and b 
(cis V) are favored for smaller metal ions. Configurations c and a 
are complexes in which ligand is trans coordinated to the metal and 
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feature that allows configuration c to more favorably complex 
larger metal ions is that the metal can rise out of the plane of the 
four nitrogens to more effectively adapt to the coordination 
geom etry.
In addition to the conformational preferences mentioned above, 
the size of the chelate rings formed in a complex has a strong 
influence in determining com plex stability .29-31 Typically, five-
membered chelate rings are favored for larger metal ions and six- 
membered chelate rings are favored for smaller metal ions. This can 
be explained by comparison of the chelate ring conformation formed 
in a complex to the steric requirements of low-strain cycloalkanes. 
According to MM calculations,30 the ideal geometries for five and 
six-membered rings are those shown in Figure 1.2.
Figure 1.2
The six-membered case only allows for a metal-nitrogen bond 
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retained. The five-membered case allows for a much longer metal- 
nitrogen bond distance (2.5 A) for the minimum energy twist 
envelope conformation. Therefore, smaller metal ions form more 
stable complexes with six-membered chelate rings and larger metal 
ions form more stable complexes with five-membered rings.
3. Applications of Macrocyclic Polvamines
Several examples of crown ethers, aza-crowns and aza- 
macrocycles have been utilized in medical, chemical and 
pharm aceutical applications. For exam ple, tetrabenzylcyclam 1 3 
forms complexes with copper, gold, and silver which have been 
studied with respect to their antitumor activity.32
A commonly used method to treat tumors utilizes a ligand- 
radioisotope complex which is attached to an antibody. Cyclic 
polyamines form strong complexes with radioactive metal ions
1 3
1 2
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which are kinetically inert and resistant to dissociation at 
physiological pH. These types of complexes have been described by 
several authors .33 The application of aza-crown macrocycle metal 
ion complexes as proton relaxation enhancement agents for Nuclear 
Magnetic Resonance Imaging (M R I) has received much attention. 
Several reports34  of metal complexes useful for this purpose have 
appeared in the literature. Macrocyclic compounds have long been 
used for the treatment of metal intoxication. Cations of metals 
such as arsenic, lead, mercury and nickel can be immobilized by 
complexation with a macrocyclic host. Derivatives of cyclamss have 
successfully been used for N i(ll) detoxication by increasing the 
urinary excretion of N i(ll), presumably by complex formation.
Several macrocyclic ligands have been tested with respect to their
a n tim ic ro b ia l,36 anticonvulsive,37 antiarrhythm ic,38 and 
antihypertensive39  activity. It has been suggested by Kimura 40 that 
aza-crown macrocycles might be used for the treatm ent of kidney 
stones.
Extensive research in the area of polyamines has established 
many fundamental concepts concerning the complexation behavior, 
functionalization, and synthesis of te traaza  macrocycles. Some
1 3
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macrocyclic complexes as described above have been shown to be of 
therapeutic and diagnostic value. The research described in this 
thesis has contributed to this area of study.
1 4
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Chapter II
Bridged Tetraamine Ligands and Selectively Bridged
Tetraamine Ligands
I. Introduction
Structurally-reinforced polyam ine m acrocycles and their 
complexes have been studied by a number of research groups .41 -48 it 
is believed that the bridging of adjacent or non-adjacent nitrogens 
in a tetraamine macrocycle should change the proton-transfer and 
metal complexation characteristics significantly com pared to non­
bridged tetraam ine macrocycles. This structural reinforcem ent will 
restrict conformational flexibility, which may result in increased  
com plex stability.
W e have developed a general synthetic strategy to cross­
bridged tetraam ines (Figure 2 .1 )4 9
1 5
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Figure 2.1
R
X = (CH2)m m>n = 0
m = 1 , n =  0  
Y = (CH2) n m,n = 1
R = H, CH3, CH2Ph or 
a ligating group
Several exam ples of compounds with functionalized non-adjacent 
nitrogens are described in detail in Chapter III. Some of the ligating 
groups contain ionizable moieties in which coordination might be 
controlled by altering the pH of the medium. There are many 
exam ples in the literature of macrocyclic tetraam ine syntheses and 
functionalization but very few which deal with the ethylene cross 
bridging of non-adjacent nitrogens. A background of structurally 
reinforced polyamine ligands and their metal complexes will be 
discussed before the synthetic strategy utilized to make cross­
bridged tetraamines is presented (Figure 2.1).
II. Background
A. Bridged Tetraam ines
1 6
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Structurally reinforced macrocycles 1 4 and 1 5, having 
adjacent nitrogens bridged with an ethanediyl (-C H 2 CH2-) linkage  
were first synthesized by W ainwright42, who reacted 1,2- 
dichloroethane with cyclam (8 ) in ethanol to give a mixture of 1 4 
and 1 5 (Scheme 2.1).
Scheme 2.1
Macrocycles 1 4 and 1 5 were separable, however the separation 
procedure was lengthy and the yields were low. The bridging of 
adjacent nitrogens creates a steric barrier, according to molecular 
models. Therefore, these structurally reinforced macrocycles are  
forced to complex with metal cations in which the ligand is “trans” 
coordinated to the metal. For example, the Ni(ll) complexes of 1 4 
and 1 5 were prepared and exhibited square planar geometry.
An alternative procedure for the synthesis of 1 4 developed by 





8 1 4 1 5
1 7
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Scheme 2.2
HN NH H' h A  NHC 1  = r C i j “ “ A  ]
HN NH T J " T sN PhCH3 n H
, o  ° H °  r Y  nM MU . !  . .  M .  M I.
96P/o
8 1 6  1 4
In this procedure, the reaction of cyclam (8 ) with aqueous glyoxal, 
by the method of W e is m a n ,4 4  afforded tetracyclic glyoxal adduct 1 6 . 
Reduction of 1 6  with diisobutylaluminum hydride (DIBAH) gave pure 
1 4 in 96%  yield. The second bridge was introduced by reaction of 1 4 
with oxalyl chloride in dichloromethane (Scheme 2.3).
Scheme 2.3
After purification by chromatography, the diamide 1 7  was reduced 
with DIBAH to give 1 5.
The bridging of adjacent nitrogens of cyclen was accomplished
n °h° A  r^ i rYi—rNi rNY0^ HrNi rNi
N NH !«%Cl2 N Hexane ^ n N ^
1 4 1 7 1 5
1 8
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
by Wainwright25 using a method similar to that developed for the 
adjacent bridging of cyclam 8.42 Reaction of cyclen (1 1) with 1,2- 
dichloroethane in the presence of potassium hydroxide gave 1 8  as 
the major product (Scheme 2.4).
Scheme 2.4
The significant difference in volatility between 1 8  and 1 9 allowed 
separation by fractional sublimation. The N i(il) complex of 1 8  was 
prepared and the ligand was trans coordinated according to UV-Vis 
and 1 3C NMR spectra. The bridging of adjacent nitrogens causes the 
ligand to coordinate with N i(ll) in a trans fashion, whereas Ni(ll) in 
the cyclen complex is cis coordinated.
Ciampolini and M ic h e lo n i4 6 ,4 7  reported the bridging of non- 
adjacent nitrogens in the 1 ,7 -d im ethy l-1 ,4 ,7 ,1 0 -te traa za -  
cyclododecane system (Figure 2 .2). Their successful synthetic 
methodology enabled the synthesis of several bridged structures, 
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bridging units is shown in Figure 2.2. 
Figure 2.2
X=
The protonation and metal complexation abilities of these 
macrocycles were determined and evaluated in terms of the length 
of the bridging chain and the nature of any associated donor atoms. 
Most of these macrocycles are selective lithium binders, and a few 
of them are strong bases, as determined potentiometrically. These  
macrocycles are unique because conformational flexibility allows 
for the formation of a small “tridimensional” cavity, which makes 
the ligand well suited for complexation of a proton or metal cation. 
For exam ple, 1 ,7-dimethylcyclen (2 0), readily reacted with succinyl 
chloride to give the diamide 2 1 in 64%  yield (Scheme 2.5).
20






2 22 0 2 1
The reduction of the diamide 2 1 gave non-adjacent bridged 
macrocycle 2 2 in 69%  yield. A recent report of the synthesis of 2 4 
by the same authors has recently appeared in the lite ra tu re .*8 The 
synthetic approach utilized an acylation/reduction approach (Schem e
2 .6 ) analogous to the approach used for the preparation of 2 2 . 
Compound 2 4 was synthesized several years ago in our research
g ro u p .so a
Scheme 2.6
HN n Bj v g r
\  69%
>
2 0 2 42 3
21
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The X-ray crystal structure of the trihydrochloride salt of 2 4 was 
also reported.
B. The Synthesis of Cross-bridged Tetraam ine Ligands bv Reductive 
Rina Expansion of Tetracyclic Bis-Aminals.
N .N ’-D im e th y l- IA S .H -te tra a z a b ic y c lo fe .e ^ h e x a d e c a n e  (2 5) 
was first reported by Rogers and W eisman in 1990.49 Reaction of 
cyclam (8 ) with aqueous glyoxal in acetonitrile gave 1 6 (Scheme
2.7) as previously reported.44 
Scheme 2.7
Bisaminal 1 6 was subsequently regioselectively alkylated with
CH3CN 









2 6 2 5
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excess methyl iodide to give bis-quaternary bis-aminal dimethiodide  
2 6. The regioselectivity is a result of the conformation of 1 6, 
which has two readily accessible nitrogen lone pairs (Scheme 2.8). 
Compound 1 6 has a concave face and a convex face. The two 






The high temperature (100°C ) iH-decoupled 13C NMR spectrum of 
bis-am inal 1 6 showed that the compound undergoes rapid 
enantiomerization (top of Scheme 2.8). The room temperature 13C 
NMR {1H} spectrum of 1 6 exhibited six peaks (C2 symmetry), two
2 3
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pair of which broadened and coalesced with increasing tem perature  
to give a total of four 13C NMR peaks at 100°C (time averaged C2 V 
symmetry). The activation barrier for this process was m e a s u r e d * *  
AG* = 15.36 ±  0.2 Kcal/mol (at 57.5  ±  3°C ). The first alkylation 
(Schem e 2 .8 ) freezes the conformational enantiomerization of 1 6  
and thereby directs the second alkylation to the non-adjacent 
nitrogen (Scheme 2.9).
Scheme 2.9
The reduction of 2 6  with NaBH4 in 95%  EtOH gave cross­
bridged tetraam ine 2  5. It is believed that the mechanism of this 
reaction involves the intermediacy of iminium ion interm ediates, 
which are reduced by borohydride to give tetraamine 2  5 (Scheme 
2.10).
i  z < -
2 4
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So far, experimental methods have been unable to provide 
information as to the detailed conformations of 2 5. However, it is 
evident that the central -C H 2 CH2- bridging unit cannot “tuck 
through” the center of the 14-membered ring on the NMR timescale. 
The 1H NMR of 2 5 shows that all geminal pairs of hydrogens on the
2 5
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
bridging unit are in slow exchange on the NMR timescale (360 MHz).
The first attempts at alkylation of bisaminal 1 6  with benzyl 
bromide were performed by Rogers.soa Benzylation was 
accomplished by stirring 2  molar equivalents of PhCH2 Br with 1 6  in 
M eCN for 3-8 days. The white solid product which precipitated from 
the reaction mixture was a mixture of monoalkylated and dialkylated 
products as indicated by 1H and 13C NMR. In one case the reaction 
mixture was heated, but this run gave decomposition products, 
complicating isolation of pure product. Pure dibenzylated 2 7 (>99%) 
was prepared when 1 6  was stirred in MeCN at room temperature 
with a large excess of benzyl bromide for 1 week (Scheme 2.11).
2 6
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Scheme 2.11
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Bis-quaternary bisam inal dibromide salt 2 7 was reduced with NaBH4 
in 95% ethanol to give 2 8 . The X-ray crystal structure of 2 8  shown 
in Figure 2 .3  was determined by Jasinski and coworkers.sob The 
debenzylation of 2  8  was achieved by catalytic hydrogenolysis (1 
atmosphere) with 10%  Pd/C in glacial acetic acid. The crude product 
was worked up with aqueous base, extracted with benzene, and 
recrystallized from Et20  at low temperature (-78 °C) to give pure 
2 9. The successful synthesis of parent ethylene cross-bridged 
cyclam 2 9 established a reaction sequence which was subsequently
2 7
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Figure 2 .3  
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utilized to prepare similar cross-bridged tetraam ines (see Results 
and Discussion). IR and NMR spectra strongly suggest that the 
solution conformation of 2 9  is “diamond-lattice like." The NH  
chemical shift of 2 9 in the 1H NMR (CeCfe) is shifted downfield (3.59  
ppm) compared to typical secondary amines (0 .5 -3 .0  ppm). This 
shift is clearly rdue to strong intramolecular hydrogen bonding which 
should move the NH resonance towards the lower field end of the 1H 
NMR spectrum. The IR spectrum of 2 9 in chloroform (0.13 M) 
exhibited an N-H stretching frequency at 3260 cm -1 which is shifted 
somewhat towards longer wavelengths compared to typical 
secondary amines (3350 -33 10  cm -1). Hydrogen bonding typically 
shifts the N-H stretching frequency of amines toward longer 
wavelengths. If 2 9 was not intramolecularly hydrogen bonded, a 
very dilute solution (<0.01 M) would show a shift in the N-H  
stretching frequency. A dilution study performed by Rogerssoa 
confirmed that 2 9 exhibited intramolecular hydrogen bonding since 
no observable shift in the N-H stretching frequency occured upon 
dilution (0.05 M and 0 .016 M ) of the sample. It is worthy to note 
that 2 9 and related parent cross-bridged tetraam ines are soluble in 
polar solvents (H20  (pH<10), DMSO, CH3CN) as well as non-polar
2 9
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solvents (C6 H6 , pentane, CCU). The solubility in non-polar solvents 
is undoubtly due to the fact that these compounds form strong 
intramolecular hydrogen bonds presenting a lipophilic exterior to the 
solvent. Compound 2 9 has subsequently been functionalized with 
ligating groups containing heteroatoms useful for coordination.
These new functionalized derivatives are discussed in Chapter III.
Rogers51 first established that bisaminal 3 0  could be carried 
on through the alkylation/reduction sequence to give macrocycle 2 4 










1 1 3 0
xs NaBH4
3 1 2 4
3 0
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C. Selectively M onofunctionalized Tetraam ines
In comparison to their tetrafunctional analogs, 
monofunctionalized m acrocyclic tetraam ines will coordinate to 
metals, but in a less complicated fashion. Monofunctionalized 
cyclams (3 2) shown in Figure 2.4, have fewer possible modes of 
coordination since they contain only one coordinating arm. Some of 
the various approaches developed toward monofunctionalized 
macrocyclic tetraam ines will be briefly discussed.
Figure 2.4
Parker and c o w o r k e r s 5 2  have synthesized tritosyl cyclam (3 3) 
which was monofunctionalized at the secondary amine and 
subsequently detosylated to give monofunctionalized cyclams (3 2). 
F a b b r i z z i 5 3  and coworkers have synthesized one-armed macrocycle 
3 4 starting with 3 3 and tosylaziridine.
CH2COOH
c h 2 c h 2s h
CH2CH2OMe
3 3 3 2
31
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HN NH
3 4
B e r n a r d 5 4 a  has prepared monofunctionalized tetraaza- 
m acrocycles 3 7  by protection of three of the nitrogens of 3 5 as 
shown in Scheme 2.13.
Scheme 2.13
Tris(d im ethylam ino)borane reacts with tetraam ines 3 5 to form  
protected interm ediates 3 6 , which were N-alkylated and 
subsequently hydrolyzed to give monofunctionalized tetraam ine  
m acrocycles 3  7.
Y a o u a n c s ^ b  and coworkers have successfully protected three of
B(NMe2)3
HN NH
V.W = (CH2)m 
m = 0 , m = 1
3 5
3 2
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the nitrogens of tetraazam acrocycles 3 5 as a chromium complex 
(3 8 ) as shown in Scheme 2.14.
Scheme 2 .14
3 5
Treatm ent of tetraam ine macrocycles 3 5 with chromium  
hexacarbonyl gave tridentate complexes 3 8 , which were then N- 
alkylated and air oxidized in aq HCI. Workup with aqueous base gave 
monofunctionalized tetraam ine m acrocycles 3 7.
The synthesis and functionalization of 1,4,8-trim ethyl-
1 ,4 ,8 ,1 1 -te tra a za c y c lo te tra d e c a n e  (3 9) has been reviewed by 




V.W = (CHdm 
m = 0, m = 1 3 8  3 7
3 3
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Figure 2.5
R R = C H 2CH2OH
c h 2c o o h
c h 2c h 2sh
CH2 CH2OMe
CH2CH2 NH2
3 9 4 0
D. Macrocyclic Tetraam ine Complexes with Li+. Na+. and H+.
The study of azamacrocycles containing convergently arranged  
binding sites with respect to coordination of metal cations has been 
recently reviewed.56 The coordination chemistry of lithium ion, 
with emphasis on amine complexes and lithium selective ionophores 
has recently been reviewed.57
General reviews covering the thermodynamic and kinetic data  
for m acrocycle interaction with cations,58a anions,58a and neutral 
species58b have been compiled by Izatt and coworkers. These reviews 
contain extensive lists of macrocyclic compounds and tables which 
include macrocycle complexation param eters for transition metal 
ions,58a alkaline earth metal ions,58a anions,58a and neutral 
species.58b An earlier review also published by Izatt covers the 
thermodynamic and kinetic parameters of mainly
3 4
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polyazam acrocycles.5 9 This earlier review focuses on tetraaza- 
macrocycles and their transition metal, alkaline earth, and proton 
com plexes.
M arte liso  and coworkers have recently investigated the factors 
which affect the stability of macrocyclic and macrobicyclic 
complexes in solution. The major contributing factors are listed as 
follows: 1) size of the chelate ring, 2) basicity of the donor atom, 3) 
charge neutralization upon complex formation, 4) steric effects, and 
5) preorganization of ligand.
Some of the first work on the coordination chemistry of 
cyclam (8 ) with Li+ was done by Truter and coworkersei, who 
reac ted
8  with excess UCIO4 in methanol to give a mononuclear LiC ICV 8  
complex. Evaporation of the mother liquors of this reaction gave the 
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structure of tetraprotonated 8  was determined by Subramanian e t  
al.G*
H e r l i n g e r 6 3  has recently reported the preparation of the 
sodium and lithium thiocyanate com plexes of 1 ,4 ,8 ,1 1-tetram ethyl-
1 ,4 ,8 ,1 1 -te tra a za c y c lo te tra d e c a n e  (4 1).
In the LiSCN complex of 4 1, all the methyl groups are equivalent 
according to NMR analysis (CDCI3). It was shown by X-ray that the 
complex exhibits square pyramidal coordination geometry, with SC N - 
at the fifth coordination site.
Ruangpornvisuti e f a / . 64  reported the stability constants of the 
Mg+ and Li+ complexes of cyclen (1 1 ) .
4 1
r ~ \
cNH HN,NH HNv _ _ y
1 1
3 6
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Ciampolini and c o w o r k e r s 4 6 , 4 7 ,65-71  have synthesized and 
studied several aza-cages. For example, the Li+ complexes of 4  248  
a n d  4  3 7 0  were synthesized and characterized by X-ray  
crys ta llo g rap h y .
The second protonation constants of these macrocycles were 
determination potentiometrically while the first and third were  
respectively too high and too low to measure using this method.
M i c h e l o n F 2  has studied azamacrocycles with more than six 
donor atoms (Figure 2.6).
Figure 2.6
These polyazamacrocycles are polyprotic bases and can potentially
A T r v \
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form polynuclear metal complexes. For example, polyaza- 
macrocycles are strong bases in the first protonation step and are . 
weaker bases in the last protonation step. This decrease in basicity 
can be explained by charge repulsion effects. It was shown that 
when protonated, these polyazamacrocycles can form adducts with 
polycharged anions.
Ab initio calculations64 on protonated 1 1 were performed in 
order to compare the results to those obtained experimentally.
Dye and c o w o r k e r s 7  3 prepared the first alkalide of azacage 4 3. 
This alkalide, Li+(4  3)Na-, was characterized by 2 3Na and 7Li NMR.
The alkalide is reasonably stable and did not thermally decompose 
below 65°C .
R o g e r s s o  showed that macrocyclic polyamine ligands 2 4 and 
2 5 form complexes with lithium perchlorate as demonstrated by X- 
ray crystallography, 1H NMR, and iH-decoupled i 3C N M R .50c,d
2 4 2 5
3 8
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The X-ray crystal structure of the lithium complex of 2 4 is shown in 
Figure 2.7. This complex exhibits distorted octahedral geometry at 
Li+ with perchlorate binding in a bidentate fashion. Each of the 9- 
membered rings in the bicyclic structure is in a  [45] conformation.™  
The X-ray crystal structure of the lithium complex of 2 5 is shown in 
Figure 2.8. This complex is trigonal bipyramidal at Li+ with 
perchlorate binding in a monodentate fashion. Each of the 10- 
membered rings in the bicyclic structure is in a [2323] 
con form atio n?* and the complex has C2 symmetry.
Compounds 2 5 and 2 4 are strong bases as determined by 
R ogers.49 ,50a,c,d The X-ray crystal structures of the diprotonated and 
monoprotonated forms of ligands 2  59  a n d  2  4 ioc,d respectively were  
determined by Jasinski and coworkers. The addition of NaBPIu to an 
aqueous solution of 2 4  resulted in the precipitation of the 
monoprotonated tetraphenylborate salt 4 4. An inspection of the X- 
ray crystal structure data of 4 4 (disordered) (Ortep diagram in 
Figure 2.9) reveals that the structure is inside-protonated at the 
methyl-substituted nitrogens. This is supported by the shorter C-N  
bond lengths to those nitrogens. Ligand 2 5 was titrated with 
trifluoroacetic acid (TFA) in CD3 CN. In the absence of acid,
3 9
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• [451/(451 ligand conformation
• distorted octahedral at Li*
• bidentate perchlorate
Figure 2 .8
• L iC I04
A
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compound 2 5 exhibited 7  sharp lines in the 1 3C NMR spectrum. When 
TFA  was added (0.5 equivalents), a separate set of 7 13C NMR peaks 
was observed which indicated 2 5 and its monoprotonated complex 
were in slow dynamic exchange with respect to the NMR timescale. 
When more TFA was added (1 .5  equivalents total) two sets of 7 13C 
NMR peaks were observed, indicating that the diprotonated species 
was in slow dynamic exchange with the monoprotonated species.
The X-ray crystal structure of 2 5* H22+ b is-trifluoroacetate is 
shown in Figure 2.10. The structure has C2 symmetry with each 10- 
membered ring in a slightly distorted [2323] conformation. Each N-H 
in this complex is within hydrogen bonding distance to two 
transannular nitrogens. Modeling of the dication with the AMBER 
force field in Macromodel gave a structure that was in good 
geometric agreem ent with the X-ray crystal structure.soe.d Rogerssi 
has also performed a titration of ligand 2 4 with TFA. In this 
example the ligand and the monoprotonated species were in slow 
dynamic exchange.
The X-ray crystal structure of trihydrochloride dihydrate 4 5 
was recently reported by BiancinH8 and coworkers, as mentioned 
prev ious ly .
4 2
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I J  J  .3HC|.2H20
W \
4 5
They describe the structure of 4 5 as clamp-like, with the two N -C H 3 
nitrogens protonated and a third proton shared between the two 
bridgehead nitrogens. An NMR titration of 2 4 (D2O/DCI) indicated a 
monoprotonated species was present at pH 10 which exhibited time 
averaged C2 V symmetry, indicating a rapid exchange of a proton 
between the two methylated nitrogens. As more acid was added, the 
diprotonated species formed (pH 3.8) as indicated by the 1HNMR  
spectrum. The 1H NM R spectrum at pH 1 supports a distinct 
triprotonated species.
HI. Results and Discussion
A. Synthesis of N .N ’-Dimethvl Cross-bridged Tetraam ines.
Tetraam ines 8 , 1  1 ,4  6 , and 4 7, used as starting materials for 
ligand synthesis, were either purchased or prepared in this 
lab o ra to ry .
4 3
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
. . n  n  r i
HN NH HN NH HN N H ^  HN NH-i
^HN NH ^HN NH HN NH HN NH
U J  \ _ /  l ^ J  V _ /
1 1  4 6 g 4 7
Tetraam ines 1 1 ,4  6, and 4 7  were prepared by the Kellogg CS2 OO3 
m odification75,76  of the cyclization procedure of Richman and 
A tk in s 7 7  In this procedure, tosylamide 4 8, 5 1, or 5 4 was converted 
to the dicesium salt with 2  equivalents of CS2OO3 and cyclized with 
1 equivalent of the appropriate ditosylate (4 9, 5 2, or 4 9) in DMF at 
100°C. The cyclized product (5 0, 5 3, or 5 5) was detosylated using 
the conc. H2SO4 method.77.78 Workup with base followed by 
extraction with CHCI3 gave pure tetraamine 1 1, 4 6, or 4 7 (Scheme 
2 .1 5 ).
4 4
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Scheme 2.15
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Tetraam ine 4 7  and cyclen (1 1) were prepared on multigram scales 
by Fagan.79 Tetraamine 4 6  was prepared by the same method. 
Cyclam (8 ) was purchased from Strem Chemicals.
Weisman and H o ** reported the synthesis of 3 0, 5 6 , and 5 7 by the 
same route previously described to make bisaminal 1 6 .
4 5
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3 0 5 6  5 7
1. Synthesis of N .N ’-D im e th v l-1 .4 .8 .1 1-Tetraazab icvclo [6.6 .2J- 
pentadecane (2 5 ).
2 5
The synthesis of 2 5 was previously discussed in the 
background section of this chapter. The reaction sequence was 
repeated several times and similar yields were obtained.
2. Synthesis of N .N ’-D im e th v l-1 .4 .8 .1 1-Tetraazab icvc lo [6 .5 .2 ]- 
pentadecane (5 8 t .
Ho and Weisman first established that the reaction of 4 6  with
4 6
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aqueous glyoxal in M eCN gave two isomeric products, 5 6  and 5 9.44  
Compound 5 6  was formed along with a side product 5 9, which was 
separable by chromatography (Scheme 2.16). The detailed structure 
of 5 9 was not established by Ho and Weisman, who reported a 1H 
NMR and obtained a 92%  yield of the isomeric mixture (78%  of 5 6 , 
and 18% of 5 9).
Scheme 2.16
When the reaction was repeated on a larger scale a lower yield was 
obtained (50%  of 5 6 , and 5% of 5 9 after chromatography). The  
major component, 5 6 , exhibited severe dynamic exchange broadening 
(intermediate) in both the 1 H a n d l e  NMR spectrum at room 
temperature. Low tem perature 13C NMR experiments performed by 
W eism an4 with 5 6  showed that the dynamic process, which is an 
enantiomerization, can be frozen out below -55 °C (see experimental 
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distinct resonances in the m  NMR for the upfield methylene. The 13C 
NMR of 5 9 spectrum exhibits five upfield signals and one downfield 
signal (one methine). The upfield methylene in the 1HNMR  
(CH2CH2CH2) exhibits two distinct multiplets, each integrating to 
one hydrogen. Trans fused product 6  1 can be ruled out since the 
upfield methylene in the 1H NMR would exhibit a single multiplet due 
to symmetry (C2).
Trans fused product 6  0 can also be ruled out since the downfield 
methine region in the is c  NMR would exhibit two different 
resonances (C2). In the case of 5 9 the enantiomerization is very 
likely in fast exchange with respect to the NM R timescale. At room 
tem perature bisaminal 1 6  and its enantiomer are in slow dynamic 
exchange with respect to the 1 3C NMR timescale (90.56 MHz) as 
discussed earlier. However, 13C NMR spectra (20.25 MHz) indicate 
that 3 0 and its enantiomer are in fast dynamic exchange with
\JLI v _ y
6 0 6 1
4 8
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respect to the NMR timescale. To date, the characterization of 
compound 5 9 is incomplete (13C and 1H NMR only).
The regioselective methylation of 5 6  gave bis-quaternary salt 
6  2 in 87-92%  yield. NaBH4 reduction of 6  2 gave cross-bridged 
macrocycle 5 8  in 96%  yield (Scheme 2.17).
Scheme 2.17
Compound 6  2 was characterized by IR, elemental analysis, 1H, and 
1 3C NMR. Compound 5 8  was characterized by IR, high resolution 
mass spectrometry (H R M S), 1H, and 13CNMR.
3. Synthesis of N .N ’-D im ethv l-1 .4 .7 .10 -te traazab icvc lo [5 .5 .21- 
tetradecane (2 41.
The Rogersso synthesis of 2 4 was repeated several times with 





5 6 6 2 5 8
4 9
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Scheme 2.18
o  o
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3 1
4. Synthesis of N .N ’-Dimethvl Cross-bridaed Isocvclam  
The reaction of aqueous glyoxal with isocyclam (4 7) gave 
glyoxal adduct 5 7 in 50%  yield after chromatography (Scheme 2.19). 
Compound 5 7 had been synthesized previously and reported as an 
o i l .44 Upon scaleup of this procedure, 5 7  was isolated as a low 
melting solid.
5 0






V J CH3CN 50°C 1 h \ J U
4 7 5 7
A low tem perature 1 3C NMR spectrum of 5 7 (-72 °C) indicated no 
observable dynamic exchange broadening; only slight changes in 13C 
NMR chemical shift values were noted. In addition, no separate set 
of peaks corresponding to a minor conformer were noted at this 
temperature. This experiment showed that 5 7 is very biased toward 
a single conformation. Inversion of all four nitrogens of a single 
enantiom er of 57  would give a diastereomeric conformation.
Scheme 2 .20  shows the four possible isomers of 5 7 and describes 
their relationship to one another.
51
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Scheme 2.20










The pairs of 
conformers are:
A and B 
A' and B'
F a g a n ? 9 methylated isocyclam bisaminal 5 7  to give a mixture
of products ( 6  3 and 6  4) which were not separated. The reduction of
this mixture gave two poiyamines 6  5 and 6  6  (in ratio 9:1 in one run;
less selective in another) which could not be distinguished from one
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Scheme 2.21
The two products are identified as having either two ten membered  
rings (6  5) or having a nine and an eleven membered ring (6  6 ) in the 
macrobicyclic structure. The lack of selective methylation 
complicated the preparation of a single isomer (6  3 or 6  4), and 
attempts to purify this mixture by recrystallization were  
unsuccessful. Compound 5 7  was characterized by IR, elemental 
analysis, 1H, and 1 3C NMR.
B. Synthesis of Parent (N-H1 Cross-bridged Ligands
1. Synthesis of 1 .4 .8 .1 1-Tetraazabicvclo[6.6.21hexadecane
( 2 9 L
5 3
V J
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The scaleup synthesis of the sequence first established by 
R o g e rs s o a  (Scheme 2 .22) resulted in yield improvements for every 
step. The yield of 2 7  was significantly improved (-1 0 0 % ) by 
increasing the reaction time from one to three weeks.
Scheme 2.22
■ f t
xs PhCHgBr ^  xs NaBHg
CHaCN Ph 95% EtOH
1 week J 7  2Br- 1 week
(-100%)




H2. 10% Pd/C 
‘Ph ----------------> -
HOAc
NaOH work-up h n
Recryst. @ -78°C 
Et20
«w » 2
The precipitated product was isolated by filtration and no further 
purification was necessary. The NaBH4 reduction of 2 7 was 
repeated on a large scale (20 g of 2 7) to yield dibenzyl cross­
bridged cyclam (2 8 , 89%) which was >99%  pure according to 1H and 
13C NMR. Toluene was substituted for benzene in the extraction step. 
The removal of the benzyl groups was accomplished by catalytic
5 4
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hydrogenolysis (atmospheric pressure H2 ; 24 hours) using 10% Pd/C 
in glacial acetic acid. The hydrogenolysis was stopped after the 
theoretical amount of H2 (97%  of theoretical) was taken up. After 
workup with aqueous base and extraction with benzene, the crude 
product 2 9 (oil) was crystallized using the Rogers method to give 
85%  yield of pure 2 9. The low temperature recrystallization is not 
essential since the crude oil product is >99% pure by NMR. Compound 
2 7 was characterized by IR, elemental analysis, 1H, and 1 3CNMR.
2. Synthesis of 1 .4 .8 .1 1-Tetraazab icvclor6 .5.2lpentadecane
( 6 7 ^
Macrocyclic tetraam ine 6  7 was synthesized by the same basic 
procedure used to synthesize 2 9 (Scheme 2.23).
5 5
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Scheme 2.23
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The alkylation and reduction steps go cleanly in 99%  and 6 6 % yield 
respectively. However, the debenzylation step leading to 6  7 did not 
go cleanly and attempts to recrystallize the crude solid product 
from Et20  (-78 °C) failed. The hydrogenolysis was stopped after the 
theoretical amount of H2 (104%  of theoretical) was taken up. So, 
after workup with aq KOH and toluene extraction, the crude product 
( -8 5 -9 0 %  pure, 82%  crude yield) was dissolved in absolute ethanol 
and converted to the hydrochloride salt by addition of a few drops of 
12M HCI. The precipitated hydrochloride salt was isolated by
5 6
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filtration and washed with cold ethanol. It is not known at this 
point whether this solid is a mono-, di-, or trihydrochloride salt.
This salt was dissolved in aq KOH and the free amine was extracted 
into benzene. Concentration of the extracts gave an oil which was 
kugelrohr distilled. This material solidified upon standing and was 
shown to be pure 6  7  (47%  yield). Compound 6  8  was characterized by 
IR, elemental analysis, 1H, and 13C NMR. Compounds 6  9 and 6  7 were 
characterized by IR, high resolution mass spectrometry (HRM S), 1H, 
and 1 sc NMR.
3. Synthesis of 1 .4.7.10-TetraazabicvcloF5.5.21tetradecane
(7 2 1 ,
The synthesis of 7 2 proceeded as described in Scheme 2.24  
following the R o g e rs s o a  procedure. Rogers first established that 3  0 
could be carried on through the alkylation/reduction sequence in 
much the same way as 1 6 . His findings were based on 1H and 13C 
NMR spectra. A single attempt by Rogers to prepare 7 2 by 
hydrogenolysis of 7  1 gave a complex mixture of products.
5 7










2  days 
(92%)
/------\ 1) 1  atm. /  \
N h2, 10%Pd/C N NH
'  "  > -C O HOAcP h ^ ^ T l 2) KOH workup, HN ^ N '
" \  I Extract PhH \ ___ /
7 1  3) Distil!
'  1 (58%) 1 *
The alkylation/reduction sequence was repeated in order to fully 
characterize 7 0 and 7 1. The yields for these two steps were 
significantly improved during scaleup. Several attempts at 
hydrogenolysis of 7  1 using 10% Pd/C in glacial acetic acid gave 
(atm osphereic hfe; 24 hours) the desired product 7 2 but in only -8 5 %  
purity. The best yield of pure 7  2 was obtained by hydrogenolysis 
(atmospheric pressure) for 40 minutes using this procedure (2.3  
equivalents of H2 taken up). After workup with aq KOH and benzene 
extraction, the crude solid product was kugelrohr distilled. During 
the distillation, the collection bulb was changed such that two
5 8
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portions were collected (see experimental section). The first 
fraction was a solid which was sublimed to give pure 7 2 in 55%  
yield. 1H NMR of the second fraction (liquid) showed that it 
consisted of a mixture of the desired product and some partially 
debenzylated material. An attempt to obtain more product by 
hydrogenolysis of the second fraction and the distillation residue 
was unsuccessful.
The 1 3C NMR of the crude reaction mixture indicated an 
impurity with shifts consistent with monoacetylated cyclen 7 3 
(peak at 164.1 ppm present).
The 1H NMR of the crude product exhibited a sharp singlet at 1.74 
ppm, likewise consistent with an acetyl group. Alternatively, the 
crude solid product could be purified by conversion to the 
hydrochloride salt by the same method used to purify 6  7. Mixing a 
solution of 7 2 in ethanol with a few drops of 12M HCI resulted in 
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salt was recrystallized from acetonitrile containing a small amount 
of water. Subsequent workup with aqueous base, extraction with 
benzene, and removal of solvent gave solid product which was 
sublimed. The yield of pure product for this alternative procedure 
was 50%. Compound 7 0 was characterized by IR, elemental analysis, 
1H, and 1 3C NMR. Compounds 7  1 and 7 2 were characterized by IR, 
high resolution mass spectrometry (HRM S), 1H, and 1 3CNMR.
4. Attempted Preparation of Cross-bridged Isocvclam.









7 9 7 6 7 7
6 0
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There are several possible products of the reaction which are shown 
in Scheme 2.25. Stirring 5 7 in acetonitrile with an excess of 
bromide resulted in the crystallization of a solid product which was 
isolated by filtration. The 1 H a n d l e  NMR of this solid indicated a 
complex mixture, possibly monoalkylated (7 4, 7 5, 7  6 , 7 7) and 
dialkylated (7 8 , 7 9) products as suggested in Scheme 2.25. The  
reaction mixture was filtered after 5 days at room tem perature  
because darkening of the mixture was evident which could very well 
be attributed to the formation of decomposition products. This lack 
of selective benzylation was not unexpected given the results 
observed by Fagan?9 for methylation of 5 7.
C. Synthesis of N-Methvl Non-adiacent Cross-bridged Tetraam ines.
Significant progress was made towards the synthesis of N- 
methyl cross-bridged tetraam ines (Figure 2 .11 ).
Figure 2.11
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To date, no attempts have been made to functionalize secondary 
amine portion with a group containing heteroatoms. These cross­
bridged monofunctionalized tetraamines might best be described as 
“one-arm bandits” (Figure 2 .12) since the pendant arm can assist in 
coordination to a metal cation.
Figure 2.12
The initial attempts by Rogers to synthesize 2 7 by alkylation of 
bisaminal 1 6  with benzyl bromide in MeCN at room temperature 
showed that the reaction was slow, and heating of the mixture only 
resulted in the formation of decomposition products as discussed 
earlier (Schem e 2 .26).
(^JC H 2)2 
O ne-arm  bandits'
X  = OH,NH2 ,SH, 
COOH,CONH2 ,OMe.
6 2






1 6 2 7 8  0
In one example, small amounts of 8  0 were detected by 1 H and 1 3C 
NMR. This result suggested that it might be possible to prepare 8  0 
by proper choice of reaction time and solvent.
1. Synthesis of N -M eth v l-1 .4 .8 .1 1 -Tetraazab icvc lo f6 .6 .2 )- 
hexadecane (8  1).
Clean monoalkylation of bisaminal 1 6  was achieved by adding 
1 equivalent of benzyl bromide to a stirred solution of 1 6  in toluene 
The quaternary salt 8  0, crystallized due to its limited solubility in 
toluene. After one week, the product was collected by filtration in 
6 6 % yield; it needed no further purification (Scheme 2 .27).
6 3
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Scheme 2.27
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Compound 8  0 analyzed as a monohydrate. The remaining non- 
adjacent nitrogen was then be methylated by the sam e procedure 
used for the methylation of bisaminal 1 6  as discussed previously in 
this Chapter. Compound 8  2 (conceivably be a mixed salt) was 
characterized by IR and NMR spectroscopy. It was then reduced with 
excess NaBH4 in 95% EtOH for 1 week, although a similar yield was 
obtained in a separate run when the reaction was run for 2 days. The 
two step yield from 8  0 to 8  3 ranged from 64 %to 6 8 %.
Hydrogenolysis of 8  3 was carried out using 10% Pd/C (H2 , 1
6 4
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atmosphere) in glacial acetic acid. The hydrogenolysis was stopped 
after 21 hours (103%  of the theoretical uptake of H2 ). The workup 
with aq base followed by extraction with toluene gave pure 8  1. The 
1H NMR of 81 exhibited a singlet corresponding to the methyl group 
at 2.01 ppm. The 1H NMR chemical shift of the NH proton (4.75 ppm) 
of 81 is shifted considerably downfield (Figure 2 .1 3A), compared to 
acyclic secondary amines, suggesting strong intramolecular 
hydrogen bonding. A D2O exchange experiment confirmed the 
assignment of the downfield multiplet at 4 .75  ppm as the NH proton 
as shown in Figure 2 .13B. Compound 8  0 was characterized by IR, 
elem ental analysis, 1H, and 1 3C NMR. Compounds 8  3  and 8  1 were  
characterized by IR, high resolution mass spectrometry (HRM S), 1H, 
and 13C NMR.
6 5
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Figure 2.13A  





Figure 2.13B  
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2. Synthesis of N -M eth v l-1 .4 .7 .1 0 -T etraazab icvc lo [5 .5 .2 |- 
tetradecane (8  4).
The same sequence utilized to prepare 8 1 was applied to 
bisam inal 3 0 (Scheme 2.28).
Scheme 2.28
The monobenzylation of 3 0 proceeded in 84% yield. Subsequent 
methylation of 8  5 gave a mixed bis-quaternary bisaminal dihalide 
salt (8  6 ) which was pure according to 1 H a n d l e  NMR. The reduction 
of 8  6  with excess NaBHU successfully produced 8  7. The workup 
with aqueous base followed by benzene extraction gave 8  7, which 
was >98%  pure according to m  and 13C NMR spectra. The two step
r m n r \ nr\
1 eq. PhCH2Br
Y iU (84%) \JL7 Br'
Ph
3 0 8  5 8 6
xs NaBH4 J— \ p^ i i atm os.
H2, 10% Pd/C
r ~ \
95% EtOH I I 
2  days S v |
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yield (70% ) from 8  5 to 8  7 is reported since the mixed salt (8  6 ) was 
not completely characterized (IR , 1H, and 1 3C NMR only). Compound 
8  5 was characterized by IR, CHN analysis, 1H, and 1 3C NMR.
Compound 8  7  was characterized by IR, high resolution mass 
spectrometry (HRM S), 1H, and 1 3C NMR. The hydrogenolysis 
(atmospheric pressure) of 8  7 was carried out using 10% Pd/C in 
glacial acetic acid. The workup with base followed by toluene 
extraction gave impure 8  4. The product was about 75% pure (50%  
crude yield) after debenzylation and was not successfully purified 
by any of the following methods: 1 ) distillation of the crude product, 
2) recrystallization of the hydrochloride salt of 8  4. To date the 
characterization of 8  4  is incomplete (IR, 1H and 1 3C NMR).
Alternative hydrogenolysis conditions (10%  Pd/C, EtOH, 10% aq HCI) 
were attempted without success. A similar problem with the  
hydrogenolysis was encountered in the debenzylation step for the 
preparation of cross-bridged cyclen (7 2), but was eventually 
overcome. Perhaps fine tuning of the reaction conditions could 
provide cleaner 8  4. Choosing other solvents as well as catalysts 
might help solve this problem.
68
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D. Complexation (Li+ and Na+) and Protonation Competition 
Experim ents with Cross-Bridaed Tetraam ine Ligands
In this section the measurement of the relative basicities and 
the relative Li+ and Na+ complexation abilities of three cross­
bridged tetraam ines (2 4, 5 8 , and 2 5) are reported.
Conformational flexibility allows the four nitrogen lone pairs to 
converge on a cleft or cavity when protonated or complexed with a 
metal cation as shown in Figure 2.14.
2 4  5 8 2 5
6 9




Compound m n a
24 2 2 2
58 2 2 3
25 3 2 3
The variation in chelate ring sizes of 2 4, 5 8 , and 2  5 might be 
expected to lead to observable variations in metal ion selectivity 
and basicity. In most of these competition experiments the ligands 
and their complexes or conjugate acids were in slow exchange and 
the concentrations of all species were determined using either 1H or 
13 C {1H} NMR. Each component had a set of resonances corresponding 
to it, thus allowing the proportions to be determined by integration 
of specific i3 C a n d 1H resonances. A competition equilibrium 
constant (Krei) can be calculated since the concentrations of all the 
species can be measured in an appropriately designed competition
7 0
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experiment. Multiple integrations were run and enabled multiple 
calculations of Krei. Error analyses were performed in order to 
obtain confidence intervals for the calculated equilibrium constants. 
In all cases a dramatic change in the appearance of 1H an d i3C N M R  
spectra indicated conformational biasing as a result of metal ion 
complexation or protonation.
1. Theory for the Determination of Competition Equilibrium 
Constants.
The chemical shifts of the tetraamine ligands 2 5, 2 4, and 5 8  
and their NaBPh4 and LiC I04 complexes and CF3COOH salts in CD3CN 
were determined experimentally by iH a n d i3 C { iH }  NMR (Table 2.1A, 
2.1B, and 2.1C; 1 3C chemical shifts only). Tables 2.1A  and 2.1B were 
produced from the results obtained by Rogers.soa
71
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U C IO 4 
com plex  
(5)(0.10 M)
NaBPh4 
complex (6 ) 
(0 .07 M)
M onoprotonated  
(CF3 CO2 H) (5) 
(0 .16  M)
28.70 (C6 ,13) 24.59 (C6 ,13) 25.58 (C6,13) 25 .02  (C6 , 13)
43 .02  (CH3) 46.57 (CH3) 46 .52  (CH3) 43 .7 4  (CH3)
5 2 .2 9 5 1 .7 5 5 0 .7 9 5 2 .4 7
56 .81 5 2 .2 0 5 1 .2 7 5 3 .01
5 6 .9 6 5 8 .8 9 5 9 .0 7 5 4 .2 2
5 7 .7 7 5 8 .9 4 5 9 .1 4 5 8 .2 3
6 1 .6 7 5 9 .6 4 5 9 .21 5 8 .6 5
2 5
7 2
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(0 .17  M)
U C IO 4 





M onoprotonated  
(CF3OO2 H) (5) 
(0 .17 M)
44.51 (CHg) 46.95 (CH3) 4 6 .1 3 * (br, 
CH3)
44 .12  (QH3)
5 7 .2 5  
(Ci 3 , 14)
5 0 .7 9  
(C 13 ,14)
5 7 .5 4 * 48 .97  (C 1 3 , i 4)
5 7 .6 0 5 7 .4 5 61 .60* (br) 4 9 .8 3
6 0 .5 9 6 1 .6 2 5 3 .8 9
‘ These chemical shifts actually correspond to dynamically averaged  
peaks of complexed and uncomplexed ligand since the ligand was 
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Table 2.1C: 13C NMR Chemical Shifts for 58 and the Na+, Li+ and H+
Complexes (CD 3 CN).
Host (5) 
58 (0.11 M)






M onoprotonated  
(CF3C02 H) (5) 
(0.25 M)
28.01 (C6) 24.77 (C6) 25.49 (C6) 22 .82 (C6)
43 .62 (CH3) 45.43 (CH3) 45 .54  (CH3) 42 .40  (CH3)
44 .19 (CH3) 47.10 (Chb) 46 .89  (CH3) 44 .70  (CH3)
5 4 .1 5 5 1 .3 0 4 9 .5 3 4 7 .2 3
5 4 .4 9 52 .22* 5 0 .3 5 49 .30*
5 4 .8 6 5 6 .6 9 5 1 .8 9 5 2 .2 7
5 5 .2 2 5 7 .7 4 5 6 .9 3 5 2 .6 9
5 6 .1 0 5 7 .9 4 5 7 .8 5 5 3 .3 6
5 6 .7 9 5 8 .7 3 5 8 .3 0 5 3 .9 5
5 8 .0 6 5 9 .3 2 5 9 .5 4 56 .31
5 8 .2 5 5 9 .5 6 5 9 .7 3 5 9 .1 0
6 0 .5 4 6 0 .4 6 6 1 .3 3 5 9 .5 1
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The complexation reactions were performed using CD3CN as the 
solvent (CD3CN as ref. set at 1.93 ppm in the 1HNM R, CD3CN as ref. 
set at 1.30 ppm in the 13C NMR). In the examples where 13CNMR  
peaks were integrated, no account was made for differences in T-i 
values. Typically it is advisable to wait five T-i’s between pulses 
when using FT-NM R. To reduce error associated with differences in 
NOE corresponding carbons in the complex and uncomplexed ligand 
were integrated when possible.
a. Determination of Krei Where All Liaand and Complex 
Concentrations can be Measured.
In a competition where two ligands compete for a single guest 
metal cation, the following equilibrium expressions may be written, 
where [L t ]  and [L 2] are the concentrations of the two free ligands at 
equilibrium and [G+] is the guest concentration at equilibrium. G+ 
represents the metal cation or proton and X- represents the 
counterion. Equations 1 and 2 are separate equilibrium expressions 
describing the complexations of ligands 1 and 2  and Ksi and KS2 are 
associated nominal stability constants. Ion pairing effects are
7 5
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ignored in this treatment since they have been shown to be 
unimportant in CD3CN in related cases.so
G+ + L1 G L-|+ (Equation 1)
G+ + L2  ^  G L 2 + (Equation 2)
[ G L / ]  [G L 2 + ]
Ks1 = ---------------------  (Equation 3) =    (Equation 4)
[ L iH G +] [L 2] [G +]
[ G L ^ H l * ]
Krei = K s i/K s 2 =  --------------------  (Equation 5)
[ G L / H L j ]
The relative equilibrium constant Krei is the ratio of Ksi (Equation 3) 
and Ks2 (Equation 4) as shown in Equation 5. The competitions were 
performed with the molar ratio of the three components (GX:Li t : I - 2  t )  
being 1:1:1, where Li t and L2 T are defined as follows: Li t  = [L-i] + 
(G L ^ l,  and L2T = [L2] + [GL2+]. Li t and L2T also correspond to the 
concentrations of ligands Li and L2 in the absence of guest. The 
relative equilibrium constant Krei was used to calculate the free 
energy of competition for the reaction AG°rei-
AG °rei =  -RTInKrei (Equation 6 )
7 6
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In most examples repetitive integrations were performed allowing 
several calculations of Krei- Statistical analyses were performed on 
these results allowing the calculation of standard deviations, which 
were used to calculate confidence intervals (90% ). The above 
analysis depends on having neglegible free guest at equilibrium.
b. Determination of Kroi W hen the Relative Concentrations of 
Only One Ligand and its Complex Can Be Measured.
In a competition between two ligands for a guest where only 
the concentrations of one ligand and its complex are measurable due 
to overlapping 13C o M H  NMR resonances, the Krei was obtained. For a 
1:1:1 molar mixture of L -i, L2 , and GX the total concentration of 
free ligands at equilibrium ( [Li 1+ [L 2 ]) is equal to the concentration 
of complexes at equilibrium ([L i G+]+ [L 2 G+]). It is also true that 
[G L |+] = [L 2] and [G L2+] = [L i] | .  The substitution shown below
simplifies the equation used to calculate the competition 
equilibrium constant (Krei) to Equation 7.
7 7
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[ G L / ] [G L2+]
(Equation 3) k s2 = (Equation 4)
[M H G + ] [ l 2 H G +]
Since [L 2] = [ G L 1+] and [G L 2+] = [L ,]  then,
[G L , + ] 2 [G L 2 + ] 2
Krei =  ^ / K s  2 = or (Equation 7)
[L a i2
Equation 7 was used to determine Krei if the relative concentration 
of only one ligand and its complex were measured. Identifiable 1H 
and 1 3C resonances of a single ligand L i and the complex Li G+ were 
integrated to provide the fraction of each component. Repetitive 
integrations were performed enabling multiple calculations of Krei. 
Again, statistical analyses allowed the calculation of standard 
deviations and confidence intervals for Krei.
c. Determination of Relative Equilibrium Constant in a Li*/Na+  
C o m p etition .
In a competition where two ions compete for a single host the 
following equilibrium expressions may be written, where [L iL +] and 
[NaL+J are the concentrations of two complexes at equilibrium and
7 8
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[ L i - ]  and [N a +] are the concentrations of uncomplexed guest ions at 
equilibrium. Again, ion pairing effects are not accounted for. 
Equations 8  and 9 are separate equilibrium expressions describing 
the complexations of each ion. The relative equilibrium constant Krei 
is the ratio of Ku+ (Equation 10) and l<Na+ (Equation 11) as shown in 
Equation 12.
KNa+
L + Li------------ ^ --------  L iL  (Equation 8)
L + Na.  N aL* (Equation 9)
[L iL+] [NaL+]
KLi+ = (Equation 10) KNa+ = -------------------  (Equation 11)
[L ][L i+] [L ][N a+]
[L iL +] [ N a +]
K r e i  = KLi+/ K Na+=   (Equation 12)
[L i+] [N a L +]
For a 1:1:1 molar mixture of L i , sodium salt, and lithium salt, 
assuming no uncomplexed ligand is present, [ L iL +] = [ N a +] a n d [L i+]
= [N a L +]. The calculation of the relative equilibrium constant of Li+ 
relative to Na+ (Krei) is shown in equation 13.
7 9
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Since [Na*] = [LiL*] and [NaL*] = [Li*] then,
[L iL *]2
Krei = * W  Kn3+ = --------------  (Equation 13)
[NaL+] 2
2. Determination of pK3 Relative to that of DBU.
The pKa values of tetraamines 2 4, 5 8 , and 2  5 relative to that 
of d iazabicyclo[5.4.0]undec-7-ene (8  8 , DBU) in CD3CN were 
determined by monitoring 13C NMR chemical shift changes associated 
with DBU.
8 8
Several research groups have studied the acidity/basicity of 
various compounds in acetonitrile. Anslyn and coworkers have 
recently studied the pKa of several ketones in acetonitrile s i The 
pKa of the conjugate acid of 8  8  was determined in C D 3CN by Leffek 
( 2 3 . 9 ) . s o  and more recently by Schwesinger ( 2 4 . 3 ) 8 2
In CD3CN, the protonated and unprotonated forms of 8  are in 
fast dynamic exchange with respect to the 1 3C NMR timescale (90.56
8 0
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
MHz), resulting in one set of 13C NMR resonances. Thus, in the 
presence of 1/2 equivalent of trifluoroacetic acid (TFA) the 
chemical shift values observed for 8  8  actually represent the 
concentration weighted average chemical shift values for protonated  
and unprotonated 8  8 . Variation of 1 3C chemical shifts can therefore  
be used to measure the degree of protonation of 8  8 . The pKa (of 2  4,
5 8 , or 2 5) can be determined by mixing a 1:1:1 molar mixture of 
8  8 :TFA :tetraam ine 2 4, 5 8 , or 2 5 and measuring the 13CNMR  
chemical shift changes associated with 8  8 . In our example, a 
tetraam ine (2 4, 5 8 , or 2 5) and 8  8  compete for the proton of 
trifluoroacetic acid (TFA). Equation 14-16 shows how the pKa of 
the tetraam ine was calculated.
81
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5a =  Chemical shift of unprotonated DBU 
5b = Chemical shift of protonated DBU 
5C = Chemical shift of DBU in competition
|5 C - 5a |
----------------- X  100 =  % Protonated DBU (Equation 14)
I 5b - 5A |
/  (% Protonated DBU )2 \
-log (100-%  Protonated DBU)2 j  = PKeq (Equation 15)
pKa + pKgq = pKa. (Equation 16)
pKa = pKa of DBU
pKa. = Calculated pKg of ligand
The chemical shift values for the fully protonated and unprotonated 
8  8  were determined experimentally beforehand. The tetraamine was 
then added to a solution of monoprotonated 8  8  in CD3CN and the 1 3C 
NMR shift values of 8  8  were measured. There are nine different 1 3C 
resonances of 8  8  from which seven were selected since they 
exhibited large A5’s. Equation 16 was used to calculate the pKa of 
the tetraam ine relative to that of 8  8 .
3. Results of Liaand/Liaand Competitions with 2 4. 5 8 . and 2 5. 
a. 5 8  vs. 2 5 Competition for LiCIO^ in CDgCN.
8 2
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2 55 8
A competition between ligands 5 8  and 25 for Li+ (UCIO 4 ) was 
performed and quantified by 1H NMR. For this competition 1HNMR  
resonances corresponding to the free ligands and their complexes 
were clearly resolved. This allowed the integration of 
representative resonances from which the relative equilibrium  
constant could be determined. A 1H NMR spectrum of a 1:1 molar 
mixture of free 5 8  and 2 5 in which the peaks corresponding to the 
ligands are labelled is shown in Figure 2 .15A. The peak at 3.37 ppm 
(ddd) corresponds to ligand 5 8  and integrates to one proton. The 
peak at 3.73 ppm (td) corresponds to ligand 2 5 and integrates to two 
protons. The 1H NMR spectrum of the 1:1 mixture of 5 8  and 2 5 after 
the addition of one equivalent of UCIO 4 is shown in Figure 2.15B.
The peak at 1.83 ppm (dd) corresponds to one proton of the lithium 
complex of ligand 5 8 . The peak at 1.73 ppm (dm) corresponds to two 
protons of the lithium complex of ligand 2 5. These clearly resolved
8 3
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2 5 vs. 5 8  Competition for U C I0 4 in CD3CN 
Figure 2 .15A
1 :1 2 5:5 8
(No LiC I04)
2 5 5 8
Figure 2.15B
1 :1:1 2 5:5 8:L iC I04
2 5 5 8
r  1 11
>•* M 1.1 l.t 1.1 W ^ ^ l .1
■T " » T 1 1 "" > • 1 - 1l.t «.• i.t i.t i.t u
8 4
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1H NMR resonances corresponding to all four species were 
integrated. The total concentration of a single amine component 
(either 5 8  or 2 5) was 0.09 M. The signal to noise ratio for this 
example was 80:1. Multiple integrations of these resonances were 
performed and the results are shown in Table 2.2. The competition 
equilibrium constant (2 5 relative to 5 8 ) derived from this data is 
Krei = 1.22 ±  0.04. The free energy of competition (2 5 relative to 
5 8 ) was calculated AG° = -0 .12  ±  0 .004 kcal/mol at 25° C. It is 
clear that 2 5 is a slightly better complexer of Li+ than 5 8 .
bl 2 4 vs. 5 8  Competition for UCIOa in CDoCN.
2 4 5 8
Method of detection: 13C {1H}N M R
Signal:Noise = 50:1
Concentration of a single amine component: 0.27 M
Peak Integrated (uncomplexed 5 8 ): 27.92 ppm (C6)
8 5
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Peak Integrated (complexed 5 8 ): 24.80 ppm (C6 )
Multiple integrations of these resonances were performed and the 
results are shown in Table 2 .3 . The competition equilibrium 
constant (5 8  relative to 2 4) is Krei = 138 ±  11. The free energy of 
competition was calculated (5 8  relative to 2 4) AG° = -2.92 + 0.23  
kcal/mol at 25° C. It is clear that 5 8  is a better complexer of Li+ 
than 2 4.
cl 2 5 vs. 2 4 Competition for UC IO a in CDgCN.
Method of detection: 1HNM R  
Signal:Noise = 60:1
Total concentration of a single amine component: 0.21 M in both 
experim ents .
2 4 2 5
Peak Integrated (uncomplexed 2 5): 3 .73 ppm (td, 2H)
Peak Integrated (complexed 2 5): 1.73 ppm (dm, 2H)
86
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For this competition two separate NMR experiments were run with 
the same sample. Each result was analyzed separately to determine 
the reproducibility of the technique. The results of these 
competitions are shown in Tables 2.4 and 2.5. The calculated 
com petitive equilibrium constant (2 5 relative to 2 4) in each case 
was determined: experiment #1 Krei = 168 ±  8, experiment #2  Krei = 
186 ±  18. The free energy of competition was calculated in each 
case: experiment #1 AG °298 k = -3 .03 ±  0 .14 kcal/mol, experiment #2  
AG°298 k = -3 .09  ±  0 .27 kcal/mol. These results are within 
experim ental error, demonstrating that this technique (integration  
of corresponding is c  NMR peaks) gives reproducible results. It is 
clear that 2 5 is a better complexer of Li+ than 2 4.
8 7
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Table 2.2 a) 2 5 vs. 5 8  Competition for UCIOa in CDqCN.
Integra­
tion #




Krei (25 rel 
to 58). (Xj-X)2
1 2 .3 4 2 0 2 .5 2 3 5 3 .4 7 6 1 4 .3 7 3 9 1 .1 6 7 8 3 .0 9 1  e -3
2 2 .2 6 6 0 2 .3 9 2 1 3 .4 5 1 9 4 .4 2 5 1 1 .2 1 4 4 8.1 O e-5
3 2 .2 7 8 8 2 .3 9 8 7 3 .3 6 2 6 4 .3 9 2 1 1 .2 4 0 9 3 .0 5 2 e -4
4 2 .2 7 8 8 2 .3 5 7 8 3 .3 2 7 4 4 .3 9 4 6 1 .2 7 6 5 2 .8 1 7 e -3
5 2 .3 1 7 0 2 .3 7 0 5 3 .4 6 4 0 4 .3 8 9 9 1 .2 3 8 7 2 .3 3 8 e -4
6 2 .2 4 3 1 2 .3 6 4 6 3 .3 6 2 6 4 .3 8 7 6 1 .2 3 7 8 2 .0 6 7 e -4
7 2 .2 8 9 4 2 .3 2 6 6 3 .3 5 5 3 4 .3 9 5 1 1 .2 8 9 0 4 .2 9 7 e -3
8 2 .1 6 9 4 2 .3 2 3 2 3 .3 6 8 0 4 .3 8 7 6 1 .2 1 6 5 4 .7 7 8 e -5
9 2 .1 0 9 8 2 .4 1 0 0 3 .3 5 8 7 4 .3 9 4 5 1 .1 4 5 4 6 .0 8 2 e -3
1 0 2 .2 9 6 3 2 .3 9 4 5 3 .4 9 0 8 4 .4 0 3 7 1 .2 0 9 8 1 .8 5 5 e -4
1 1 2 .2 6 6 0 2 .3 9 3 6 3 .3 8 4 2 4 .3 8 2 9 1 .2261 7 .1 0 8 e -6
1 2 2 .2 8 5 0 2 .4 5 1 3 3 .3 6 2 6 4 .3 9 4 0 1 .2181 2 .8 3 4 e -5
‘ Integral values shown have been divided by 2 for the determination 
Of Krei-
S = Standard deviation
N = Number of replicate measurements
t = Student t values
|i = Confidence interval (90% )
X = Average (mean)
s = /  Si(Xj - X ?
V  N— 1
X =  1.22 
S = 0.04  
N = 12 
t = 1.80
Kre| = 1.22 ±  0.04  
(25 relative to 58)
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Table 2.3 b) 5 8  vs. 2 4 Competition for. LiCIOj. in CDsCN.
Integration # 5 8 5 8 * L i+ Krei (5 8 relative 
to 2 4) (X|-X)2
1 0 .2 1 5 8 2 .7 6 3 7 164 .01 6 5 0 .2 5
2 0 .2 8 2 3 2 .8 0 7 9 9 8 .9 3 1 5 6 6 .5 8
3 0 .2 1 1 9 2 .6 7 0 9 1 5 8 .8 7 4 1 4 .5 3
4 0 .2 3 1 7 2 .7 9 2 5 1 4 5 .2 6 4 5 .5 6
5 0 .2 2 3 6 2 .6 8 5 0 1 4 4 .1 9 3 2 .2 6
6 0 .2 2 5 4 2 .7 6 3 8 1 5 0 .3 5 1 4 0 .1 9
7 0 .2 3 3 3 2 .6 7 2 9 1 3 1 .2 6 5 2 .5 6
8 0 .2 3 3 3 2 .6 5 1 0 1 2 9 .1 2 8 8 .1 7
9 0 .2 3 3 8 2 .6 4 6 2 1 2 8 .6 5 9 7 .2 2
1 0 0 .2 2 7 3 2 .6 3 5 5 1 3 4 .4 4 1 6 .5 6
S = Standard deviation 
N = Number of replicate measurements 
t = Student t values 
p = Confidence interval (90% )
X  =  Average (mean)
N— 1 
f  =  > < ±
X = 138.51 
S = 18.57  
N = 10
S = /  W - X )2 t =  1.83
Kre( = 138 + 11 
t S/ . ___  (58 relative to 24)
8 9
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Table 2.4 c) 2 5 vs. 2 4 Competition for IJCIO a in CDqCN.
Trial #1
Integration # 2 5 2 5* Li+ Krei (2 5 relative 
to 2 4) (Xj-X)2
1 0.7435 9.7896 173.37 32.72
2 0.7932 9.8838 155.271 153.20
3 0.8055 9.9071 151.27 268.15
4 0.7767 9.9330 163.55 16.79
5 0.7727 9.9227 164.907 7.51
6 0.7560 9.8731 170.555 8.45
7 0.7757 9.8982 162.826 23.25
8 0.7690 9.9751 168.260 0.37
9 0.7386 9.8963 179.526 141.08
10 0.7534 9.8263 170.11 6.06
1 1 0.6744 9.9227 216.483 2384.84
1 2 0.8053 9.8388 149.269 337.80
13 0.8023 9.9572 154.028 185.51
S = Standard deviation 
N = Number of replicate measurements 
t = Student t values 
p = Confidence interval (90%)
X = Average (mean)
s = /  ij(Xj - X)2 
V  N— 1
»*=x ±  ts/rir
X = 167.6  
S = 17.24  
N = 13 
t = 1.78
Kre, = 168 + 8  
(25 relative to 24)
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Table 2.5 c) 2 5 vs. 2 4 Competition for LiCIQ/t in CDqCN.
Trial #2
Integration # 2 5 2 5- L i+ Krel (2 5 relative 
to 2 4) ( X i - X ) 2
1 0 .7 8 4 5 9 .8 3 5 2 1 5 7 .1 7 8 4 6 .3 4
2 0 .6 0 8 5 9 .8 8 6 8 2 6 3 .9 9 6 0 4 1 .3 3
3 0 .7 0 6 4 9 .8 7 8 1 1 9 5 .5 4 8 6 .0 8
4 0 .7 4 0 0 9 .7 7 4 7 1 7 4 .4 8 1 3 8 .9 3
5 0 .7 4 0 0 9 .9 0 5 4 1 7 9 .1 8 5 0 .2 7
6 0 .7 3 2 3 9 .7 9 7 1 1 7 8 .9 9 53 .01
7 0 .6 8 7 5 9 .9 0 1 2 2 0 7 .4 1 4 4 7 .0 7
8 0 .7 6 8 7 9 .8 3 8 6 1 6 3 .8 2 5 0 4 .0 5
9 0 .7 3 2 3 9 .9 2 5 0 1 8 3 .6 9 6 .6 4
1 0 0 .7 2 3 5 9 .7 9 6 3 1 8 3 .3 4 8 .5 9
1 1 0 .7 7 8 0 9 .8 8 1 6 1 6 1 .3 2 6 2 2 .1 5
S = Standard deviation 
N = Number of replicate measurements 
t = Student t values 
p = Confidence interval (90% )
X = Average (mean)
s = /  Wi - W
V  N— 1
“ =  ts/ r v
X = 186.3  
S = 29.67  
N = 11 
t =  1.81
Kre, = 186 ± 16 
(25 relative to 24)
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d) 5 8  vs. 2 5 Competition for Sodium.(NaBPfu)
. r " >
\ l  I ^N>M M "
'nu ^  U v
5 8  2 5
Method of detection: 13C {1H} NMR 
SignakNoise =  42:1
Concentration of a single amine component: 0 .16 M
Compound 5 8  Compound 2 5 
Peak Integrated (uncomplexed): 43 .63  ppm 42.96 ppm
Peak Integrated (sodium com plex):45 .53  ppm 50.68 ppm
In this case, multiple integrations were not performed in the 
determination of Krei. The carbons chosen were not necessarily 
corresponding, but were the only few which were clearly resolved 
and were not obscured due to overlap. The results of this 
competition are shown below. In this competition the equilibrium  
constant of 2 5 relative to 5 8  was calculated to be Krei =  12 ±  3. The 
calculated free energy of competition is AG° = -1 .47 + 0.37
9 2
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Kcal/mol. The error analysis was performed by measuring the 
intensities of the 13C NMR signals and reporting the result ±  the 
intensity of the noise.
[ N a » 2  5+] [ 5 8 ]  [2 .7 0 ]  [1 .0 0 ]
Kre| =  ------------------------------  =----------------------------  = 1 1 . 5
[ N a * 5 8 +] [ 2 5 ]  [0 .7 1 ]  [0 .3 3 ]
Krei = 1 2  ±  3
el 5 8  vs. 2 5 Competition for Protonation bv TFA
2 55 8
A competition between ligands 5 8  and 25 for a proton 
provided by CF3OO2 H (TFA) was performed and quantified by 13C 
{1HJNMR. For this competition carbon resonances corresponding to 
the free ligands and their complexes were clearly resolved. This 
allowed the integration of representative resonances from which the 
competition equilibrium constant could be determined. A 13CNMR
9 3
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spectrum of the 1:1 molar mixture of free 5 8  and 2 5 is shown in 
Figure 2 .16A. The 1H NMR spectrum of a 1:1 mixture of 5 8  and 2 5 
after the addition of one equivalent of TFA is shown in Figure 2 .16B. 
The peaks corresponding to the free ligands and their conjugate 
acids are labelled in an expansion of the upfield portion of the 13C 
{1H}NMR spectrum (Figure 2.16C). The peaks chosen for the 
integration were the upfield methylene peaks (CH 2 CH2CH2 ) which 
should have similar T 1 and NOE values. The peak at 28.00 ppm arises 
from ligand 5 8  and corresponds to one carbon. The peak at 28.57
ppm arises from ligand 2 5 and corresponds to two carbons. The peak
at 22.82 ppm arises from the conjugate acid of ligand 5 8  and 
corresponds to one carbon. The peak at 24.95 ppm arises from the 
conjugate acid of ligand 2 5 and corresponds to two carbons. These 
clearly resolved carbon resonances corresponding to all four species 
were integrated. The total concentration of a single amine 
component (either 5 8  or 2 5) was 0.15 M. The signal to noise ratio in 
this example was 50:1. Multiple integrations of these resonances 
were performed and the results of this study are shown in Table 2.6.
The calculated competition equilibrium constant (5 8  relative to 2 5)
was calculated to be K r e i = 21 ±  1 and the A p K a  (5 8 - 2  5) = 1.33 +
9 4
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5 8  vs. 2 5 Basicity 
Com petition in 
CD3CN
Figure 2.16A
1:1 2 5:5 8
(No CF3CO2 H)
A . i . r  « ^  ,  / r»rT‘-iiL>c^n m w
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0.06. From these results it is clear that 5 8  is a stronger base than 
2 5. The free energy of competition is AG° = -1.80 ±  0 .09 Kcal/mol. 
A TFA protonation competition between 2 5 and 2 4 (performed by 
Rogers), showed that 25 was a stronger base than 2 4. Given this 
result, 5 8  is the strongest base encountered so far in this series 
(5 8 , 2 5, and 2 4).
Table 2.6 el 5 8  vs. 2 5 Proton Competition
Integra­
tion #




1 2 .0 6 6 7 0 .4 2 2 7 0 .4 7 4 2 2 .0 8 8 9 2 1 .5 4 0 .3 6 3 8
2 1 .9 9 6 3 0 .4 1 4 8 0 .4 9 3 1 2 .1 4 6 5 2 0 .9 5 1 .5 3 7 e -4
3 1 .9 6 9 3 0 .4 3 4 3 0 .4 8 9 6 2 .1 5 2 4 1 9 .9 4 1 . 0 0 2
4 1 .9 8 5 3 0 .4 2 4 9 0 .4 9 4 5 2 .1 2 4 4 2 0 .0 7 0 .7 4 3 2
5 1 .9 7 6 3 0 .4 0 1 8 0 .5 0 8 5 2 . 1 2 1 2 2 0 . 2 0 0 .5 4 2 1
6 1 .9881 0 .4 2 2 3 0 .4 7 5 4 2 .1 0 8 2 2 0 . 8 8 3 .3 2 9 e -3
7 2 .0 9 1 9 0 .4 3 0 1 0 .4 8 0 3 2 .2 3 9 2 2 2 .6 7 3 .0 2 1 3
8 2 .0 2 2 5 0 .4 2 0 9 0 .4 9 0 1 2 .0 8 5 9 2 0 .4 5 0 .2 3 6 0
9 2 .0 0 0 3 .0 4 2 6 8 0 .4 8 9 6 2 .0 5 1 8 1 9 .6 4 1 .6 7 4 4
1 0 2 .0 1 4 1 0 .4 3 4 3 0 .4 8 4 6 2 .0 8 9 9 2 0 . 0 0 0 .8 7 7 6
1 1 1 .9 7 1 2 0 .4 3 7 2 0 .4 7 9 8 2 .0 8 0 2 2 0 .2 7 0 .4 4 7 6
1 2 2 .0 8 4 0 0 .4 0 9 2 0 .4 9 4 4 2 .3 0 6 9 2 3 .7 6 7 .9 8 6 3
1 3 2 . 0 1 0 0 0 .4 3 2 4 0 .4 9 6 7 2 .2 2 0 6 2 0 .7 8 0 .0 2 3 4
1 4 1 .9861 0 .4 1 6 3 0 .4 7 1 7 2 .1 7 0 5 2 1 .9 5 1 .0 3 1 6
9 6
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‘ Integral values shown have been divided by 2 for the determination 
of Krei-
S =  Standard deviation 
N = Number of replicate measurements 
t =  Student t values
H = Confidence interval (90% ) x  = 20 94
X = Average (mean) S = 1.175
N = 14
  t = 1.77
S = /  £i(Xj - X)
N— 1
t s
K r e i =  2 1  ±  1
(58 relative to 25)
ApKa = 1.32 ± 0.06
|i = X  ±  ! / r j j -  PKa = 26.2 (calc)






The above competitions were cases where two ligands compete 
for a single metal cation. In this case, Na+ (NaBPtu) and Li+ (UCIO4) 
ions competed for a single ligand (5 8 ). This experiment determined 
the selectivity of the ligand for Li+ over Na+. The method of data 
analysis was much simpler in this case and involved measuring the
9 7
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line intensities of the observed complexes. The chemical shifts of 
the upfield methylene carbon (C6 ) in the Na+ (25.49 ppm) and Li+ 
(22.82 ppm) complex differ by 2 .67  ppm and are easily resolved in 
the 1 3C NMR spectrum. The sodium complex in this case was not 
observed experimentally. An estimation of the relative equilibrium  
constant was obtained by assuming that the height of the peak  
corresponding to the sodium complex was less than or equal to the 
height of the noise. The signal to noise ratio for this example was 
270:1. The total concentration of tetraamine 5 8  was 0.21 M. The 
calculation of the lower limit Krei is shown below.
[ L i* .  5 8  l2 [ 1 3 0 ] 2
Krel *    -    -  3.5 X 104
[N a +* 5 8  ]2 [ 0 .4 8 ] 2
KrC| > 4 x 1 0 4
Other ion selectivity studies performed by Rogerssoc.d are presented 
alongside this result in Table 2.7.
9 8
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Table 2 .7
Li* Selectivity: LiCi04/NaBPh4 Competitions
LNa* + Li* ^    LU* + Na*
13C NMR-slow exchange; CD3CN 
Ligand K Na+
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5. Attempted Determination of the Relative pKg values of 5 8
Method of detection: 13C{1H}NM R  
SignahNoise =  130:1
Total concentration of a single amine component: 0.21 M 
In the competition between 5 8  and 8  8  for the proton of TFA only a
trace of the free ligand 5 8  was detectable by 13C NMR. When an 
additional equivalent of 8  8  was added to the 1 :1:1 mixture of 
5 8:8  8 :CF3 (X)2 H no significant change in the amount of observable 
free 5 8  occurred. As a result, this experiment did not allow the 
determination of the ApKa (5 8  relative to 8  8 ). The result only
qualitatively shows that 5 8  is a much stronger base and cannot be
accurately compared to 8  8 . However, the pKa of 5 8  was calculated  
relative to 2 5 which was previously determined relative to 8  8  by 
Rogers.49 The results of the competition between 5 8  and 2 5 for the
and 8  8 .
Y _ / ' 8 8
5 8
1 0 0
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proton of TFA was presented earlier.
IV . C o n c lu s io n s
A. N .N ’-Dimethvl Cross-bridaed Tetraam ines
An efficient approach to the synthesis of N ,N ’-dimethyl cross­
bridged cyclam (2 5) has been extended to the synthesis of two other 
N ,N ’-dimethyl cross-bridged tetraam ines (2 4 and 5 8 ) ,  which have 
been completely characterized.
All three ligands (2 4, 2 5, and 5 8 ) are strong Li+ binders and fast 
equilibrating proton sponges. Their protonation properties and metal 
ion selectivities, have been compared.
B. Synthesis of Parent Cross-bridaed Tetraam ines.
The previously established Rogerssoa procedure for the 
preparation of 2 9 was successfully scaled up to a multi-gram scale.
2 4 5 8 2 5
101
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The synthesis of two new cross-bridged tetraamines 6  7 and 7 2 was 
achieved by utilizing this procedure. Functionalization of 
macrocycle 2 9 with ligating groups containing heteroatoms will be 
discussed in Chapter III.
In the future, macrocycles 6  7 and 7 2 should be functionalized in the 
same manner as 2 9.
C. Synthesis of N-Methvl Cross-bridaed T e traam in es .
The attempts m ade at preparation of monofunctionalizable 
cross-bridged cyclam and cyclen has led to the full characterization  
of 8  1. The characterization of 8  7  was completed but the final 
debenzylation step to 8  4 does not go cleanly.
7 2 6  7 2 9
102
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8  7
\ /  \M NI ' 'C l
N NH
N NH | |
I— J  k k
8  4 8  1
Purification of tetraam ine 8  4 was problematic and will require 
further work. The synthesis of monofunctionalized derivatives of 
8  1 has yet to be attempted.
Monoalkylation of 5 6  will undoubtedly lead to two possible 






\ " J  B<" 
9 08  9
If a single isomer does not predominate in this, alkylation the two 
products may be separable by fractional recrystallization. If a 
single isomer can be isolated or prepared then the possibility of 
carrying it through the sequence described in this chapter may 
permit the synthesis of either 9 1 or 9 2 in the future.
103
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C U  c x ).N  N HN N
^ V _ J  \ _ /
9 1 9 2
The hydrolyses of 8  5 and 8  0 have yet to be attempted. This might 
provide a new method for the monoprotection of cyclam and cyclen 
as shown in Scheme 2.30.
Scheme 2.30
n r \ ^  i— \
N ^ N .  Ph aq K0H HN < " ^ P h
PhCHj L J
\ h ^ Br' extraction HN NHV JL/ Br__________ \_ I
8  5 9 3
Br’
8 0
HN N C  Ph
H r  ^
L J
N Nextraction HN NH
9 4
The successful preparation of 9 3 and 9 4 would permit 
functionalization of the remaining secondary amine groups to give 
selectively functionalized cyclams and cyclens.
1 0 4
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D. Complexation Studies
Both ligands 5 8  and 2 5 are strong complexers of Li+ compared 
to 2 4 as shown in Table 2.8. Ligands 2 4 and 5 8  are very selective 
for Li+ over Na+ as shown in Table 2.7. Ligand 2 5 is selective for Li+ 
over Na+ but is at least a factor of 100 less selective than ligands 
2 4 and 5 8 . Ligand 5 8  is unique in that it is a strong complexer of 
L i+ like 2 5, but is very selective for Li+ over Na+. The comparison of 
the basicity of these three ligands revealed 5 8  as the strongest 
base, which is consistent with the pKa determ inations of 
tetraam ines 2 4 and 2 5 relative to DBU done previously by Rogers.soa 
The results of pKa determinations and proton competitions 
performed by Rogerssoa are summarized in Tables 2 .9  and 2.10.
More attempts should be made to prepare pure 6  5 or 6  6 .
It would be useful to compare isomers 6  6  and 6  5 to ligands 2 4, 5 8 ,
6 6 6  5
1 0 5
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Table 2.8
Ligand/Ligand’ Competitions for Li* (CD3CN)
L + M L’* L* + ML*
Ligand Ligand1 k /K'
n






r xnl n ;  n
1.22 ± 0.04 H
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Table 2.9
Protonation Competition Experiments 
1:1:1 Base 1:Base 2:CF3COOH
(Monitored by 1H and 13C NMR)
Base 1 Base 2 Solvent Result
NIL I  \
;n n ' CD3CN 65% protonated 2 5
N N
u
pKa = 24.9* pKa = 24.2 (calc)
i ^ iN N 1 1 /
^  V / M  'Nv_y
pKa = 24.9* PKg = 26.2 (calc)
* calculated from DBU competition
CD3CN 19% protonated 2 5
107
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I/
Table 2.10
Protonation Competition Experiments 
1:1:1 Base 1:Base 2:CF3COOH
(Monitored by 1H and 13C NMR)

















pKa =  24.32 (lit)
\  /  
-N  N -
c d 3c n
c d 3c n
c d q 3
c d q 3
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Result




no free 2 5
no free 2 5
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and 2 5 with respect to metal ion selectivity and proton affinity.
It would be interesting to compare the metal selectivities and 
protonation properties of the cross-bridged ligands synthesized in 
this laboratory to the bridged tetraam ine macrocycles synthesized  
by C i a m p o l i n i 4 7 , 6 7 -7 2  and coworkers. The length of the chain used to 
bridge non-adjacent nitrogens should play a significant role in 
determ ining protonation characteristics and alkali metal 
selectiv ities.
1 0 9




Over the past twenty years the area of research including the 
synthesis of N-functionalized tetraam ine macrocycles has grown 
several fold. Several reviews have been written regarding this 
sub ject.83  The properties of functionalized macrocyclic polyamines 
are unique with respect to their ability to coordinate with metal 
ions. Unfunctionalized tetraam ine macrocycles can coordinate with 
metal ions but cannot fill the coordination sphere of a five- or six- 
coordinate transition m etal. N-functionalization of tetraam ine  
macrocycles with one or two pendant arms containing heteroatoms 
leads to macrocycles capable of completing the coordination spheres 
of such metal cations. Furthermore, functionalization allows the 
lipophilicity to be adjusted by changing the identity of the pendant 
arms. The incorporation of lipophilic groups may also allow metal 
cations to be transported across lipid membranes, as was discussed 
in Chapter I.
1 1 0
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Some functionalized macrocycles are useful for NMR  
im ag in g ,84 radiopharm aceutical applications,85 removal of toxic 
metal ions (lead, cadmium, chromium) from the environment,86 and 
for the treatment of heavy metal poisoning.87
II. Background
Before discussing the results obtained in this laboratory, the  
topic of functionalized tetraam ine macrocycles will be briefly 
reviewed. Some representative tetra-N-functionalized cyclams are 
shown in Figure 3.1.
1 1 1
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Figure 3.1
R =
R ^ f^ l  JK
C N N)  
< J ' R
^ A o a  k A NH2 'SH
'CN S' ^ Y '
,OMe ,0 H
O
K ^ y « H 2
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A. Functionalized Tetraam ine Macrocvcles
The synthesis of 9 5 by Stetter and F r a n k 8 8  jn 1976 was 
accomplished by the reaction of cyclam (8 ) with chioroacetic acid in 
the presence of aq NaOH. The inorganic salts were separated from 
the ligand using ion exchange chromatography to give 
tetrafunctionalized  m acrocycle 9 5 (Scheme 3.1).
Scheme 3.1
In a similar fashion Stetter and Frank tetrafunctionalized cyclen 
(1 1) to give macrocycle 9 6 (D O T A ) .8  8
The Cu(ll) complex of macrocycle 9 6 was synthesized by K a d e n 8 9  and
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NaOH(aq)
2)Dowex 2X8 H O 
ion exchange
n o  o
8
 
chromatography O 9 5
O
HO OH
O 9 6 o
1 1 3
an X-ray crystal structure indicated that two non-adjacent pendant 
acetato groups coordinate through axial positions with the metal ion 
lying within the macrocyclic cavity. The macrocyclic complex 
exhibited octahedral geometry. Much work has been done on the 
coordination chemistry of cyclam and cyclen tetraacetic acids (9 5 
and 9 6). For example, the protonation constants (pKa’s) have been 
determined by Ascenso90a and Clarke.90b Several other workers have 
studied other transition metal com plexes,9ia-t heavy metal 
com plexes,92a-t lanthanide complexes,93a-f,94 and alkaline earth 
metal com plexes,95 of 9 5 and 9 6. The terbium(lll) complex of 9 5 
was studied by Spirlet.9 6 The thorium complex of 9 6 was recently 
synthesized by Jaques.9 7
A high yield synthesis of tetraester 9  7 was accomplished by 
W eiss.97 Ligand 9 7 was prepared by stirring a suspension of cyclam 
(8 )  and methyl acrylate for two days at room temperature (Scheme 
3 .2 ).
1 1 4









 H r t2 4 h70% ^
9 7
The a,p-unsaturated esters in this example functioned as the 
solvent; excess was removed by reduced pressure distillation to give 
pure 9 7. Tetraester 9  7 was hydrolyzed to the tetraacid 9 8 (as the 
tetrahydrochloride) in 20%  aqueous HCI at room temperature 
(Scheme 3.3).
Scheme 3.3
3 M HCI 






Tetran itrile  derivative 9 9 was first reported by W ainw right,99  
who prepared 9 9 by the conjugate addition of 8 in neat acrylonitrile 
(Scheme 3.4).
1 1 5





Macrocycle 9 9 coordinated with Ni(ll) in a tetradentate fashion 
binding through the tertiary amine nitrogens alone. Reduction of 9 9 
with sodium and ethanol in toluene gave octaamine 1 0  0 (Scheme 
3 .5 ).
Scheme 3.5
Attempts to make the mononuclear Ni(ll) complex of 1 0 0 resulted in 
a complex where the four tertiary amine nitrogens and a single 
pendant amino group coordinated to the metal. The coordination 
chemistry of ligand 100 was reported by several different
Na°. EtOH 




Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
authors.ioo
Murase and coworkersioi reported the synthesis of tetrakis(2- 
aminoethyl) cyclam 1 0 1 .  The reaction of cyclam with tosylaziridine 
gave 1 0  2. The deprotection of 1 0 2  in 48%  HBr/HOAc (1:1) gave pure 
octaamine 1 0 1 as the octahydrobromide salt (Scheme 3.6).
Scheme 3.6
1 0 1




8 1 0 2
47% H
1 1 7
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Figure 3.2
h 2n n h 2
h 2n n h 2
Kida discovered by X-ray crystallography that octaam ine ligands 
1 0 3 -1  0 5  formed binuclear complexes with N i(ll). When ligand 1 0 1  
w as protonated103a or complexed with C u (ll)103b jt formed strong 
association complexes with anions. The Ni(ll)io3c and Cr(ll)i03d  
complexes of 1 0 1 have also been studied.
The synthesis of 1 0 6  was reported by Moorei04a and 
coworkers. The reaction of cyclam (8 ) and 2-(chlorom ethyl)pyridine  
proceeded in a mixture of dichloromethane and aq NaOH (Scheme 3.7). 
Scheme 3.7
r   ^ci^ n w r ^
HN NH ___________ ^  . S n  N ^
C HgCfe/NaOH^q) ^
1 1 8
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Attempts to make a mononuclear Cu(ll) complex were unsuccessful.
A dinuclear Cu(ll) complex was obtained according to the X-ray  
crystal structure. Each Cu(ll) center was five-coordinate involving 
two adjacent pyridyl nitrogens, two tertiary amine nitrogens from 
one of the NCH2 CH2 N bridges, and one bromide ion. Magnetic 
susceptibility m easurem ents showed that there is no interaction 
between the two copper centers. The coordination chemistry of 1 0 6 
with Ni(ll) has also been studied by other research groups.1 o4b,c
Hancock and coworkers1 os reported the tetra(2-hydroxyethyl) 
cyclam derivative (1 0  7), which was synthesized by the addition of 
excess ethylene oxide to a stirred solution of 8 in ethanol (Scheme 
3 .8 ).
Scheme 3.8
8 1 0 7
The ligand 1 0 7 more rapidly complexes Co(ll), and Ni(ll) as 
compared to tetram ethyl cyclam (4 1).
1 1 9
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n4 1
It was postulated that the hydroxyethyl groups of macrocycle 1 0  7  
increase the rate of incorporation of metal ions by providing initial 
points of attachment for the incoming metal. Other groups have 
studied metal complexation of ligand 1 0  7106  with Hg(ll) and Pb(ll). 
T h e  Eu(lll) and La(lll) complexes of tetra(2-hydroxyethyl)cyclen  
(1 0 8) have been studied by Morrow.io7a Lincoln and c o w o r k e r s 1 °7b 
have studied the Li+, Na+, K+, and Cs+ complexes of ligand 1 0  8.
Several derivatives of 8 and other tetraamines were reported 
by T s u k u b e .1 08  The ligands were prepared directly from the 
tetraam ines and N .N ’-diethylchloroacetam ide, ethyl chloroacetate, 
chloroacetonitrile, phenacyl bromide, or benzoyl chloride to give
1 0 8
1 2 0
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tetrafunctionalized ligands 1 0 9 ,1  1 0, and 111 as shown in Figure 
3.3.
Figure 3.3
Pyrazole groups were attached to 8 by a method developed by 
Malachowki.109 Treatment of a solution of 8 in acetonitrile with 1- 
(hydroxym ethy!)-3,5-dim ethylpyrazole gave crude 1 1 2 ,  which was 
purified by conversion to the copper (II) complex, followed by 
treatment with EDTA to yield free ligand 1 1 2. Ligand 1 1 2  was 
prepared as shown in Scheme 3.9.
Scheme 3.9
CH2CON(C2H5);
C H 2 C 0 0 C 2 H 5
CH2CN
CH2COC6H5
c o c 6h5
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This sam e functional group was attached to 1 1 by DiVarini 10,111 and 
coworkers.
The homologous ligand 1 1 3  was synthesized by a different 
route by M a la c h o w k P 0 9  as shown in Scheme 3.10.
Scheme 3.10
o hHO.
rN / V %
N -N
OHHO
Compounds 1 1 2  and 1 1 3  formed stable dinuclear complexes with 
C u(ll), both of which catalyzed the oxidation of catechol to quinone. 
The initial rate of oxidation was much faster with the Cu(ll) 
complex of 1 1 2, demonstrating the influence of arm length on 
ca ta ly tic  activity.
The synthesis of two cyclam-based chelators containing 
hydroxamate and acetylacetone pendant arms have recently been 
reported by Koshti and coworkers.112 The ligands 1 1 4  and 1 1 5  were 
designed for the potential binding of plutonium (IV ) through the 
pendant arms.
122
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HONH,
^ ----- (CH2)3 ^  ^
HNOH






Lehn and Z ie s s e ln 3  reported the synthesis of a variety of 2 ,2 ’- 
bipyridyl functionalized ligands derived from acyclic and 
macrocyclic polyamines. For example, cyclam (8 ) was 
tetrafunctionalized by re a c tio n . with 6 -(b ro m o m e th y l)-2 ,2 ’- 
bipyridine in a  mixture of MeOH and aqueous NaOH to give 1 1 6  
(Scheme 3.11).
1 2 3










T s u k u b e ii^  and coworkers reported the synthesis of a 
tetrafunctionalized cyclam bearing furan moieties (1 1 7). The ligand 
was prepared by the addition of furoyl chloride to a solution of 
cyclam (8 ) and pyridine in TH F (Scheme 3.12).
Schem e 3.12
30%
The resulting amide was reduced with borane in THF, affording 1 1 7  
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experim ents, 1 1 7 discriminated between NH4+ ion and K+ 
effectively.
The functionalization of cyclen with alkylphosphinic and 
arylphosphinic substituents was reported by P arker.n s  The ligands 
were synthesized by condensation of cyclen (1 1) with 
paraformaldahyde in TH F  to yield an interm ediate hydroxymethyl 
species 1 1 8  (not isolated) which was reacted with various 
dialkoxyphosphines (1 1 9) to give polymethylenephosphinate esters 
( 1 2  0) (Scheme 3.13).
Scheme 3.13
IHr ~ \  H
HN NH 1) (CH20 )2







CR’. y—-N N>—. R’
r  o -p  \ ---- 1 P—O R
N N— .
/  \ ___/  \\ '----- 1 tOH







Me Et 29a /  50%
3^P xOR  
1 1 9
Ph Me 29b / 37%
Bu Me 29c / 46%
The ligands were designed to complex 9 0Y3+andGd3+ which are 
metal ions commonly used for MR! (NM R) contrast agents. Some of
1 2 5
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the ligands described in this paper are bifunctional and can 
conceivably be attached to antibodies through a remote protected 
amine moiety. The functionalization of c y c l a m i i 6  and cyclenii?  with 
coordinating arms containing phosphorus has been examined by 
several research groups.
P a rk e d  18 and coworkers studied the complexation of 1 2 1 with 
L i+,N a +, andC a2 + by spectroscopic methods (13C NMR, IR, fast atom 
bombardment mass spectrometry (FABMS). The compound was 
synthesized by the alkylation of cyclen (1 1) with N ,N ’-diethyl 
bromoacetamide in ethanol using CS2OO3 as the base (Scheme 3.14). 
Scheme 3.14
Ligand 1 2  1 forms a very strong complex with Ca2 + in water. 
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B. Functionalization of Aza-lariat Ether 1 2  2.
Diazacrown ether 1 2  2 is a related macrocycle that can be 
functionalized at nitrogen with pendant arm s in much the same way 
as cyclam. Functionalization enables further coordination by 
pendant-arm donor groups when a metal ion is complexed in the 
macrocyclic cavity as discussed in Chapter I. Tsu kube ii9  has 
synthesized macrocycle 1 2 3 by reaction of 1 2 2 with 2- 
thiophenecarbonyl chloride in TH F (Schem e 3.15).
Scheme 3.15
The resulting amide was reduced with borane in TH F  and following 
the standard workup gave 1 2  3.
D e -F e n i2 0  and coworkers synthesized lariat ethers 1 2 4  and 
1 2 5 by treating an acetonitrile solution of 1 2 2 with 2-chloroethyl 
alkyl sulfides or 2-chloroethyl allyl sulfide (Schem e 3 .16).
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O
pyridine
1 22 4) NaOH60% 1 2 3
1 2 7
Scheme 3.16
/ s  c i - ^ SR / . n / v
m T °  tm  Na2° ° 3 ,  R S . ,S RHN NH  *► N N ^
0 \_ j0  CH3CN 0 \J \>
12  2 R = alkyl 1 2 4
R = allyl 1 2  5
Anhydrous sodium carbonate was used to scavenge the HCI formed 
the reaction. Monofunctionalized lariat ethers 1 2  6 and 1 2  7 were 
also prepared by this method.
RS,
N NH
R = alkyl 1 2  6  
R = allyl 1 2  7
The high pressure addition of 2-vinylpyridine to 1 2 2 was 
accomplished by N o lte is i, who prepared macrocycle 1 2 8  (Scheme 
3 .1 7 ).
1 2 8





Compound 1 2 8  forms a 1 :2  coordination complex with Cu(ll) in 
which both Cu(ll) ions are five-coordinate. Each Cu(ll) ion is 
coordinated by two nitrogen atoms (one pyridyl and one macrocyclic 
nitrogen) and two oxygen atoms from the macrocycle. The fifth 
coordination site is a hydroxo group which bridges the two Cu(ll) 
centers. The redox behavior of the Cu(ll) complex of 1 2 8  was 
studied by cyclic voltametry in acetonitrile. The reduction of this 
complex was irreversible due to possible ligand oxidation or 
decomposition.
The preceding overview of the different types of functional 
groups attached to the tetraamines cyclam (8 ), cyclen (1 1 ), and 
diaza crown ether 1 2 2 is not comprehensive. Some of the examples 
presented are representative of the successful attempts made at 
functionalization of ethylene cross-bridged cyclam (2 9). The
1 2 9
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
overview also points out some examples of functionalization which 
may hold future potential.
The procedure used to synthesize cross-bridged cyclam 2 9 
was successfully scaled up as discussed in Chapter II to give 
multigram quantities of product. This enabled several attempts at 
functionalization since the secondary amine portion of 2 9 is well 
suited for many of the arming reactions mentioned in the background 
section of this Chapter. Functionalization resulted in tetraam ines  
containing ligating arms useful for coordination. Some of these  
functionalized polyamines have ionizable groups in which metal ion 
coordination might be controlled by pH adjustment.
111. R e s u lts  and  D iscu ss io n
A. Synthesis of Diester 1 2  9 and Related Derivatives.
Cross-bridged cyclam 2 9 can be alkylated effectively with 
ethylbrom oacetate in acetonitrile using a procedure similar to that 
of P a r k e r i 22  and coworkers (Scheme 3.18).
1 3 0




Na2C 0 3, CH3CN, 50° C
o
2) aq NaOH, 0° C
3) CHCI3 extraction, 0° C
(85-100%)
2  9 1 2 9
1H NMR evidence strongly suggested that the crude product 1 2 9  
(after step 1 ) was monoprotonated and as a result was not amenable  
to chromatography. The yellow oil that resulted from evaporation of 
acetonitrile was dissolved in aq KOH and extracted with CHCI3 . All
of the reagents used for this extraction were cooled to 0°C  
immediately prior to use and all manipulations were performed 
quickly so as to prevent possible hydrolysis of the ester groups. The
product was >99%  pure (Yield 85-100% ) and was characterized by IR, 
high resolution mass spectrometry (HRM S), 1H, and 13C NMR.
Cross-bridged cyclen (7 2 ) was functionalized using this 
procedure to give 1 3 0  in 69%  yield. Compound 1 3  0  was not fully 
characterized, but the 1H a n d i3 C  NMR indicate it was >98%  pure. The  
IR and high resolution mass spectra (HRMS) still need to be obtained 
to fully characterize 1 3  0 .
131
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1. Diester Hydrolysis Leading to Diacid 1 3  1.
Diester 1 2  9 was hydrolyzed in 6 N HCI to give the acid derivative 
131 (Schem e 3.19).
Scheme 3 .19
Compound 1 2  9 was very slow to hydrolyze and required heating at 
100°C for 48 hours. The 6 N HCI was removed under reduced pressure 
to give a solid. Diacid 1 3 1  was characterized by IR, 1HN M R , 13C 
NM R, and elemental analysis as the hygroscopic tetrahydrochloride 
hydrate (1 .5  H20 ). 1H NMR evidence indicated the hydrolysis was 
incomplete after 24 hours at 100°C.




1 2 9 4HCM.5H20
1 3 1
1 3 2
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2. Attempted Aminolvsis of Diester 1 2  9.
Several attempts to prepare the diamide 1 3  2 from diester 1 2 9 
failed. The procedure for aminolysis is quite general and required 
refluxing the ester in conc. aqueous NH3.
1 3 2
The first attempt at the preparation of diamide 1 3  2 involved 
heating 1 2 9  in conc. aq NH3 for 3 hours at 80°C. The isolated 
product was actually 1 3 1 ,  which was obtained in 51% yield. When  
the reaction was run in a pressure tube (3 hours, 100°C) no change in 
the outcome of the reaction was observed and 1 3 1  was isolated in 
62%  yield. 1 H and 13C NMR indicated the isolated product was very 
pure, however it was not 1 3  2. The low and high resolution mass 
spectra (HRM S) indicated a molecular ion at 343 (M+1, Cl, NH3). This 
molecular ion is consistent with 4,11-b is-(carboxym ethyl)- 
1 ,4 ,8 ,1 1-te traazab icyc lo [6 .6 .2 ]hexadecane  ( 1 3 1 )  as shown in
1 3 3
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Scheme 3.20.
Scheme 3.20




P tn ' . pressure tube
Eto 1 1 (62%) HO
1 2 9  1 3 1
3 . Reduction of Diester 1 2  9 with NaBHjL.
Diester 1 2  9 was reduced with excess NaBH4 in 95%  EtOH (4 hours at 




OEt O H1) NaBH4, 95% EtOH '
|| L L J 100°C 4 h
A  .N  N 2) 3M HCI
E t0  J 3) NaOH, PhCH3 H 0
4) Distill (22%)
1 2 9  1 3 3
Decomposition of excess NaBH4 by slow addition of 3M HCI followed 
by workup with aq KOH and extraction with toluene gave pure 
product. The modest yield of 1 3 3 (22% ) might be improved by 
employing a stronger reducing agent such as LiAIH4. Compound 1 3 3
c
1 3 4
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was characterized by IR, high resolution mass spectrometry (HRM S), 
1H, and 1 3C NMR. The 360 MHz 1H NMR spectrum of 1 3 3 in CDCI3 is 
shown in Figure 3.4A. A D2O exchange experiment identified the 
hydroxyl protons at 2 .85 -3 .00  ppm, which were overlapped with a 
portion of the AA’XX’ of the NCH2 CH2N bridge (Figure 3.4B). The  
multiplet at 3 .5  ppm changes drastically upon addition of D2 O. This 
change in CffeOH fine structure is due to the loss of coupling after 
D2O exchange.
B. Conjugate Additions with 2 9.
Conjugate additions of cross-bridged cyclam to acrylonitrile 
and methyl acrylate have resulted in diester 1 3  4 (Scheme 3.22) and 
dinitrile 1 3 5  (Scheme 3.24) respectively.
1. Conjugate Addition using Methvl Acrylate.
A general procedure for the addition of 8  to methyl acrylate 
was demonstrated previously by Weiss.98 in our example, 2 9 was 
stirred for 24 hours with excess methyl acrylate (Scheme 3.22).
1 3 5





5 . 0 2 . 5 2.03 . 04 . 5
Figure 3.4B
10
2 . 55 . 0 3 . 5
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Scheme 3.22
r v j l
2 9 1 3 4
Excess methyl acrylate was removed under reduced pressure to give 
1 3 4 as an oil. The crude product was >96% pure and used in the 
subsequent hydrolysis without purification. Compound 1 3  4 was 
characterized by IR, high resolution mass spectrometry (HRM S), 1H, 
and 1 3C NMR. In one attempt to distill the product (80°C, 0 .04 mmHg) 
elimination of the pendant arms was observed. A 1H NMR of the 
distillate indicated 2 9, 134 and a one-armed version of 1 3 4  were 
present.
The hydrolysis of 1 3 4 was first attempted by heating in 3M aq 
HCI for 24 hours at 100°C. The 3M HCI was removed under reduced 
pressure to give solid product (1 3 6 ) which was approximately 80%  
pure as indicated by 1 3C NMR. However, lowering the temperature (4 
days, room temperature) increased the purity of 1 3 6  to >90%  
(Scheme 3.23).
1 3 7
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Scheme 3.23
1 3 4
20 % HCI 




It is very possible that the loss of one arm occurs, which is 
consistent with the impurities observed in the 13C NMR spectrum. It 
may be that hydrolysis was complete after only a few hours at room 
temperature. The characterization of compound 1 3 6  is incomplete 
at this point OH and 1 3C NMR only).
2. Conjugate Addition using Acrvlonitrile.
A procedure for the Conjugate addition of acrylonitrile to 
amines was reported by Miilhaupt and W o rle r i23 , who utilized an 
addition/reduction sequence for dendrimer synthesis. Compound 2 9 
was stirred for 24  hours with a large excess of acrylonitrile 
(Scheme 3.24).
1 3 8
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Scheme 3.24
(79%)




2 9 1 3 5
After the excess acrylonitrile was removed under reduced pressure, 
the residue was dissolved in toluene, dried over Na2 8 0 4 , and filtered. 
The solvent was removed to give an oil which crystallized when 
stored at 10°C for 14 hours. The solidified product (1 3  5) was >98%  
pure (79-91%  yield) and characterized by IR, elemental analysis, 1H, 
and 13C NMR.
Hydrogenolysis of 1 3 5  in 95%  EtOH (1.4 M in NaOH) with W -2  
Raney Ni at moderate pressure (32 psi H2) gave a mixture of products 
(Scheme 3.25).
1 3 9





95% EtOH, NaOH H^N 
2) Fitter, remove







Investigation of the is c  NMR spectrum of the distilled product 
revealed 24  major peaks. This is consistent with the formation of 
the desired product 1 3  7  and one-armed macrocycle 1 3  8 . In addition 
to the 24 major peaks in the NMR spectrum, several small peaks 
were also observed. The mass spectrum (El, CH4 ) indicated two 
molecular ions at 283 and 240, corresponding to the two products 
1 3 7  and 1 3 8  respectively. The relative proportions ( -1 :1 ) of the 
two products were estimated on the basis of the 1 3C NMR line 
intensities of the macrocyclic upfield m ethylene carbon (CHCHCH2 ) 
peaks. It is clear that elimination was competing with reduction.
The basicity of 1 3 5 and related tetraam ines strongly suggested that
1 4 0
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even in very strong base (1.4 M NaOH in 95% EtOH) 1 3 5  is partially 
monoprotonated and as a result, subsequent elimination of one of the 
pendant arms occurs. Utilization of sodium in ethanol has been 
successful for the reduction of similar nitriles as demonstrated by 
W ain w rig h t.99  However, this procedure has yet to be attempted with 
nitrile 1 3  5.
Another approach toward the preparation of 1 3 7  might involve 
the DCC coupling of 2 9  with Boc protected p-alanine (Scheme 3.26). 
Scheme 3.26
1) Boc (J-Alanine, 
DCC ►
2) BH3
3) aq HCI, NaOH H2N
4) CHCI3 extraction
N N
Successful coupling would lead to an amide which could be reduced 
with borane to give hexamine 1 3  7 after workup as shown above.
C. Synthesis of 2-M ethoxvethvl-arm ed 2 9.
Acylation of 2 9 with methoxyacetyl chloride (Schem e 3.27) 
was achieved following a procedure analogous to one used by
141
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1) 2eq Cl 
THF, Et3N
O
2 9 (95%) 1 3 9
Both the 1 H a n d  ">30 NMR spectra of chromatographed material are 
complex. W e believe that the spectral complexity is due to the fact 
that 1 3  9 is a  mixture of conformational isomers which interconvert 
on the NMR time scale by slow amide bond rotation at room 
temperature. This effect is well known and has been previously 
reported.i25a-d T h e is c  NMR spectra can be interpreted in terms of 
three conformational isomers which are interconverted by slow 
amide bond rotation. The four resonances observed in the upfield 
portion of the 1 3C NMR spectrum (CH2 CH2 CH2 ) are consistent with 
three conformational isomers, two C2 symmetric rotamers and one 
C! rotamer. Compound 1 3  9 was characterized by IR, high resolution
1 4 2
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mass spectrometry (HRM S), 1H, and 1 3C NMR.
Several attempts at LiAIH4 reduction of 1 3 9 resulted in 
reductive cleavage of armed material and recovery of 2  9. In one 
example an old batch of LiAIH4 was used and resulted in product 
which was a mixture (-1 :1 ) of 2  9 and monomethoxyethyl-armed  
cyclam. W hen the reaction was repeated with fresh LiAIH4 pure 2 9 
was recovered quantitatively from the reaction mixture. Diamide 
1 3  9 was successfully reduced with B IV T H F  using a procedure 
similar to that of V a c h o n i2 4 b  to give 2-methoxyethyl armed cyclam 
1 4 0  in 60%  crude yield (Scheme 3.28). This reagent (B IV T H F ) was 
originally shown by B r o w n ie  to be quite effective for the reduction 
of tertiary amides under mild conditions.
Scheme 3.28
Purification was achieved by the conversion of crude 1 4 0 to the
1) BH/THF
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monoprotonated tetraphenylborate salt 1 4 1  (Scheme 3.29). 
Schem e 3.29
+ N:














W hen 1 4  0 was dissolved in M eOH an equilibrium is established as 
shown in the top of Scheme 3.29. A solution of NaBPh4 in MeOH was 
added to this solution and resulted in the precipitation of a solid 
product, which is very likely 1 4 1 .  This solid ( 1 4 1 )  was isolated by 
filtration, dissolved in aq KOH and extracted with toluene. This 
resulted in 56%  recovery of pure 1 4  0 giving an overall yield of 34%
1 4 4
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
from 1 3  9. Compound 1 4 0  was characterized by IR, elemental 
analysis, 1H, and 13C NMR.
D. Attempted Preparation of Liaand 1 4  2.
Some progress was made toward the synthesis of ligand 1 4  2.
W ie g h ard ti2 6  has previously functionalized cyclic triamines with 
this sam e functional group.
The starting material necessary for our approach to the 
synthesis 1 4  2 was protected alkylating agent 1 4  4, which was 
obtained by Karlin’s m e t h o d .1 2 7  The acylation of o-cresol 1 4 5  with 
acetic anhydride/pyridine (1:1 v/v) gave 1 4 6  (Scheme 3.30) in 81%  
y ie ld .
o x
X = Na 1 4 2
x =  H 1 4 3
OX
1 4 5
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Scheme 3.30
CH2Br
CH3 c h 3
,0  H Ac20 ,OAc NBS, (PhCOO)2
Pyridine
81%
80°C, CCI4 1 4  4 CHBr2
1 4 5 1 4 6
1 4 7
The bromination of 2-methylphenyl acetate 1 4 6  with NBS in CCI4, 
however, did not go as cleanly as described by Karlini27 (Scheme 
3.30). The crude product was distilled to give a clear liquid which 
w as a mixture of monobrominated (1 4 4) and dibrominated products 
( 1 4  7) (4 :1 -determined by 1H NMR integration). Compounds 1 4 4  and 
1 4 7  were separated by fractional distillation. The total yield of 
products was 70% (56% of 1 4  4, and 14% of 1 4 7) which was much 
better than that reported by Karlin who obtained a 33%  yield of 1 4  4.
Several attempts to alkylate bisaminal 1 6  with 1 4  4 failed. In 
the first attempt 1 6  (0.015 M) and 1 4 4  (0 .03  M) were combined in 
stoichiometric proportions in CH 3CN. After one week at room 
tem perature, the alkylation had proceeded very little as indicated by 
1H NM R of the crude reaction mixture. A small amount (1-2% ) of
1 4 6
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very pure 1 4  8  crystallized out of an NMR sample (CDCI3) containing  
an aliquot of this crude mixture. The next several alkylation 
attempts w ere performed by stirring an excess of 1 4 4 with 1 6  in 
DM SO at various temperatures (room temperature to 100°C). In 
every case a small amount of the desired product 1 4 8  was formed, 
as indicated by 1 H a n d l e  NMR. Heating of the reaction mixture 
usually accelerated the formation of decomposition products, 
further complicating isolation of pure 1 4 8 . Compound 1 6  (0.037 M) 
cleanly dialkylated in MeCN at room temperature after 3 weeks. In 
the presence of a large excess of alkylating agent (1 4 4, 0 .377 M) the 
desired product (1 4 8 ) crystallized and was isolated by filtration 
(Schem e 3 .31).
Scheme 3.31
Several washings with Et2 0  and CH2C I2 were necessary to remove 
excess 1 4  4. Elemental analysis identified 1 4 8  as the monohydrate
1 4 7




1 6 1 4 8
(71-74%  yield). The IR, 1H, a n d i3 C  NMR were consistent with the 
formation of 1 4  8 .
A few attempts were made to reduce 1 4  8  with NaBH4 in 95%  
EtOH (Scheme 3.32) using the same procedure to prepare cross­
bridged dibenzyl cyclam 28 (described in Chapter II).
Scheme 3.32
T h e 1H NMR spectrum of the reduced product was complex, indicative 
of a mixture. Cross-bridged cyclam derivatives usually have a 
distinct downfield multiplet in the range of 3 .50 -4 .00  ppm in the 1H 
NMR spectrum. The 1H NMR of the crude product exhibited a 
characteristic multiplet at 4 .50 ppm. A 1H NMR of this reduced 
material was very similar to the 1H NMR spectra of other related
R =
h
1) xs NaBH4 
n. 95% EtOH 
| 5 days
2Br 2) HCI
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functionalized cross-bridged cyclam ligands. Acetyl groups were  
cleaved in the reduction step (the peak at 172 .97 was absent in the 
1 3C NMR of the reduced product). The mass spectrum (El, CH4) 
identified two molecular ions at 332 and 438 . These two molecular 
ions do not correspond to the sodium salts 1 4  9 and 1 4  2, instead 
correspond to the free ligands. The presence of water in the sample 
submitted for a mass spectrum may explain why the free ligands 
were observed in the mass spectrum. The downfield region of the 1H 
NM R spectrum showed that two ortho-disubstituted aromatic rings 
were present. All of these results agree with the interpretation 
that the reduced material is a -1:1  mixture of 1 4 9  and 1 4 2 .  The  
combined yield of the two products was over the theoretical amount. 
Ion exchange chromatography might be utilized to separate 1 4  2  
from 1 4  9.
E. Synthesis of Tritvl-orotected N .N '-B isf2-m ercaD toethvn Cross- 
bridaed Cvclam (1 5  01.
Trujillo et ah 28 published a procedure describing the 
preparation of 2 -(chloroethyl) trityl sulfide (1 5 1 ) . Compound 1 5 1  
was synthesized by stirring equal molar amounts of trityl chloride
1 4 9
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( 1  5 2 ) and thiirane ( 1  5 3) in CH2 CI2  (Scheme 3.33).
Scheme 3.33
r.t. 4 Cl 
C H2CI2
1 5 2  1 5 3 1 5 1
Compound 1 5  1 crystallized after removal of residual solvent. 
Alkylation of 2 9 (1 equivalent) with 1 5 1 (2 equivalents) in MeCN in 
the presence of K2OO3 or Na2<X)3 was slow at room temperature. The  
mixture was then refluxed for 3 days after the addition of two times 
the stoichiometric amount of Kl. The desired product 1 5  0, isolated 
in 37%  yield, was about 80-85%  pure. The use of DMF or N ,N ’- 
dim ethylpropyleneurea (DMPU)129 have improved this procedure since 
these are good solvents for Sn2 alkylations. In one attempt, 1 5 1 (4 
equivalents) was stirred with 29 (1 equivalent) in DMF. The product 
( 1 5  0 ) was isolated in 50%  yield and was -9 3 %  pure (Scheme 3.34).
1 5 0
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Scheme 3.34





2 ) separate sol/liq




An attempt was made to chromatograph the crude product on basic 
alumina, which resulted in partial removal of the trityl groups as 
indicated by a 1H NMR of chromatographed material. A preparative 
HPLC attempt to purify 1 5  0, and alternative suggestions for the 
preparation of protected thiol ligands are discussed in Chapter V. 
Compound 1 5  0 was characterized by IR, high resolution mass 
spectrometry (HRM S), 1H, and 13C NMR.
F. Synthesis of Tritvl-protected N-m ercaptoethvI Cross- bridged  
Cvclam (1 5 41.
Compound 1 5 4 was synthesized by heating 3 equivalents of 
1 5 1  and 1 equivalent of 2 9 in DMF at 80 °C  for 3 hours in the 
presence of Kl (2 x stoichiometric) and K2 OO3 (2 x stoichiometric). 
The resulting solution was stirred overnight at room tem perature
151
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(Scheme 3.35). 
Scheme 3.35
Kl, K2CO3, 80°C, 2h 
DMF
2) separate sol/liq
T r S ^ ^ I
2 9 4) extract PhCH3
3) treat aq. KOH
N  (54%) 
1 5 0  +
(70%)
T r S ^ ^ I  I
(21%)
1 5 4
After 24 hours a component of the mixture crystallized, so the 
solution and solid were separated. The crystals and the mother 
liquors were worked up separately with aq KOH and each extracted 
with toluene. The material that had originally crystallized 
overnight was very pure 1 5 4  (21% ). The mother liquors portion 
ended up being impure 1 5 0 (-5 4 %  yield, -8 5 %  pure). Compound 1 5  4 
was characterized by IR, elemental analysis, 1H, and 13C N M R .
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1 5 2
G. Results of Liaand/Liaand Competitions with 1 4 0  and 2 5.
1 .Table 3 .1 : 13C NMR Chemical Shifts of 1 4 0  and the Li+ and 
Na+ Complexes (CD3CN).
Host (5) 
1 4 0  
(0.11 M)
U C IO 4 complex (5) 
(0.11 M)
NaBPfu complex (6 ) 
(0.10 M)
28 .95 (Ce.is) 25.87 (C6t13) 26 .32 (C6t13)
5 1 .5 7 50.37 5 0 .2 9
5 4 .9 0 5 3 .7 9 5 1 .6 1
5 5 .8 4 5 9 .4 6 5 9 .2 8
5 7 .7 5 59.79 5 9 .4 9
58 .31 5 9 .9 4 5 9 .6 5
58 .7 1 6 0 .4 3 6 0 .2 5
6 1 .0 6 6 2 .2 7 6 1 .4 4
7 2 .6 9 7 0 .6 3 6 9 .9 8
(CH2 CH2OCH3) (CH2 CH2OCH3) (CH2£H 2OCH3)
1 5 3
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1. 1 4 0 vs. 2 5 Competition for (NaBPh/t)
.0
U
1 4 0 2 5
Method of detection: 1 3C {1H} NMR 
SignakNoise = 60:1
Concentration of a single amine component: 0 .10 M 
Peak Integrated (uncomplexed 1 4 0): 28.95 ppm (C6)
Peak Integrated (complexed 1 4  0): 26.32 ppm (Ce)
In this case, multiple integrations of these resonances were not 
performed in the determination of Krei. The competition equilibrium 
constant (1 4  0 relative to 2 5) is Kre i =  1.0 ±  0.07 The free energy of 
competition was calculated (5 8 relative to 2 4) AG °298  =  0.0 ±  0.07
kcal/mol at 25° C. It is clear that 1 4 0 is just as effective as 2 5 in
the complexation of N a B P Iv
1 5 4
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2. 1 4 0 vs. 2 5 Competition for (LiCICM
2 51 4 0
Method of detection: 1 3C {1H} NMR 
Signal:Noise = 50:1
Concentration of a single amine component: 0.11 M 
Peak Integrated (uncomplexed 1 4 0): 28.95 ppm (C6)
Peak Integrated (complexed 1 4 0): 25.87 ppm (Cq)
In this case, multiple integrations of these resonances were not 
performed in the determination of Krei. The competition equilibrium
constant (14 0 relative to 2 5) is Krei =  32 ±  2 .2  The free energy of
competition was calculated (14 0 relative to 2 5) AG°298 k = 2.05 ±  
0.14 kcal/mol at 25° C. It is clear that 14 0  is a better complexer of 
Li+ than 2 5.
1 5 5
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IV. Conclusions
The efforts at functionalization of cross bridged cyclam have 
led to several new functionalized tetraam ines. A list of 
characterized ligands shown below in Figure 3 .5  highlights the 




I s A q h  K ^ O H
O
^ CN ^ S T r
Some of the functionalized ligands synthesized contain ionizable 
groups which would form neutral complexes with divalent metals. 
Figure 3.1 indicates that there are several other possible functional 
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Chapter IV
Selectively Functionalized Tetraamines
I . In t roduct ion
Selectively protected tetraam ines are frequently sought-after 
reagents for the preparation of selectively N-functionalized  
tetraam ines. There are many examples of selectively functionalized 
te tra a m in e s ,is o  several of which form thermodynamically stable 
coordination complexes with G d (lll) .i3 i Some of these Gd(lll) 
complexes are suitable paramagnetic relaxation agents for Nuclear 
Magnetic Resonance Imaging (MRI).
Various techniques for the selective functionalization of 
cyclen 1 1 ,132 cyclam 8,133 and isocyclam 4  713 4  have been 
demonstrated. Selective protection of non-adjacent nitrogens in 
tetraamines such as cyclam and cyclen would allow
functionalization of non-adjacent nitrogens to give 1 ,8 -
difunctionalized cyclam and 1,7-difunctionalized cyclen. The  
functionalization of non-adjacent nitrogens in a tetraam ine would
produce a ligand capable of complexing with a metal ion in an
1 5 7
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octahedral fashion. The ligating arms enable the ligand to 
completely “wrap up” the coordination sphere of a metal cation. The 
expected geometry would involve coordination of the four 
macrocyclic nitrogens equatorially while the pendant arms 
coordinate through axial positions. For example, C h e n i3 3 a  and 
coworkers have synthesized the C u(ll), N i(ll), and Co(ll) complexes 
of 1 5  5.
The complexes exhibited trans-octahedral geometry with the four 
macrocyclic nitrogens in a plane while the two carboxylate arms 
coordinate through axial positions.
I I .Background
The selective 1,7-diprotection of cyclen has been achieved by 
D e s r e u x i3 5  and coworkers by a method in which the protecting 
groups are positioned prior to macrocyclization. The starting
1 5 8
h n  n : COOH
HOOC :n n h
1 5 5
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diprotected triam ine 1 5  6  was prepared as described by Martin 
(Schem e 4.1).136 
Scheme 4.1 
Ts
^  N -H  
H—N
O f - "
Ts 
1 5 6
Compound 1 5  6  was mesylated to give 1 5  7. Compound 1 5  7 was 
cyclized with 1 5 8  by the method of Richman and A tk in s 1 37 to give
1 ,7 -d im e s y l-4 ,1 0 -d ito s y lc y c le n  (1 5  9). The selective removal of 
the tosyl groups was achieved by heating 8  in concentrated H2SO4 by 
the general method of R a y m o n d .1 38 Basic workup gave 1,7- 
dim esylcyclen (1 6  0) which was functionalized in the 4 and 10 
positions and demesylated to give various 1 ,7-difunctionalized  
cyclens. The strong reducing conditions necessary to remove the 
mesyl groups often caused reaction of the newly introduced
1 5 9
Ts
1>MsCI- Py M s -N
2)NaOMe
MeOH
''N ' Na+ MsO'x \
+ N -









Ts. I  \  Ms 
)




H2S 0 4 
100 °C
Ms^  \  J
1 6 0
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functional groups. For instance, amide arms were easily reduced 
during demesylation.
A highly regioselective method for the preparation of 1,7- 
ditosyl cyclen 1 6 1  has been reported by D e s r e u x . is s  The addition of 
a pyridine solution of cyclen (1 1 ) to two molar equivalents of tosyl 
chloride in pyridine gave 1 6  1 in 90%  yield (Scheme 4.2).
Scheme 4.2
W hen one equivalent of tosyl chloride was used, only the 1,7- 
regioisomer 1 6 1  was obtained in 45%  yield. Unreacted cyclen was 
recovered from the reaction mixture by aqueous extraction.
Attempts to tosylate cyclen in CHCl3/ E t 3N gave some very 
different results.135 For a 1:1 ratio (TsCI:cyclen) 63% of 1 6 2  and 





1 1 1 6 1
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Scheme 4.3
/  \  T K /  I  Ts I — \ tsx / — \ is
/ HN Nhk .  TsCI, Et3N J *  NH\ ,  NHv . %
L  J  CHCI3,40^C v. J + ^  , J + C  3
HN NH HN N H HN N HN N
v _ /  v _ j  v _ y sTs v _ / > s
1 1  1 6 2  1 6 1  1 6 3
1 eq. TsCI ®&/o 16P/o °°/o
2 eq. TsCI 15% 24% 52%
For a 2:1 ratio (TsCI:cyclen) 15% of 1 6  2, 24%  of 1 6  1, and 52%  of 
tritosylcyclen (1 6  3) were isolated. The products of this reaction 
were easily separated due to solubility differences.
Selective protection of cyclen was also achieved using 
diethylphosphate to give the 1,7-regioisom er 1 6  4 (Scheme 4.4). 135 
Scheme 4.4
0I —^  E tO — p ^  i---------y
.H N  NH 2 eq. HPO(OEt)2 E t0
'HN NH C C '4 HN N OEt
\ ------1 \ ------ 1 //P^OEt
01 1  1 6 4
The reaction of cyclen (1 eq. in CCI4 ) with diethylphosphate (2 eq. in 
CCI4 ) in a two phase system gave 1 6  4 in 90%  yield. The N-P bonds
161
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were readily cleaved with 6 M aq HCI.
Another synthesis of 1 ,7-diprotected cyclens has been 
achieved by Avellii 39 and coworkers. The monoalkylation of cyclen 
has been achieved using a variety of alkylating agents (Scheme 4.5). 
Scheme 4.5
Monoalkylated products 1 6  5 have been treated with 
dim ethylform am ide diethylacetal to quantitatively yield tricyclic  
orthoamides 1 6  6 , which can be hydrolyzed in EtOH/hfeO to give 1- 
alkyl-7-form yl cyclen derivatives 1 6  7. These disubstituted 
macrocycles were functionalized on the remaining 4  and 10 
positions to give selectively functionalized cyclens. M ic h e lo n i i4 0  
and coworkers have previously reported the synthesis of 1 6  8 .
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HN NH J ^ N ^ - HN N H ^  C6H6 R-T. HN N
reflux \_  I  SCHO
1 6 71 1 1 6 5 1 66
1 6 2




/  \ /
1 68
Their macrocyclization technique requires several 
protection/deprotection steps giving a rather low overall yield (8 %) 
of 1 6  8 .
A synthesis of 1,8-difunctionalized cyclams has been reported 
by Parker.141 This was achieved by tosylation of cyclam (8 ) with 1.5 
equivalents of TsCI, which generates the statistical products as 
shown in Scheme 4.6.
Scheme 4.6
1 7 1
The desired product 1 6  9 can be separated by chromatography in 30%
1 6 3
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yield. A small amount of 1 7 0  (3.5% ) was isolated along with the 
tritosylated derivative of cyclam (1 7  2 ), which was the major 
product of the reaction (54% ). A small amount of 1 7 1 (>3.5%) 
apparently forms in this reaction as indicated by 1H NMR, but could 
not be isolated. The remaining secondary amine groups of 1 6  9 were 
then functionalized to give 1 7  3 as shown in Scheme 4.7.
Scheme 4.7
Et<X __  o .  OEt 0^ H
Ts
O. ^  ^
- O h ^  Ts O , ^  hO . ^/  \  Na2CQ3 y* \  HBr/HQAc f  ^
HN NC Ch3CN N ph0H y  N,H
U  *  x U  1 U  -
F t O ^ f Q  H 0 ^ 0  7  A
1 6  9 Eto °  1 7 3 1 7 4
The deprotection step also hydrolyzed the ester functionality to give
1 ,8 -difunctionalized hexadentate macrocycle 1 7  4. The low 
selectivity of tosylation makes this sequence undesirable for large 
scale preparation due to the low yield of the desired 1 ,8 -diprotected  
cyclam .
N orth i42 previously synthesized several 1,8-dialkyl cyclams by 
a different route. The tricyclic bis-formal adduct 1 7 5143 .144  jS 
easily prepared from cyclam 8  and a formalin solution (Scheme 4.8).
1 6 4
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Scheme 4.8
n  n  ^ r T i
(■" 'I CH2O | j PhCH2Br T  j
HN^  jviH CH3CN CH3CN
2Br-
8 1 7 5 1 7 6
The conformation of 1 7  5 is such that there are two intraannular 
nitrogen lone pairs and two extraannular nitrogen lone pairs (Figure 
4 .1 (a )) .
Figure 4.1
— -N - 7
kA N .—




The X-ray crystal s t r u c tu r e ^  and solution conform ationi44 are both 
consistent with a rectangular [2323] diamond lattice conformation 
for the 10-membered ring of 1 7 5 (Figure 4 .1(b )). The tricyclic bis- 
aminal can undergo a topomerization via sequential inversion of all
1 6 5
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four nitrogens. W e is m a n i4 4  demonstrated by dynamic i 3 C N M R t h a t  
the topomerization barrier is AG t =  9.1 kcal/mol (Figure 4.2).
Figure 4.2
The dialkylation of tricyclic bis-formal adduct 1 7  5 with benzyl 
bromide gave selectively alkylated bis-quaternary dibromide salt 
1 7 6  (Scheme 4.8). In the presence of an alkylating agent, the first 
alkylation occurs at one of the extraannular nitrogen lone pairs, 
which locks the conformation, forcing the second alkylation to occur 
at the other extraannular nitrogen lone pair (Figure 4.3).
Figure 4.3
This regioselectivity is very similar to that observed for the 
alkylation of cyclam bis-aminal 1 6  as discussed in Chapter II.
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1 6
I I I .R e s u l ts
North showed that NaBhL* reduction of 1 7 6  leads to 1 ,8 - 
d ib en zy l-4 ,11 -d im eth y lcyc lam  1 7  7. The hydrolysis of 1 7 6  in 6  M 
NaOH followed by benzene extraction gave 1 ,8 -dibenzylcyclam 1 7  8  
(Scheme 4.9).
1 6 7
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Scheme 4.9
j C X  P h ^ r T ^ l i ^
r  V  ^1 PhCHaBr | | N a B H 4 [  ]
N '^^ 'N  CH3CN N ^ ^ N ^ ^ .P h  950/0 EtOH ^  f]l\ / ' Ph
2Br-
1 7 5  1 7 6  1 7 7




W e repeated the benzylation/hydrolysis sequence using the 
procedure outlined by North in an attempt to fully characterize 1 7  8 . 
The benzylation procedure involved heating a mixture of 1 7 5 and 
excess benzyl bromide in acetonitrile at 100 °C  (steam bath) for 4  h. 
The product precipitated as the dibromide salt 1 7  6 , however an 
impurity was evident by 1H NMR. When the reaction was repeated at 
room temperature for 24. h, instead of 4  h at 100 °C, the amount of 
this impurity was significantly decreased. Isolation by filtration 
gave a pure white solid 1 7 6  in 87%  yield. 1 7  6  was hydrolyzed in 3M
1 6 8
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
aq NaOH to give pure 1 7  8 in 88%  yield.
R o g e rs '!  4 5  had previously demonstrated that bisaminal 
dim ethiodide 3 1 (preparation described in Chapter II) could be 
hydrolyzed (20%  KOH) to give 1 6 8  in 79%  yield (Scheme 4.10). 
Scheme 4.10
This method for the preparation of 1 6  8 is more efficient than the 
M ichelonh 1 route, which requires several additional steps and gives 
a low overall yield (8% ).
Using the general Rogers procedure, related salt 7 0 was 
hydrolyzed to give 1 7 9  in 80%  yield (Scheme 4.11). Compounds 8 2 
and 8 6 were also hydrolyzed in a similar fashion to give 
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1 6 9
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Scheme 4.11
W 1> ^ K0H'4i npT I c 'm
+ i i  2) PhH extraction
Na2S04 m u
^  aB r 3 )n  ^ n\ _ ; h
c  J
80%
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2) PhH extraction L  J
Na2S ° 4  Me- N  NH








'Phn r \  ^  i \ ^^  N. I  N ^ P h  1) 20% KOH, 4 h N H N\
xs Mel S  N ' * '  + N  ------------------- ►  r
— ► L + JL J 2) PhH extraction L
'Nv i ^  n CH3CN > ^ T n^  Na2S 04 m^ N. NH
\_ H J  B r  Me y_H_y 2X' 3) Distill Me \ ___ /
8 5 8 6 X Br * 1 8 1Two step yield
(68%)
The synthesis of dihalide salts 8 2 and 8 6 is discussed in Chapter
II. Bis-quaternary dibromide salt 7 0 was synthesized previously by 
R o g erses  as discussed in Chapter II, but only partially
1 7 0
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characterized. The dihalide salts 7 0, 8 2, and 8 6 were hydrolyzed in 
20%  aq KOH at room temperature for 4 h. The two step yields for the 
synthesis of 1 8 0 from 8 0 and 1 8 1 from 8 5, are reported (Schemes  
4 .12  and 4 .13) since the dihalide salts were not completely 
characterized (IR , 1H and 13C NMR only).
IV .D iscussion
W e have developed a highly efficient synthesis of 1,8- 
diprotected cyclams and 1 ,7-diprotected cyclens. It should be 
possible to functionalize the remaining secondary amine nitrogens 
with ligating arms. The removal of the benzyl groups by 
hydrogenolysis would give 1 ,8-difunctionalized cyclams. In a 
similar fashion, 1 ,7-difunctionalized cyclen derivatives could also 
be synthesized. North has referred to these di-armed ligands as 
“fullbacks” since the ligand could adopt a conformation in which the 
arms complex in an over-under fashion (Figure 4 .4), as previously 
discussed in the Introduction.
171
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Figure 4.4
r  H
x = N H 2 , 0 H i0 R
*sJ )
"fullbacks"
The non-adjacent functionalized polyamines 1 6 8, 1 7 9, 1 8 0 and 
1 8  1 could conceivably be functionalized with arms in the sam e way 
as cross-bridged cyclam (see Chapter III).
The most interesting aspect of this method is the ability to 
functionalize cyclam or cyclen with two different ligating groups. 
For exam ple, 1-benzyl-8-m ethylcyclam  (1 8  0) could be 
functionalized with two ligating groups to give 1 8 2  (Scheme 4.14).
1 7 2
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Scheme 4.14
r ^ l  9  M eo
HN l i ^ F H  X  O . V 1 N O 01c 1 'iflX ' c „)
>  NH 2 )B H 3
1 8 0  _ 1 8  2
H2, Pd/c
MeO. MeQ
O L | I   JO H
& NH . o -  II / N N>
%  D ^ X x j j - QEt {
N n r  2>HCIW) * "  l> ?  f
^  I
1 8  3 OMe 1 8  4 OMe
1 8  2 could be debenzylated by hydrogenolysis to give 1 8  3, which 
could then be alkylated and hydrolyzed to give 1 8 4  (Scheme 4.14). 
The synthesis of functionalized macrocycle 1 8  4 would certainly be 
challenging by typical macrocyclization methods. This same type of 
sequence could also be applied to cyclen derivatives, thus providing 
a route to selectively functionalized cyclens.
1 7 3
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Chapter V
99mTechnetium Labelling Studies with Functionalized
Tetraamine Ligands
I.In tro d u c tio n
In collaboration with The Dupont/Merck Pharmaceutical 
Company Imaging Agents Research and Development Division, 
99mjechnetium radiolabelling experiments were performed on 
several of the ligands previously discussed in this thesis. 
Radiolabelling has become a valuable diagnostic tool in nuclear 
medicine and continues to grow as a relatively new area of research. 
The fundamental principle of radiolabelling relies on the 
combination of an organic ligand and a radionuclide, (QSmTechnetium, 
for example), forming a complex which can be injected into the blood 
stream, typically in a saline solution. The complex can then be 
metabolized or accumulated in a particular organ in the body. At 
this point, the radionuclide will then undergo gamma decay and the 
emission can be detected using a gamma camera.
Radiopharm aceuticals are typically divided into two classes,
174
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according to the mode of distribution. For one type the biological 
distribution is dependent on the interaction between the 
radiolabelled complex and the tissue it adheres to (perfuses into) 
while traveling through the blood stream. For instance, some 
labelled complexes are better suited for imaging the brain, while 
some are well suited for imaging the heart. The other type is 
dependent on specific biochemical or receptor binding interactions. 
For instance, monoclonal and polyclonal antibodies have been 
labelled with 99mjc while maintaining their imm unoreactivity.
Injections of radiolabelled agents into humans allows 
visualization (imaging) of internal organs without the need for 
investigative surgery. The size and lipophilicity of radiolabelled  
ligands are determining factors that affect where the complex is 
accumulated or metabolized. Research has led to the development of 
novel ligands whose 99mTc complexes target such organs as the 
heart, brain, liver and the kidneys.146 Several rev iew si47-is i have 
discussed radiolabelling with 99mTc. Labelled 99mTc complexes of 
the ligands discussed herein were designed to be pharmaceuticals 
for imaging. One of these labelled 99m jc complexes was used for a 
biodistribution study in mice to determ ine where (in what organs) it
1 7 5
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accum ulates .
99mTechnetium generators were eluted daily on site at The  
DuPont Merck Pharmaceutical Company Radiopharmaceutical 
Research and Development Organization Discovery Division at the 
Billerica site in MA to supply Na9 9 mjc0 4  in a saline solution for 
labelling studies. The half-life of 99mjc (6.01 h) makes it very 
convenient for in -v ivo  studies.
99mjc originates from 9 9M o which is generated by irradiation 
of 98M o with thermal neutrons in a nuclear reactor (Scheme 5.1).
Scheme 5.1
9»Mo S9Mo _ L _  9 9 ^
The form of 98Mo is usually molybdenum trioxide, ammonium  
molybdate, or molybdenum metal. Na299MoC>4 undergoes beta decay to 
generate Na99mTcC>4. Na99mTcC>4 is isolated by placing 99Molybdenum  
(Na299MoC>4) on an alumina column, which is then eluted with saline 
solution every 24 hours. The more highly charged 99Mo04-2 is  
retained while the 9 9 m jc0 4 - is eluted from the column due to its 
lower charge. The labelling procedures employed for preliminary 
testing of the macrocyclic polyamine ligands synthesized for this
1 7 6
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project were developed at DuPont Merck.
99mjc can occupy oxidation states from -III to +VII, the most 
common being V, III, II, IV, and I. The following examples are 
representative of the oxidation states typically found in 99m jc  
complexes. 99mTc(v)0 -g lucohep tonate i52  1 8 5 (Glucoscan, DuPont 
Merck; TechneScan Gluceptate, Mallinckrodt) is an example of a 
radiopharmaceutical believed to be a Tc(V) species as shown. 
Glucoscan has been approved by the Food and Drug Administration 
(FDA) for kidney and brain imaging to determine renal and brain 
perfusion.
99m Tc-penetate i53  (AN-DTPA (DTPA = diethylenetriam inepentaacetic  
acid), Syncor International; MPI DTPA Kit, MediPhysics; Techniplex, 
Bristol-Myers Squibb; DTPA, DuPont Merck) is an example of a 
radiopharmaceutical believed to be either a Tc(IV ) 1 8 6  or a Tc(V)
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99mTc-HIDAi54a (HIDA = hepatobiliary iminodiacetic acid) is an 
example of a Tc(lli) complex. 99mTc-HIDA is FDA approved for 
imaging of the liver, gall bladder, bile duct, and intestines. The  
actual structure of this complex is unknown, but FAB mass spectral 
analysis reported by Davisoniss are consistent with the proposed 2:1 
complex 1 8 8  originally postulated by Loberg.i54a
1 8 8
99m Tc-sestarnib ii54b (C ard io lite® , Dupont Merck) is an example of a
1 7 8
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Tc(l) complex ( 1 8 8  a). 99mTc-sestarnibi is an octahedral complex in 
which the 99mTc is surrounded by isonitrile ligands. 99mTc- 




1 8 8 a
II.R e s u lts  and D is c u s s io n
A. General
Our investigation of 99mTc “labelling” included studies of the 
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SH  f ^ )
N
1 8 9 1 9 0
“Labelling” refers to the technique used to combine a ligand with 
99mjc to form a radiolabelled coordination complex. Typically, a 
reducing agent (for example SnCb) and 99mTc (Na99mTcC>4) are 
combined in an aqueous medium such as saline in the presence of the 
desired ligand (Scheme 5.2).
Scheme 5.2
Under these conditions the 99mTc(VII) is reduced to a lower oxidation 
state (99mTc(V), 99mTc(lll)I 99mTc(ll), 99mTc(IV), 99mJc(l)) Species
180
Na99mT c 0 4 + Ligand
SnCI2
Saline
■>- C o rn p le x ("mT c (n ))
n = oxidation state 
n =  V, III, II, IV, I
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which combines with the ligand to form a complex. The solvent for 
this reaction should be either saline or a buffered aqueous solution, 
however small amounts of EtOH would be acceptable. Organic 
solvents cannot be used because injection into the test subject 
(mouse) may result in accidental death and thus interfere with 
crucial biodistribution data. Ultimately, solvents are avoided since 
the complex may eventually be used in human subjects.
All of our attempts to label ligands 2 9, 7 2, and 1 3 1  with 
99m jc failed or resulted in the formation of very polar 99mTc 
containing species according to HPLC analysis. Labelling conditions 
including identity of reducing agent, pH, tem perature, and reaction 
time w ere all varied separately without success. Four reducing 
agents: stannous (II) chloride (SnCfe), stannous (II) tartrate, 
TPPTS156 (triphenylphosphine-m -trisulfonate) and Na2S2Q 3 (sodium 
thiosulfate) were tried, since they are water soluble and are 
frequently used at DuPont Merck for labelling new ligands. Several 
attempts to label 2 9 in the pH range 7-11 using SnCl2 or 
Sn(tartrate) as reducing agents failed. Attempts to label 7 2 at pH 
11 using either Na2S2 0 s or SnCl2 following this sam e procedure did 
not result in labelling. Attempts to label 1 3 1  at pH 5 and pH 11
181
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failed. A few representative procedures of the unsuccessful 
attempts are included in the experimental part of this thesis. 
Compounds 1 8 9 and 1 9 0 were successfully labelled with 99mTc but 
not cleanly.
B. Preparation of Thiol Ligands
1. Deprotection of Tritvl-protected Liaand Precursors 1 5 0  and
1 5 4.
Ligand precursor 1 5  4 used for labelling studies was  
completely characterized in the laboratory at UNH and was >98%  
pure. Ligand precursor 1 5  0 was synthesized in the laboratory at 
UNH and was no greater than 93%  pure. Thiol-containing ligands 1 8  9 
and 1 9  0, were prepared by detritylation of 1 5 4 and 1 5  0 
respectively using trifluoroacetic acid (TFA ) and triethylsilane  
(EtsSiH) just prior to labeling experiments (Schem es 5 .3  and 5.4). 
Triethylsilane reduces the trityl cation to triphenylm ethane, thus 
making the deprotection sequence irreversible. Solid 
triphenylmethane is easily removed by filtration.
1 8 2
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Scheme 5.3
HN N
STr ^  ^SH
CF3 COOH, Et3SiH yf l *













Both ligand exchange and direct reduction of generator eluent in the 
presence of ligand led to complex formation in each case, proving 
that ligands 1 8 9 and 1 9 0 label 99mTc. Unfortunately, the labelling 
experiments resulted in mixtures of 99mTc-containing products, one 
of which was isolated in the case of ligand 1 9  0.
2. Preparative HPLC of 1 5 0
Several attempts in the laboratory at UNH to purify 1 5 0 to
1 8 3
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purity greater than 93%  were unsuccessful (chromatography and 
recrystallization). Reverse-phase preparative HPLC was attempted  
on site at Dupont Merck in Billerica, MA. A chromatogram is shown 
in Figure 5.1. Each of the solids resulting from lyophilization of 
fractions #1 -4  were submitted for high resolution mass 
spectrometry (HRM S) analysis. The desired ligand precursor (1 5  0) 
was found in fraction #4 while fractions #1, 2, and 3 contained 
mixtures of 1 5 4  and 1 5  0. A 1 H  NMR of fraction #4 indicated that 
1 5  0 was present but appears to have decomposed considerably under 
the chromatography conditions used for separation (Figure 5.2).
3. Attempted Analytical HPLC of 1 5 4 .
Reverse phase analytical HPLC was attempted on compound 
1 5 4 to compare the results to those obtained for the preparative 
HPLC of 1 5 0. The result indicated that compound 1 5  4 appeared to 
have also decomposed considerably under the HPLC conditions used. 
The fact that compound 1 5  4 would be protonated under the 
chromatographic conditions used may also help explain why 
chromatography was unsuccessful.
1 8 4
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Figure 5.1
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C. Techniques used for the Labelling of Bisfthiol-armed) Liaand 1 9 0 .
The first method used to label 1 9  0 was ligand exchange. The 
99m jc(V)0 (glucoheptonate) complex 1 8 8  was synthesized and to this 
was added the deprotected thiol ligand 1 9  0. The ligand exchange 
reaction is shown in Scheme 5.5.
Scheme 5.5
Ligand 1 9  0 + " mT c(V)0(glucoheptonate) 1 8 5 ------ ►
" mTc(Ligand 1 9  0) Complex + glucoheptonate
A general 99mTc labelled species is indicated in Scheme 5.5. The 
actual structure, oxidation state, and charge of the labeled complex 
is not known. The initial glucoheptonate ligand exchange 
experiments provided some interesting information about the 
labelling potential of 1 9  0. HPLC chromatograms (radiodetection of 
99mTc, a v-emitter) showed that two major components were
formed, with retention times of 7.0 and 10.0 minutes respectively. 
The chromatograms indicated the rapid formation of a complex 
(retention time = 7.0 minutes) two minutes after addition of ligand 
1 9 0 .  This complex was converted into a new complex (retention 
time = 10.0 minutes) after heating for 30 minutes or more. The
1 8 7
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intensity of the peak at 7.0 minutes slowly decreased while the 
intensity of the peak at 10.0 increased. W hen the reaction mixture 
was buffered to pH 8 and heated for 1 h at 80 °C, the major 
component had a retention time of 7.0 minutes (Figure 5.3). When  
the reaction mixture was buffered to pH 10 the major product after 
1 h at 80 °C  had a retention time of 10.0 minutes (Figure 5.4). The  
broad peak between 8.0-9 .5  minutes seems to indicate there are 
several components in the reaction mixture. Successful labelling 
was accomplished with 4 .00 -0 .04  mg/mL (5 x 10-3 M -5 x 10-5 M) of 
ligand and labelling still occurred using as little as 8.0|ug/mL (10-5  
M) of ligand. The concentration of Na9 9 mTc0 4  in the reaction mixture 
was typically in the range of 10-6 to 1 0 -8  m. There was usually very 
little labelling when the pH of the reaction mixture was below 6.0. 
The percent of colloid (99mTc02) formed on the labelling reactions 
was typically less than 10%. An important feature of this ligand is 
the fact that labelling occurred rapidly at such low concentration 
(8.0|ug/m L). It is very possible that the ligand could be used in
conjunction with a peptide based receptor. The resulting 
radiopharmaceutical would contain a chelating portion (used for 
labelling 99mjc) and a peptide portion (used for targeting a specific
1 8 8
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Figure 5.4
Labelling Procedure 1
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organ or area of the body).
An alternative method for labelling 1 9 0 by ligand exchange 
utilized a tricine complex. Tricine 1 9 1  was first labelled with
99mjc (retention time 99mjc complex = 3.3 min) using SnCfe as the 
reducing agent. The freshly deprotected 1 9  0 was then added 
displacing tricine 1 9  1 (Scheme 5.6).
Scheme 5.6
Ligand 1 9 0 + 99rnTc(tricine C o m p lex ) ►
HPLC chromatograms (Figure 5.5) indicated successful labelling of 
1 9 0  by this method, but a complex mixture of products. Two major 
peaks (retention times 7.0 and 10.0 minutes) were observed under 
these labelling conditions. A broad peak between 8 .0-9 .5  minutes 
accompanied the two sharp peaks described above. This same peak 
pattern was also observed in the labelling attempts with
HO
1 9 1
" mTc(Ligand 1 9  0) Complex + Tricine (1 9 1)
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glucoheptonate, suggesting comparable products are formed using 
this method. Again, a general 99mTc species is shown in Scheme 5.6. 
The actual structure and oxidation state of the labeled complex is 
not known.
Another method used for labelling of 1 9 0 was ligand exchange 
with a 99mTc c o m p le x '!57 of ethylenediam inetetraacetic acid 1 9 2  
(EDTA).
j — N N— \
HOOC )  (  COOH  
HOOC COOH  
1 9 2
EDTA was first labelled with 99mjc using SnCl2 as the reducing 
agent. The deprotected 1 9 0  was then added displacing EDTA 
(Scheme 5.7).
Scheme 5.7
Ligand 1 9 0  + 99mT c{IV)(ED TA )— ►
" mTc(Ligand 1 9 0) Complex + EDTA (1 9 2)
The HPLC chromatograms indicate that labelling occurred with this 
method as well (Figure 5.6) again giving a complex mixture of
1 9 3
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products. One major sharp peak (retention time 7.0 minutes) and one 
very broad peak (retention time 8 .0 -9 .5  minutes) was observed in 
the reaction mixture after one hour of heating at 50 °C. This same 
peak pattern was also observed in 99mjc labelling attem pts with 
glucoheptonate, suggesting similar products were formed using this 
method. Again, the structure and oxidation state of the 99mTc ligand 
1 9  0 complex (Scheme 5.7) are unknown.
The labelling method used for the biodistribution study 
involved direct reduction of Na9 9 f"Tc0 4  with triphenylphosphine-m - 
trisulfonate (TPPTS) in the presence of ligand 1 9  0. A mixture of 
Na99mTc04t TPPTS, and freshly prepared ligand 1 9 0  was heated to 
give a labelled complex of unknown structure and oxidation state as 
suggested in Scheme 5.8.
Scheme 5.8
A chromatogram (Figure 5.7A) of the crude reaction mixture
" mTc(Ligand 1 9  0) Complex
Ligand 1 9  0
+
1 9 5
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indicates that there are many products from the reaction. The major 
peak at 15.3 minutes (retention time) comprised about 40-60%  of 
the activity depending on the run. The major peak found at 15.3  
minutes using the phosphate HPLC method corresponds the major 
peak found at 10.0 minutes using the TFA HPLC method. The 15.3  
minute component was isolated by collection of the eluent between  
14.5 and 16.0 minutes. Solvents (^ O .C H a C N ) were removed under 
reduced pressure and the residue was dissolved in saline. This 
solution was analyzed by HPLC; the chromatogram of the purified 
material is shown in Figure 5.7B. The radiochemical purity was 
acceptable, so the reaction was scaled up for a biodistribution 
study. One problem encountered with the isolation of the 15.3 
minute component was that labelled material adhered quite strongly 
to the glass flasks used for collection of the HPLC eluent. This 
created serious losses during transfer since labelled material could 
not be effectively rinsed out with saline solution. This problem was 
solved by rinsing the flask and transfer syringes with a surfactant 
(Tween 80). The transfer of labelled material increased from 46- 
57%  using saline to 97-98%  using a 0.1%  (w/w) solution of Tween 80  
in saline.
1 9 7
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D. Labelling Technique used for Thiol-armed Liaand 1 8  9.
Successful labelling of ligand 1 8  9 was accomplished by ligand 
exchange with 99mTc(v )0  (glucoheptonate) (Scheme 5.9).
Scheme 5.9
Ligand 1 8  9 + " mT c(V)0(glucoheptonate) 1 8 5 --------►
99mTc(Ligand 1 8  9) Complex + glucoheptonate
Ligand 1 8  9 did label (Scheme 5.9) but the complexity of the crude 
product mixture discouraged further attempts to study this ligand. 
The chromatograms are shown in Figure 5.8.
E. Biodistribution Study on the Major Component of Labelled 1 9  0.
Once a suitable method for separation of the major labelled 
component of 1 9 0  had been established (Figure 5.7A), the procedure 
was scaled up to supply enough material for a biodistribution study 
in mice. The results of this study and the scaleup procedure are 
discussed below.
The chromatograms of the crude reaction mixture and of the 
isolated material are shown in Figure 5.9. The results are
1 9 8
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Labelling Procedure 5
Figure 5.8
TcOOO glucoheptonate ligand exchange, 
pH 10, 25 pL in jection.
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consistent with that observed for the small scale run. The recovery 
of activity was calculated by measurement of the amount of activity 
in each vial or syringe with a Capintec radioisotope calibrator 
(model C R C -12). The results of several isolation attempts are 
shown in Table 5.1. The typical recovery or yield for radiolabelling 
ranged from as low as 9% to as high as 68% depending on the run. 
Table 5.1




In je c te d  
Activity (m C i)
C o llec ted  
Activity (m Ci)
#41  a 3 0 0 1 6 .0 9 .5
#41  b 3 5 0 8 .0 5 .4
# 4 2 a 5 0 0 9 1 .2 1 0 .9
# 4 2 b 5 0 0 1 3 8 .0 1 6 .9
# 4 4 a 3 0 0 6 0 .0 7 .0
# 4 4 b 5 0 0 1 0 0 .2 9 .8
# 4 4 c 6 0 0 1 2 0 .0 1 0 .3
The biodistribution results are shown in Tables 5.2 and 5.3. 
The biodistribution studies using the purified isolate were carried 
out by DuPont Merck personnel. Ten mice chosen for the study were 
weighed and injected with known amounts of the labelled compound 
(2 5 0 -3 0 3  pCi). The distribution of activity in the carcass, organs,
201














Ts*Mm Labeled Ligand #HIL DMP 3307*43 leafed 11/29/84
* t  * . i < ' , i < • ' I ! # • - I I  I
Organ uptake* organ activity /  total activity x 100
Blood uptake* blood activity / blood art x 0.05 x mouse wt /  total activity x 100 
Femurs uptake- femurs activity /  femurs w t x 0.1 x mouse w t /  total activity x 100
115 min. ln*vlvo I 
House WL
Red 1 Blue 1 Purple 1 Yellow 1 Orange 1
37 g 37 g 34 g 38 g • 40 g
Femurs W t 0.118 g 0.115 g 0.112 g 0.121 g 0.110 g
Tube Wt. 13.04 g 13.07 g 13.15 g 13.08 g 12.99 g
BloodVTube WL 13.90 g 14.16 g 14.12 g 14.12 g 14.10 g
A sllilltga
Btood 7.0 pCi 9.0 pCi 9.0 pCI 7.0 pCi 8.0 pCI
Brain 0.0 pCi 0.0 pCi 0.0 pCi 0.0 pCI 0.0 pCi
Stomach 1.0 pCi 3.0 pCi 4.0 pCi 2.0 pCi 4.0 pCI
Kidneys 20.0 pCi 19.0 pCI 18.0 pCi 22.0 pCi 19.0 pCi
Liver 43.0 pCi 44.0 pCi 42.0 pCi 42.0 pCi 41.0 pCI
Lungs 3.0 pCi 4.0 pCi 3.0 pCI 3.0 pCI 3.0 pCi
Heart 1.0 pCi 0.5 pCi 0.5 pCi 0.6 pCI 0.6 pCi
Femurs 0.5 pCi 0.6 pCi 0.6 pCi 0.5 pCi 0.4 pCI
Bladder/Urine 68.0 pCi 57.0 pCi 53.0 pCi 56.0 pCi 72.0 pCI
Carcass 159.0 pCi 155.0 pC! 151.0 pCi 167.0 pCi 147.0 pCI
Total Activity 302.5 pCi 292.1 pCi 281.1 pCi 300.1 pCi 295.0 pCI
Uotske
Blood 4.51 % 5.23 % 5.61 % 4.26 % 4.89 %
Average 
4.90 %
Brain 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 %
Stomach 0.33 % 1.03 % 1.42 % 0.67 % 1.36 % 0.96 %
Kidneys 6.61 % 6.50 % 6.40 % 7.33 % 6.44 % 6.66 %
Uver 14.21 % 15.06 % 14.94 % 14.00 % 13.90 % 14.42 %
Lungs 0.89 % 1.37 % 1.07% 1.00 % 1.02% 1.09 %
Heart 0.33 % 0.17 % 0.18 % 0.20 % 0.20 % 0.22%
Femurs 5.14 % 6.61 % 6.48 % 5.23 % 4.93 % 5.68 %
Bladder/Urine 22.48 % 19.51 % 18.85 % 18.66 % 24.41 % 20.78 %













Te-69m Labeled Ligand AHIL OUP 5307-45 laatad 11/20/84
Organ uptake* organ activity /  total activity a 100
Blood uptake* blood activity /  blood wt x 0.05 x mousa w t /  total activity x 100 
Femurs uptake- lemura activity /  femora wt x 0.1 x mousa wL /  total activity x 100
160 min. In-vlvo I Rad 2 Blue 2 Purple 2 Yellow 2 Orange 2
Mouae Wt 39 g 36 g 38 g 37 g 40 g
Femurs Wt 0.117 g 0.100 g 0.124 g 0.102 g 0.104 g
Tuba Wt 12.99 g 13.18 g 13.10 g 13.07 g 13.06 g
Blood+Tube Wt 13.81 g 14.24 g 14.08 g 14.16 g 14.43 g
Aetlvltlaa
Blood 3.0 pCi 4.0 pCi 3.0 pCI 4.0 pCi 3.0 pCi
Brain 0.0 pCI 0.0 pCI 0.0 pCi 0.1 pCI 0.0 pCI
Stomach fcOpCI 1.0 pCi 1.0 pCi 1.0 pCI 1.0 pCI
Kidneys 25.0 pCI 22.0 pCi 28.0 pCi 30.0 pCi 22.0 pCI
Uvar 39.0 pCI 35.0 pCi 3Z0 pCi 37.0 pCi 39.0 pCi
Lungs 2.0 pCi 2.0 pCi iO pC I 1.0 pCi ' 1.0 pCI
Heart 0.6 pCi 0.4 pCi 0.4 pCI 0.3 pCi 0.4 pCI
Femurs 0.4 pCi 0.4 pCi 0.8 pCi 0.4 pCi > 0.4 pCi
Bladder/Urins 77.0 pCi 79.0 pCI 71.0 pCI 93.0 pCi 93.0 pCI
Carcass 143.0 pCi 106.0 pCi 143.0 pCi 102.0 pCi 111.0 pCi
ToUl Activity 292.0 pCi 249.8 pCi 280.9 pCi 268.8 pCi 270.8 pCi
Uptake Average
Blood 2.44 % 2.72 % 2.07% 2.53 % 1.62 % 2.28 %
Brain 0.00 % 0.00 % 0.00 % 0.04 % 0.00% 0.01 %
Stomach 0.68 % 0.40 % 0.36 % 0.37 % 0.37 % 0.44 %
Kidneys 8.56 % 8.81 % 9.97 % 11.16 % 8.12 % 9.32%
Liver 13.36 % 14.01 % 11.39 % 13.76 % 14.40 % 13.39 %
Lungs 0.68 % 0.80 % 0.71 % 0.37 % 0.37% 0.59%
Heart 0.21 % 0.16 % 0.14 % 0.11 % 0.15 % 0.15%
Femurs 4.57 % 5.76 % 5.45 % 5.40 % 5.68 % 5.37%
Bladder/Urine 28.37 % 31.63 % 25.28 % 34.60 % 34.34 % 30.44 %
Carcass 48.97 % 42.43 % 50.91 % 37.95 % 40.99 % 44.25 %
blood, and bones was measured by sacrificing half of the animals at 
15 minutes and the other half at 60 minutes after injection. The  
two time points were selected to determ ine if the labelled ligand 
was retained or excreted over time. After 15 minutes, the average 
organ uptake was significant in the carcass (53% ), liver (14% ), 
kidneys (7% ), and femurs (6% ). The high level detected in the 
bladder/urine (22% ) indicates that the complex was readily 
metabolized or excreted. At the one hour time point, average organ 
uptake values were: carcass (44% ), liver (13% ), kidneys (9% ), and 
femurs (5% ). The level of activity in the bladder/urine increased to 
30%. This higher level at the later time point is consistent with the 
fact that labelled compound was being excreted.
The actual structure of the 99mTc ligand 1 9 0  complex is still 
unknown since the isolated labelled material cannot be 
characterized by typical methods (13C and 1H NMR, IR, MS/HRMS, 
elemental analysis). The HPLC analysis suggests that the material 
is very lipophilic, as does the fact that transfer of the material is 
ineffective without the use of a surfactant (Tween 80). This 
evidence also points to the fact that the 99mTc labelled complex 
( 1 9  0) is not highly charged, if at all.
2 0 4
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F. Molecular Modeling of Technetium Complexes.
To investigate possible structures of the labelled 99m jc  
bis(thiol-arm ed) complex molecular modeling calculations were  
performed on a Silicon Graphics workstation using the Spartan  
molecular modelling package (version 2.0) which uses the Tripos 
force field. The purpose of the modelling studies was to determine 
if the geometry of 99mTc complexes are reasonable with respect to 
steric strain, bond distances, and bond angles. Some possible 
structures for the labelled dithiol ligand are shown in Figures 5 .10  
and 5.11; the hydrogen atoms are omitted for clarity. The Tripos 
force field does not take metal oxidation states and charge into 
account. The oxidation state of technetium in these structures is 
(III). The structure of Figure 5.10 would carry a positive charge, 
while that of 5.11 would be a  neutral species. The Tc-N and the Tc- 
S bond distances are noted in A. The bond lengths are not distorted 
and the structures a  actually quite reasonable with respect to their 
geometry. Some other possible structures that were not modeled 
are shown in Figure 5.12.
2 0 5
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Figure 5.10
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Figure 5.11
:TciZ .Z  7i
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Figure 5.12
IV.Conclusions
Unfortunately, ligands 2 9, 7 2, and 1 3 1  were not labelled by 
99mjc under the conditions described. Successful labelling was 
observed with ligands 1 8  9 and 1 9  0. Both ligands 1 8  9 and 1 9  0 
labelled but gave mixtures of products according to HPLC analysis. 
This suggests the possibility that a variety of products may result 
from ligand oxidation or from oligomerization further complicating  
the reaction mixture. In each labelling method (direct reduction vs. 
ligand exchange), the same major component was observed 
regardless of the reducing agent. In all successful 99mTc labelling  
experiments with ligand 1 9  0 a  broad peak (retention time 8 .0-9 .5  
minutes) was observed. This broad peak may be due to a complex 
mixture of products which are rapidly interconverting on the 
timescale of the separation. A major component of the labelling
2 0 8
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mixture of 1 9 0 was isolated and was stable at room temperature 
for over 2 h as long as excess ligand was present. The necessity of 
having excess ligand present during isolation suggests that the 
complex is readily oxidized, possibly by O2 . The excess “free thiol” 
added to the isolate serves as an antioxidant preserving the isolate 
so it can be used for biodistribution studies. The labelled complex 
could disproportionate which would result in complex dissociation. 
Isolation difficulties w ere encountered when transferring the major 
component. This problem was solved by rinsing transfer syringes and 
flasks with a surfactant.
A biodistribution study in mice was performed on the purified 
isolate resulting from labelling of 1 9  0. The major organs targeted 
were the liver, kidneys, and the bladder. A small amount of the 
labelled material ended up in the bone (femur).
Suggestions for further study might include an investigation of 
alternative protecting groups for sulfur. The method used to prepare 
the desired trityl-protected dithiol ligand gave 190 in 50 % yield 
(91-93%  pure). Alternative protecting groups commonly used for 
thiol protection are S-(acetylam ino)m ethyl (acm ), S- 
(benzoylamino)methyl (Bern), and S-benzyl (Bzl) (Figure 5.13).
2 0 9







Davisonis and coworkers have developed a method in which the 
deprotection of all three types of the protecting groups shown in 
Figure 5 .13  occur during labelling. A proposed metal-assisted  
deprotection occurs giving sstechnetium thiolate complexes in high 
y ie ld s .
An alternative procedure for the preparation of pure dithiol 
ligand 1 9 0  might utilize S-protected thioglycolic acid derivative  
1 9  3. The 1 ,3-dicyclohexylcarbodiimide (DCC ) coupling of 1 9 3  and 
2 9 would give 1 9  4, which could be reduced with borane, for 
example, to give S-protected dithiol ligand 1 9 5  (Scheme 5.10).
210
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Scheme 5.10
Protect







1 9  4 ------------ ------------> -
1 a *  2. aq HCI
3. aq NaOH Protect-S
Attempts should be made to prepare other dithiol ligands. For 
example, 1,8-dim ethyl cyclam could be selectively functionalized to 




The successful results of the labelling studies should promote 
further work on thiol functionalized tetraam ine macrocycles.
2 11
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PART II: SYNTHESIS AND DYNAMIC NMR STUDIES OF BICYCLIC UREAS
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Chapter I
Bicyclic Ureas
l . ln t ro d u c t io n
There has been a great deal of interest concerning an 
attractive transannular interactions betw een mutually compatible 
functional groups in medium size (8 -10  membered) rings.159a,b 
Typically, transannular attractions result from the positioning of 
electron-donor and electron-acceptor groups transannular to one 
another in a medium size ring. The extent of such transannular 
interactions has been studied by investigation of CD spectra,159c EPR 
s p e c tra ,159c photoelectron spectra,159c UV spectra,159c visible 
s p e c tra ,159d |R spectra,159e and NMR spectra.159f
One example of a transannular interaction examined by 
D u n i t z 160 jS the attraction between an amine and a ketone carbonyl 
which are situated transannular to one another in a medium size 
ring. X-ray structural analysis revealed that amino ketones with 
short transannular N -C = 0  distances had longer C = 0  bond lengths than 
amino ketones with long N -C = 0  distances. This deviation in the C = 0
2 1 3
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bond distance was determined to be directly related to the N -C = 0  
distance in bicyclic amino ketones.
Several research groups have studied intramolecular 
re a c tio n s 16 1 - 1 6 7  which are typically much faster than their 
analogous intermolecular reactions. However, the determining 
factors which qualitatively and quantitatively describe observed  
rate enhancem ents for transannular reactions are still very  
controversial. A few of these opposing viewpoints will be briefly 
discussed.
Menger has postulated that the rate of a bimolecular reaction 
depends on the time two reactants spend at a critical distance,161 a,c  
a theory known as the “spatiotemporal postulate.” Strategically 
placing two reactive functional groups transannular to one another 
holds them at a “critical distance.” For this reason, Menger 
believes, intramolecular reactions are often much faster than their 
in term olecu lar counterparts .16 ia , c
Earlier, K o s h l a n d 168  proposed that fast intramolecular and 
enzymatic reactions are a result of “orbital steering.” According to 
his theory, improper alignment of reactive functional groups by 10° 
will cause a 104 decrease in reaction rate. However, B r u i c e 1 69
2 1 4
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refuted this argument, claiming that at room tem perature these 
slight misalignments are overshadowed by vibrational and rotational 
motions of the molecule. Jencksi7o( P a g e i7 i, and Mandolinii72 
strongly believe the observed rate enhancem ents for intramolecular 
reactions are due to entropic factors. Analogous intramolecular and 
intermolecular reactions show different degrees of entropy loss as 
the transition state of the rate determining step is approached. In a 
bimolecular reaction there is a loss of translational entropy as two 
molecules come together in the transition state. However, in a 
intramolecular cyclization reaction there is only rotational entropy 
loss.
Weisman realized that bicyclic urea 1 9 7  is analogous to the 
amino ketones studied by Dunitz.160 and might be expected to exhibit 
a transannular interaction. It was anticipated that this transannular 
interaction might facilitate a degenerate transam idation  
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W ang proved the existence of the transannular interaction 
experimentally by analysis of IR sp ectra l 73 and performed dynamic 
NMR experiments on bicyclic urea 1 9  7 that demonstrated a 
rem arkably fast, acid catalyzed, degenerate transannular 
transam idation reaction (Schem e 1.1).
Scheme 1.1
< 2 > - &
H
,\u t  XV H +H r~\
h n q  n
C O
l l .B a c k a r o u n d
A. Topomerization of Bicvclic Urea 1 9  7.
W ang’s work showed that the absence of an acid catalyst, 
three sharp lines were observed for the methylene carbons of 1 9 7  in 
the iH-decoupled 13C NMR spectrum (CDCI3).
2 1 6
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Upon addition of mesitoic acid, the methylene resonances broadened, 
and substantially coalesced into a single peak. In the 1HNMR  
spectrum of 1 9  7  in CDCI3  the methylene resonances (consistent 
with Cs symmetry) also simplified as catalyst was added, to an 
AA’X X ’ pattern (consistent with C3V symmetry)as a result of the 
topomerization. This observation rules out the mechanistic 
intervention of guanidinium ion 1 9  8  (D3 h symmetry) along the  
reaction pathway, which would average the methylene resonances in 
the 1H NMR spectrum into a  singlet.
The 1H NMR results also show that the urea carbonyl cannot “tuck 
through" the ring during topomerization (Scheme 1.2) as this process 









In this work bicyclic urea 1 9  9 was synthesized in order to 
determine if it would exhibit a transannular attraction and undergo a 
similar acid catalyzed dynamic process.
Compound 1 9  9 was synthesized by a procedure similar to that used 
by W angi73 in the preparation of 1 9  7. Dynamic NMR studies of 1 9 9  
using 1H and 13C NMR spectroscopy were used to probe the dynamic 
process in solvents such as D2 O and C6D6. The results of these 
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B. Acid Catalyzed Amide Aminolvsis
The reaction of an amide with an amine is defined as an amide 
aminolysis. When the reaction products are another amine and 
amide, the reaction is a transamidation. The acid-catalyzed  
mechanism of a transamidation reaction is thought to involve initial 
O-protonation of the amide. The secondary amine then attacks the 
electropositive carbonyl carbon to produce a tetrahedral 
in te rm ed ia te .i74a-c .i75  After proton transfer, the intermediate can 
break down in either of two ways to reform an amine and an O- 
protonated amide (Scheme 1.3).
2 1 9
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Scheme 1.3
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Several research groups have studied base-catalyzed  
intramolecular transam idations using bases such as 3-aminopropyl 
am idei76 (KAPA), quinolinei??, KOtBu^e, and several others.179  
Alternatively, the reaction of an amide with an amine can produce an 
am id ineiso  as shown in Scheme 1.4.
Scheme 1.4
H R \  R\
J V  R" J s L R"
R + R* Y   R Y  + H2 0
Y  " X  ‘R
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C. Bicvclic Ureas and Topomerization of 1 9  7.
Compound 1 9  7 contains an amine and a urea functional group. 
The reactions of amines and ureas are usually extremely s l o w . i 7 4 . i s i  
However, in 1 9  7, the amine moiety is transannular to the urea 
functional group, and as a result readily reacts with the carbonyl 
upon O-protonation to form the tetrahedral intermediate 2 0  0. This 
tetrahedral intermediate can break down in any of three ways to 
reform aminourea 1 9 7  (Scheme 1.5).
221
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Scheme 1.5
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T h e  b a s ic ity  o f a  s e c o n d a ry  a m in e  is m u ch  g r e a te r  th a n  a  u re a  
o x y g e n  (p K a  o f te t r a m e th y lu r e a  c o n ju g a te  a c id  in H 2 O  is ab o u t  
2 . 0 2 1 8 2 ) . in  th e  p re s e n c e  o f a n  a c id  c a ta ly s t th e  s e c o n d a ry  a m in e  is  
p re fe re n t ia lly  p ro to n a te d , a n d  m u s t b e  d e p ro to n a te d  to  b rin g  a b o u t
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topomerization. O-protonation of ureas was demonstrated by 
Steward and Munster* 83 in the case of N ,N ’-dicyclohexyl urea (2 0 1 ) .
0
The CO stretching frequency is shifted from 1628 cm-* to 1699 cm --* 
upon protonation. The formation of a resonance stabilized conjugate 
acid in the case of O-protonation is responsible for the shifted IR 
frequency. Others'* 84 have verified the results of Steward and 
Munster. O-protonation of urea 1 9 7  is expected to bring about 
to p o m e riza tio n .
M o w l a m * 85,186 synthesized aminoureas 2 0 2  and 2 0 4, which 
are stable in solvents such as CDCI3 and DMSO-d6 , but readily 
convert to guanidinium salts 2 0 3 and 2 0 5 respectively in protic 
solvents such as methanol-d4 or D2O (Scheme 1.6). The equilibria 
are pH-dependent, low pH favoring the guanidinium ions (with 
protonation of O H-).
201
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CO■ NH H2O or CD3OD
O H -
2 0 4
A mechanism proposed by M o w l a m t s s  for the formation of 
guanidinium ion of 2 0 3  is shown in Scheme 1.7.
Scheme 1.7
£ £ h * . a M l * *inversion
‘ + OH
H




The intramolecular attack of the amine on the protonated
2 2 4
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transannular carbonyl carbon forms a tetrahedral interm ediate, 
which undergoes two nitrogen inversion as shown above. Upon 
oxygen protonation the C -0  bond is broken to give guanidinium ion 
(An uncatalyzed mechanism involving attack on unactivated carbonyl 
and final expulsion of OH- is no doubt operative at higher p H . i s s ) .
D. Acvl Transfer Studies bv DNMR
M olecules which exhibit intramolecular reactions have 
conveniently been studied by dynamic NMR techniques. The  
principles and techniques of DNMR have been extensively reviewed in 
the l i t e r a t u r e ^  and several books have been written! 88. a  few  
exam ples of intramolecular acyl transfer reactions studied by this 
technique are discussed.
C a l d e r i 8 9  and coworkers have used variable temperature NMR  
to demonstrate that a rapid intramolecular exchange occurs in the 
case of the mono- and diacetates of the napthazarin system. The  
dynamic situation in the case of the monoacetate 2 0 6 is shown in 
Scheme 1.8.
2 2 5
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Scheme 1.8
OAc O o OAc o OAc
OH O 
2 0 62 0 6
1H NMR evidence revealed that at temperatures below 100° C the 
topomerization of the monoacetate was slow with respect to the 1H 
NMR timescale (100 M Hz) as indicated by the sharp peaks resulting 
from two separate AB systems (quinonoid protons) observed in the 
aromatic region of the 1H NMR spectrum. As the temperature was 
raised to 190° C the peaks broadened into the baseline, clearly 
indicating a dynamic process. The AG* and rate constant for the 
topomerization of m onoacetate 2 0 6  were determined to be 21.8  
kcal/mol and 37 sec-1 respectively at a temperature of 140° C. The  
results of this experim ent w ere consistent with the intramolecular 
exchange of acetyl groups between peri-oxygen atoms.
M asamuneiso and coworkers clearly demonstrated by 13CNMR  
that tropolone acetate 2 0 7  exhibited a rapid degenerate 
rearrangement at room tem perature (Schem e 1.9).
2 2 6
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Scheme 1.9
AcO o
= 0  
2 0 7
At 50 °C  the proton decoupled (22.63 MHz) 13C NMR spectrum of 2 0 7 
exhibited three peaks which broadened as the sample was cooled and 
eventually decoalesced into 9 singlets at -70 °C. This observation 
is consistent with a two-site dynamic exchange process resulting 
from an acyl migration. The AG* for the migration process was 
calculated at several different tem peratures between -70° C and - 
10° C, the average being 10.8 Kcal/mol.
III.Results and Discussion
A. Synthesis of Bicvclic Urea 1 9 9 .
Tritosy ltriam ide 2 1 2  was prepared by the Kellogg75,76 CS2 OO3 
modification of the method of Richman and Atkins77  as shown in 
Scheme 1.10 and subsequently converted to medium-ring triamine 
2 0 8.
2 2 7
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Scheme 1.10
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Starting m aterial 2 1 0  was prepared by reaction of 1,3- 
propanediamine 2 0 9  with 2 equivalents of p-toluenesulfonyl 
chloride by the method of Koyama .191 Compound 2 1 0  was converted 
to the dicesium salt with two equivalents of CS2 OO3 and cyclized 
with one equivalent of tritosyl diethanolamine 2 1 1 in DM F at 100 
°C . This gave 1 ,4 ,7 -tri(p -to luenesu lfo nyl)-1 ,4 ,7 -triazacyclodecane  
2 1 2 in 59%  yield. Removal of the tosyl groups was accomplished by 
the conc. H2 SO4 method .7 7 ,7 8  Heating a solution of 2  1 2 in 97%  H2SO4 
gave the desired triamine 2 0 8  after workup with NaOH.
The reaction of 1 ,4,7-triazacyclodecane 2 0 8  a n d N ,N ’> 
c a r b o n y l d i i m d a z o l e i 9 2  (CDI) 2 1 3 in THF was used to prepare bicyclic
2 2 8
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urea 1 9 9  (Scheme 1 .1 1 ). 
Scheme 1.11
0  r ^ i
_l. N H   THF, 5 0 °C , „  N 0 N H
• U ' • u * ' L G  "  G j >
2 1 3  H 4 .  .„ „  „ 1 9 9
2 0 8
W a n g i 7 3  used this procedure to prepare bicyclic urea 197. It was 
based upon W right’s p r o c e d u r e ^  for conversion of 1,2-diamines  
into five-m em bered ureas. Column chromatography was necessary 
to completely separate imidazole from the desired bicyclic urea 
1 9  9. The chromatographed material was further purified by 
sublimation and then recrystallized (Et2 0 /pentane) to give pure 1 9  9. 
Compound 1 9  9 was characterized by IR, elemental analysis, mass 
spectrom etry, 1H, and 13C NMR. In one run, a twofold excess of N ,N ’- 
carbonyldiim idazole ( 2 1 3 )  was used with respect to triamine 2 0 8 .  
This resulted in the isolation of N-imidazolyl bicyclic urea 2 1 4 in 
75% yield after chromatography. Compound 2 1 4  was characterized  
by high resolution mass spectroscopy (HRM S), IR, 1H, and 1 3CNMR.
2 2 9
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2 1 4
B. Identification of Isomer 1 9 9 bv NMR Spectroscopy
The 13C NMR spectrum (C6D6, 90.56 MHz) of 1 9 9  exhibited eight 
sharp lines, which is consistent with bicyclic urea 1 9  9 rather than 
the alternative bicyclic urea 2 1 5  since the latter would be expected 
to exhibit five sharp lines in the 13C NMR as result of Cs symmetry.
The upfield methylene (C6-26.44 ppm) and carbonyl carbon (Ci r  
171.05 ppm) are readily assignable but further assignments required 
additional experiments. COSY and HETCOR spectra of 1 9 9 are shown 
in Figures 1.1, 1.2, and 1.3. The 1H NMR of 1 9 9  in C6D6 is complex 
but interpretable (see experim ental section-preparation of 1 9 9).
The 2D-NM R analysis (COSY, HETCOR) allowed the assignment of 
carbons C5  and C7 . The remaining carbons could be assigned in pairs
1 9 9 2 1 5
2 3 0
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as shown in Table 1.
Table 1.1: 13C NMR Assignments of Urea 1 9 9 .
Carbon
#
13c  Chemical 
Shifts (5, ppm)
C2 , C3 42 .3 3 , 48 .76
Cg, C, 0 45 .8 9 , 52.10
C5 , C7 46 .10 , 51.20 1 9 9
C. Dynamic NMR Experiments
A series of NMR experiments were performed in order to better 
understand the behavior 1 9  9 exhibited in solution and in the 
presence of an acid catalyst.
1. Enantiomerization Study of Urea 1 9 9 in DgO.
A sample of 1 9 9 was dissolved in D2O and the pD of the 
solution was measured using universal pH paper (pD 8-9). The iH a n d  
13c  NM R spectra of this sample were acquired immediately, after 48  
hours, 1 week, and 3 weeks. The pD of the mixture was measured (pH 
electrode) immediately, after 48 hours, 1 week, and 3 weeks. Figure
1.4 shows the 1H NMR spectrum of the mixture soon after mixing. It 
is clear that a significant amount of guanidinium salt 2 formed
2 3 4
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in it ia l ly .
2 1 6 X  = 0H~
2 1 7 X  = =BPh4“
The two multiplets corresponding to the upfield methylene in 1 9 9 
remained sharp (peaks at -1 .3 0  ppm and -1 .8 0  ppm) while dynamic 
broadening was observed between 2.50 and 4.00 ppm. The dynamic 
broadening is due the rapid enantiomerization shown in Scheme 1.12  
Scheme 1.12
The two interconverting species are in fact enantiomers, since the 
urea functionality cannot “tuck through” the 9-m em bered ring (on 
the NMR timescale). The pD of the sample was measured after two 
hours (pD 13.8) using an pH meter (pH = pD + 0.4194) equipped with a 
microelectrode as described in the experimental section. The  
dramatic change in pD after two hours is most likely due to the 
formation of guanidinium salt 2 1 6 . The counterion in this case is
r\ r~\
2 3 5
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hydroxide, which would raise the pH should a significant amount of 
2 1 6  form. Figure 1.5 shows the 1H NMR spectrum of the mixture
after 48  hours at room temperature.
The 1H NMR spectrum of this mixture after 1-3 weeks (Figures 1.6 
and 1.7) show little change except for the formation of a hydrolysis 
product which is triamine 2 0 8  (labelled in Figure 1.7).
Figure 1.8 shows the 13C NMR spectrum of the mixture of 1 9 9  
and D2 O soon after mixing. It is worthy to note that the upfield 
methylene C6 and the carbonyl carbon O n  in 1 9 9 remained sharp 
while the remaining six carbons were significantly broadened. The  
relative proportions (~1:1) of urea 1 9 9  and guanidinium ion 2 1 6  are 
based upon 13C NMR line intensity measurements of C3 in 2 1 6  and C6 
in 1 9  9. T h e is c  NMR spectrum, acquired 48  hours (Figure 1.9) after 
mixing the solution, also indicated that the guanidinium ion was the 
major component after 48 h. After 1-3 weeks (Figures 1.10 and 
1.11) 13C NMR spectrum showed the appearance of a small amount of 
hydrolysis product 2 0 8  (Figure 1.11). Guanidinium salt 2 1 7  was 
isolated by addition of one equivalent of NaBPfu (in 1 mL MeOH) to
the NMR sample, causing the precipitation of the salt 2 1 7.
2 3 6
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Figure 1.4
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Figure 1.7
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n<x>X 2 1 6 X  =  O H - 2 1 7  X  = =BPh4-
Tetraphenylborate salt 2 1 7  was isolated by filtration and 
recrystallized  from aceton itrile .
Table 1.2: 1 3C and 1H NMR Assignments of 2 1 7  (CD3CN).
13C Chemical 
Shifts (5, ppm)
1H Chemical Shifts 
(5 ,ppm)
23.22 (C3) 2.08 (p, 2H, J = 5.7 Hz)
42 .90  (C2,C 4) 3.22 (t, 4H, J =  5.8 Hz)
47 .86  (C6, C10) 3.48 (t, 4H, J =  7.5 Hz)




Alder et a l.186 has reported the preparation of mesylate salt 2 1 8 by 
a route shown in Scheme 1.13.
Scheme 1.13
B r ^ O H  NL
<  Y  > < Y >  Sfef3 , <  Y > Ms° '
V - N - V  THF N - V  CH2CI2 V - N ' ^ /
2 2 0  2 1 9  2 18
2 4 0
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1 H a n d l e  NMR spectral evidence was consistent with the formation 
of 2 1 7  by comparison to the 1H and 13C spectra of 2 1 8.
2. Enantiomerization of Urea 1 9 9 in DgQ-A pH Study
In this experiment, 1 9 9  was dissolved in NaOD (12 M, 40 wt. % 
in D20 ,  pD 14), the pD was measured with a micro pH meter (pD = pH 
+ 0.4), and the 1H and 13C NMR spectra were recorded. The pD of this 
solution was then adjusted with DCI/D2O (20%  DCI solution in D20 )  
and 1H and 1 3C NMR spectra were recorded. The pD was measured 
with a micro pH meter before and after each NMR experiment. There  
were a total of five different NMR experiments performed in this 
study (Figures 1 .12-1.22). The results of the pD measurements are 
summarized in Table 1.3.
Table 1.3
Exp. # PD
b e fo re
pD
a f te r
1H, 1 3C NMR figs.
1 1 3 .4 5 13 .41 Fig. 1 .12,1.18
2 1 2 .5 6 1 2 .8 9 Fig. 1 .13,1 .19
3 9 .6 7 1 2 .7 6 Fig. 1 .14,1.20
4 8 .2 3 7 .7 0 Fig. 1.15,1.21
5 1 .0 0 1 .1 2 Fig. 1 .16,1.22
241
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Figures 1.12 and 1.13 p H  NMRs, high pD) show the formation of 
guanidinium salt 2 1 6  and dynamic exchange broadening of urea 1 9  9. 
The NMR spectra shown in Figures 1.13, 1.14 and 1.15 indicate the 
magnet of the instrument was poorly shimmed, and as a result do not 
provide an accurate indication of broadening. However, it is obvious 
that as the pD was lowered, the amount of guanidinium salt 2 1 6  
increased. At pH below 8, 2 1 6 (X = CI-) is the dominant component 
in the mixture (Figures 1.15 and 1.16).
Both the 1H (Figure 1.12) and 13C NMR (Figure 1.18) spectra 
indicated that enantiom erization of 1 9 9 was occurring and that 
guanidinium salt 2 1 6  formed in D2O even at pD>12. At pD values 
lower than 12 guanidinium salt 2 1 6  predominates (Figures 1.20,
1.21, and 1.22). The small amount of remaining 1 9 9  is not exchange
2 4 2
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Figure 1.18
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2 1 6
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broadened since N-protonation shuts off enantiomerization. This 
NMR sample was then adjusted to pH14 with aq NaOD which caused a 
phase separation in the NMR tube. Removal of the organic phase was 
accomplished by extraction with C6 H6 . Combined organic extracts 
were dried (Na2 8 0 4 > and concentrated under reduced pressure to give 
pure 1 9 9  (50 %  recovery from original NMR sample, 1H NMR-Figure 
1.17). The observed phase separation seemed odd since urea 1 9 9  
was shown to be soluble in D2O at pH 13.5. The observed phase 
separation was probably due to the high concentration of NaCI in the 
NMR sample, since 12 M Na0 D/D2 0  was titrated with 20%  DCI/D2O.
In other words, “salting out” occurred.
3. Enantiomerization Study of Urea 1 9 9 in CgD«.
1H and 13C NMR spectra of 1 9 9  in CeD6 gave no indication of 
any dynamic broadening p H  NMR-Figure 1.23, and 13C NMR-Figure
1.25). Figure 1.26 shows the 13C NMR spectrum of this mixture 
immediately after the addition of mesitoic acid (2 ,4 ,6 - 
trim ethylbenzoic acid). Unfortunately, the 1H NMR spectrum of 
sample 1 9  9 directly after the addition of acid was not obtained. 
Mesitoic acid was chosen as a proton source, since it is soluble in
2 4 7
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benzene and since the conjugate base is a poor nucleophile and 
should not react with bicyclic urea 1 9  9. The spectrum shows peaks 
arising from 1 9 9  and 2 2 1 . The upfield methylene C6 (26.47 ppm) 
and the carbonyl carbon C n  (171.05 ppm) of 1 9 9  remained sharp 
while the remaining six carbons were broadened 0 3C NMR-Figure
1 .26 ).
221
Carbons C6 and C n  in 1 9 9 remained sharp after addition of acid due 
to the fact that these two nuclei do not exchange during the 
enantiomerization. The broadening of the other six nuclei of 1 9  9 
indicates that the enantiom erization process was in interm ediate  
slow exchange with respect to the NMR timescale. At the fast 
exchange limit the six broad peaks should coalesce into three peaks 
which result from time averaged Cs symmetry. However, this was 
not observed. The peaks corresponding to guanidinium salt 2 2 1  all 
remained sharp. After one week at room temperature the 1 H a n d l e
2 5 0
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NMR spectra indicated that there was a very small amount of the 
urea left (1H NMR-Figure 1.24, and 13C NMR-Figure 1.27). The  
addition of more mesitoic acid eventually converted the remaining 
1 9 9  into guanidinium salt 2 2 1.
D. Dynamic NMR Simulations.
The appearance of broad peaks in the 13C N M R  spectrum shown 
in Figure 1.28 (an expansion of the spectrum of Fig.1.26) allowed the 
estimation of a rate constant for the observed enantiomerization by 
computer simulation of the D N M R  spectrum. In order to simulate the 
spectrum, the 13C chemical shifts of urea 1 9 9  in the slow exchange 
limit must be known. Upon enantiomerization, the following nuclear 
positions will exchange in compound 1 9 9 :C 2 and C-io, C3 and Cg, C7 
and C5. Only C5 and C7 could unequivocally be assigned, as discussed 
earlier. So, these two 13C N M R  peaks (C5 and C 7) were chosen for 
simulation as a two-site mutual exchange system for compound 
1 9  9. A  first order rate constant of 90 ± 15 s-1 (0 .22  M  mesitoic 
acid concentration) w as calculated for the enantiom erization, which 
was simulated by the Complete Band Shape A n a ly s is 1 95 (CBS) method 
using N M R E X 196 a dynamic multisite N M R  simulation program (Figure
251
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
HIL1S4A
Figure 1.28
Expansion of 13CNMR 
spectrum of Figure 1.26
S im u la te d
5000 4900 4800  47 00  4600 4500 4400 4300 4200 4100 40 00  391
Chemical Shift Population T2 kl2 - 90
4168.84 .5 .08095
4628.59 .5 .08095 k21 = 90
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1.28, bottom). The population of each site is 1/2, which for the 
two-site exchange system utilizes the algorithm developed by 
S a n d s t r o m . 1 9 7  The effective transverse relaxation time was 
estimated from the reciprocal of the product of 7r and the full width 
at half height (Au =  3.9 Hz) of the methyl signal from mesitoic acid.
E. Infrared Analysis of Bicvclic Ureas.
The carbonyl stretching frequency of cyclic ureas 2 2 2198 and 
2 2 3  are 1685 cm -i (neat), and 1681 (neat) cm -i, respectively. 173 By 
constraining a urea functional group (1 9 9) in a bicyclic framework, 
the degree of frequency lowering due to resonance is decreased, 
since the urea functional group is forced to adopt a non-planar 
geo m etry .199 The stretching frequency of the carbonyl in bicyclic 
urea 2 2  4 is 1700 cm-i ( K B r ) . i 7 3  The greater stretching frequency 
observed for 2 2 4  is a result of poorer OCN conjugation.
2 5 3
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The bicyclic framework forces the urea functional group in 224  to  
adopt a non-planar geometry. Compound 1 9  9 has a carbonyl 
stretching frequency of 1689 c itH  (KBr) probably at least partly 
reflecting the resonance contribution of the transannular nitrogen, 
as was also observed with compound 1 9  7 (CO stretch at 1675 cm- 1
(K B r ) ) . i73
F. Sem iem pirical Calculations
Computer models are valuable for the investigation of 
interactions between atoms in a molecule.200-205 A M 1206  and PM3207  
semi-empirical calculations were used to model A and potential 
reaction intermediates in the observed acid catalyzed  
topomerization of compound A .  Compound A has some unique
2 5 4
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properties that make it a good candidate for study. The observed IR 
stretching frequency of the carbonyl in A is shifted towards lower 
frequency when compared to its bicyclic analog I .  This is largely 
due to the partial bonding of the amine nitrogen transannular to the 
urea carbonyl as discussed previously. The interaction decreases  
the 7t bond order of the carbonyl. The goal of these calculations was 
to determine the extent of this attraction using computational 
chemistry.
1. Results of AM1 and PM3 Calculations
Calculations on O-protonated and N-protonated bicyclic urea A , 
and guanidinium ion F or G were performed with geometry 
optimization. The heats of formation, C = 0  bond vibrational 
frequencies, NCCN torsional angles, and N -  C = 0  transannular 
distances (where applicable) for all calculated compounds are shown 
in Tables 1.4 and 1.5. The structures shown in Figure 1.29 were 
built on a Silicon Graphics workstation using the Spartan molecular 
modelling package (version 2 .0) which uses the standard geometrical 
param eters of the Tripos force field. Force-field minimized 
structures served as starting points for the AM1 and PM3 geometry
2 5 5
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optimizations. The calculations were carried out without solvation 
and must be considered “gas phase” results. The intent of this study 
is merely an overview and a detailed treatment of the data will not 
be pursed. The results of the AM1 calculations are shown in Table
1.4 and the results of the PM3 calculations are shown in Table 1.5. A 
list of the calculated structures is shown below.
2 5 6



























Structure Kev to Figure 1.29  
A-Bicyclic urea (Cs)
B-Protonation of A on oxygen (Cs) 
C-Protonation of A on urea nitrogen (C-i) 
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E-Protonation of pseudo C3 symmetric J (C-i)
F-Guanidinium ion + AH°f of H2 O (flat nitrogens sp2 hybridized-C3 h, 
note: The AH°f calculated by AM1 was -59 .24  Kcal/mol, 
the AH°f calculated by PM 3 was -53 .43  Kcal/mol)
G-Guanidinium ion + AH°f of H20  (pyramidalized nitrogens-C3)
H-Ketene iminium ion (9-m em bered ring in starting structure w a s  
in a [333] conformation)
I-B icyclic urea without transannular nitrogen
J-H yd ro xyo rth o am id e
K - ( s p 2  hybridized nitrogens were flat)
L-N-M ethyl bicyclic urea (Cs)
M -N-M ethyl bicyclic urea (alkylated at oxygen) C 1
N-Methoxyorthoamide (pseudo C3 symmetric)
O-N-Methyl bicyclic urea (alkylated at oxygen-CHOCN = gauche,
Me bisects NCN.
2 5 8
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Table 1.4












dist. in A 






A - 5 . 0 5 7 1728 2.741 - 5 5 . 3 /  + 55 . 3 A
B 151.971 1696 2 .468 - 4 5 . 9 / + 4 8 . 4 B
C 147.709 21  1 2 2.654 - 5 8 . 0 /  + 4 6 . 1 C
D 151.464 2 056 2.83 - 5 8 . 2 / + 5 8 . 2 D
E 152.585 1509 1.613 -1 3 .2 / +1  2.1 E
F 190.76 - - 0 . 0 / 0 . 0 N/A
G 180.72 - - 0 .0 / 0 . 0 N/A
H 154 .627 1974 2 .832 - 3 5 . 8 /  + 3 9 . 2 similar to /
1 - 2 2 . 9 5 8 2057 2.910 - 6 2 . 3 / + 6 2 . 3 N/A
J 6.380 1546 1.525 - 3 . 1 4 /  + 3 .14 N/A
K - 1 4 . 5 0 4 2 42 6 - 0 .0 / 0 . 0 N/A
L - 0 . 4 7 0 1602 2 .743 - 5 5 . 9 / + 5 6 . 0 L
M 159.965 1 724 2 .514 - 4 7 . 1 1 + 50 . 5 O
N 13.231 1492 1.527 - 2 . 51 + 2 . 7 N
0 165.484 1796 1.644 - 1 6 .3 / +1  6 .4 N
* The NCCN torsional angles given are 0 N (u re a )-C -C -N (a m in o )  
or the corresponding torsional angles in related structures.
2 5 9
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 1.5






















A - 3 1 . 9 4 1 696 2.824 - 5 9 .2 /  + 59.2 A
B 113.71 1 758 1.572 - 1 5 . 3 / + 1 4.5 E
C 131.52 1 729 2.663 - 6 0 .5 /  + 47.1 E
D 132.81 1 98 5 2.970 - 6 2 . 4Z + 6 2 .4 D
E 113.71 1 629 1.571 - 1 4 . 8 / + 1 4.4 E
F 152.12 - - 0 . 0 / 0 . 0 N/A
G 138.10 - - 0 . 0 / 0 . 0 N/A
H 131.69 2 0 2 2 1.599 - 5 2 . 9 /  + 63 . 8 E
1 - 4 5 . 8 9 1 983 3.003 - 6 3 . 2 /  + 63.2 I
J - 4 5 . 0 6 1 427 1.502 - 1 4 . 0 / - 3 . 3 N/A
K - 4 1 . 5 0 2541 - 0 .0 / 0 . 0 N/A
L - 3 4 . 4 9 1 988 2.796 - 5 9 .0 /  + 59.0 L
M 122.69 1 891 1.639 - 2 0 . 1 / + 2 0 . 1 O
N - 3 7 . 5 6 1 300 1.502 - 2 . 5 / + 2 . 4 N
0 122.17 1 965 1.599 - 1 9 . 2 / + 1 9.2 O
* The NCCN torsional angles given are 0 N (u re a )-C -C -N (a m in o )  
or the corresponding torsional angles in related structures.
2. Discussion of AM1 and PM3 Calculations
a. AM1 Calculations. With AM1 the .protonation of either the
2 6 0
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oxygen or the urea nitrogen of A resulted in a change in the N4 to 
C10 transannular distance indicating a transannular attraction.
Ketene imine H is also a possible intermediate in the topomerization 
pathway. An AM1 geometry optimization of input structure H did not 
significantly change the transannular N -C = 0  distance. Compounds F 
or G are very high in energy due to strain according to AM1. N- 
methyl urea L was also modeled in a similar fashion to that of A . In 
this example L was methylated at oxygen to give M which was then 
calculated. The resulting structure exhibited shortening of the 
N -C = 0  transannular distance.
b. PM3 Calculations. The results of PM 3 reflect a significant 
transannular interaction between atoms N4 and C10. Upon 
protonation at oxygen structure B closed up to structure E. Upon 
protonation at nitrogen structure C also closed up to structure E 
however the transannular distance was longer by 1.0A compared to 
the O-protonation result. Calculation of amine protonated urea D 
actually increased the transannular N—C = 0 . Calculation of ketene 
imine interm ediate H results in a minimized structure that also 
closely resembles closed structure E. Compound F and G is very high
261
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in energy due to strain according to PM3. Analogous bicyclic urea 
without the transannular nitrogen exhibits no interaction (C -C = 0  is 
3.0A). N-methyl urea L was modeled in a similar fashion to that of
A . In this example L was methylated at oxygen to give structure M 
which was calculated to give a structure (Cs symmetry) in which the 
methyl group bisects the NCN linkage. The resulting structure 0  had 
a short N—C = 0  transannular distance and very closely resembled 
closed structure N.
G. Ab Initio Calculations: Conformational Studies of A .
Ab initio calculationssos were used to begin to evaluate the 
relative energies of conformations of urea A . Three main 
conform ations were constructed: boat-chair A 1 (Figure 1.30), boat- 
boat A2 (Figure 1.31), and the chair-chair A 3 (Figure 1.32) or crown 
conformation. These three conformations were built on a Silicon 
Graphics workstation using the Spartan molecular modelling package 
(version 2 .0 ) which uses the Tripos force field. H F /3 -21G //3 -21G  
calculations were performed on these conformations and some of the 
important results are shown in Table 1.6. The ring tautomer bicyclic 
urea J (Figure 1.33) was also calculated in this study.
2 6 2
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Table 1.6: Results of Ab Initio Calculations
Compound
Number
A 1 A 2 A 3 J
R e la tiv e
Energy
k c a l/m o l
—
2 7 .7 4 0 . 0 0 7 .9 8
Point Group Ci Cs Cs Ci
D ihedra l 
0 -C 1 o- N - Ci
—
- 1 1 8 .3 ° -1 7 1 .5 °
—
N -0 = 0
d is tan ce 2 .2 9 A 2 .6 3 A
Bond orders 
M ulliken  
(Low din ) 
0 = 0  
N...C=0
—
1 .8 8 (2 .1 2 ) 
0.08 (0 .1 2 )
1 .7 4 (1 .9 8 )  
0.03 (0.36)
—
Conformer A 2 was 28 kcal higher in energy than A 3 . Ring tautomer 
J was 8  kcal higher in energy than conformer A 3  and 20 kcal lower 
in energy than conformer A 2. The amine nitrogen in A 2 is 
essentially flat. The amine nitrogen in conformer A 3  is inverted and 
the hydrogen points toward the carbonyl oxygen. The Mulliken bond 
order matrix gave values of 1.88 and 1.73 for the carbonyl in A 2 and
2 6 5
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A 3 respectively. The Mulliken bond order values for the amine 
nitrogen/carbonyl carbon interaction were 0 .08  for A 2 and 0.03 for 
A 3 . The interatomic distances between N4 and C10 were 2.29A and 
2.63A  for conformers A 2 and A  3. An attempt to submit the boat- 
chair conformer A 1  for a geom etry optimization H F /3 -21 //H F /3 - 
2 1 G was unsuccessful (convergence was not achieved after two days 
so the calculation was stopped).
Of the two conformers calculated A 3  was lower in energy by 
28 kcal/mol than A 2. The short transannular distance observed for 
A 2 strongly suggests that a transannular attraction exists and that 
interm ediate J is certainly plausible for the topomerization 
reaction A undergoes as observed experimentally.
The Mulliken bond order results are consistent with the 
rehybridization of urea carbonyl. The lone pair electrons on the 
amine nitrogen change the sp2 hybridized CO towards sp3 
hybridization The detectable Mulliken bond order values between 
atoms N4 and C10 support a transannular interaction. The 
interatomic distances between the urea carbonyl carbon and the 
amine nitrogen were well within the accepted range for typical 
transannular interactions (2 .0 -2 .5  A).
2 6 6
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The results of these calculations further support the existence 
of J as a likely intermediate for the topomerization observed 
experimentally by W ang.
2 6 7
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C h a p te r  II 
E x p e r im e n ta l S e c tio n  
I.U N H
A. General Methods
Melting Points (mp) were obtained on a Thomas Hoover capillary 
melting point apparatus and were uncorrected.
Infrared Spectra (IR) were run on a Nicolet FT IR spectrometer model 
M X-1.
1H NMR Spectra were taken on a Bruker AM 360 FT-NM R spectrometer 
operating at 360.134 M Hz. Chemical shifts are reported in parts per 
million (ppm) relative to internal M e4Si unless otherwise noted and
coupling constants (J values) are in Hertz (Hz).
13C NMR Spectra were taken on a Bruker AM 360 FT-NM R
spectrometer operating at 90.556 M Hz. Chemical shifts are reported
in parts per million (ppm) relative to internal Me4 Si unless 
otherwise noted.
Low-Resolution Mass Spectra (MS) were obtained on a Hewlett 
Packard 5988A GC/MS (using the direct insertion probe) at the
2 7 2
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University Instrumentation Center of UHN.
Hiah-Resolution Mass Spectra (HRMS) were obtained from either the 
Dupont/M erck Experimental Station in Wilmington, Delaw are or the 
M ass Spectroscopy Center at the University of Nebraska, Lincoln. 
CHN Analysis were obtained on a Perkin-Elmer Series II CHNS/O  
elem ental analyzer model 2400 at the University Instrumentation  
Center of UNH.
B. Solvents
Absolute ethanol (100%  EtOH) was obtained from AAPER Alcohol and 
Chemical Co.
A c e to n it r i le  (CHqCNI was obtained from EM Science. It was distilled 
from C aH 2 and stored over 3A molecular sieves.
Benzene (CeHe) was obtained from J.T. Baker and was distilled prior 
to use.
Carbon tetrachloride (CCI4 ) was obtained from Eastman Kodak Co. 
and distilled prior to use.
C h lo ro fo rm  (C H C I3 ) was obtained from EM Science and distilled prior 
to use.
Deuterated NMR Solvents were used as is from Cambridge Isotope
2 7 3
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Laboratories and stored over 3A molecular sieves. DM SO-d6 was 
distilled from CaFfe and stored over 3A molecular sieves.
Diethvl ether (Et2 0 ) was obtained from EM Science. It was distilled 
from purple sodium benzophenone ketyl prior to use. 
D im eth v lfo rm am id e  (DM F) was obtained from J.T. Baker It was 
distilled from CaH2 and stored over 3A molecular sieves.
Ethanol (95%  EtOH) was obtained from AAPER Alcohol and Chemical 
Co.
Glacial acetic acid ( HQAc) was obtained from Fisher Chemical Co. 
M ethanol (MeOH) was obtained from Fisher Chemical Co. It was 
distilled and stored over 3A molecular sieves.
M ethvlene chloride (CHaClot was obtained from J.T. Baker. It was 
distilled from CaH2 and stored over 3A molecular sieves.
P y rid in e  (py) was obtained from Fisher Chemical Co. It was distilled 
from CaH2 and stored over 3A molecular sieves.
T e trah vd ro fu ran  (THF) was obtained from EM Science. It was 
distilled from purple sodium benzophenone ketyl prior to use.
Toluene (PhCI-ht was obtained from EM Science. It was distilled from 
Na° and stored over 3A molecular sieves.
2 7 4
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C. Reagents
Acetic Anhydride (AcOAc) was obtained from Fisher Chemical Co. It 
was distilled prior to use.
A c rv lo n it r i le  was obtained from Aldrich Chemical Co. and distilled 
prior to use.
Benzophenone was obtained from Aldrich Chemical Co.
Benzyl bromide (PhCHoBrl was obtained from Aldrich Chemical Co. 
B orane-tetrahvdrofuran com plex (Bhh*THF. 1.0 M solution in 
tetrahrdrofuran) was obtained from Aldrich Chemical Co. 
A/-Brom osuccin im ide (NBS) was obtained from Eastman Kodak Co. 
Calcium hvdride (CaHol was obtained from Alfa Products Inc.
1 .1 ’-C a rb o n v ld iim id a z o le  was obtained from Aldrich Chemical Co. 
C e lite  was obtained from VW R Scientific.
Cesium carbonate (CS2 OO3 ) was obtained from Cabot Chemical Co. 
o -C re s o l was obtained from Eastman Kodak Co. It was purified by 
reduced pressure distillation.
1 .8 -D ia za b ic v c lo [5 .4 .0 1 u n d e c -7 -e n e  (DBU) was obtained from Aldrich 
Chemical Co. It was purified by reduced pressure distillation prior 
to use.
2 7 5
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E th v lb ro m o aceta te  was obtained from Aldrich Chemical Co.
G lvoxal (40 wt. % solution in H2O) was obtained from Aldrich 
Chemical Co.
Hydrochloric acid (12 M HCI) was obtained from Fisher Chemical Co. 
Lithium perchlorate (UCIO 4 ) was obtained from J.T . Baker. 
M ethoxvacetic acid was obtained from Fluka Chemie AG.
Methvl acrvlate was obtained from Aldrich Chemical Co. It was 
distilled prior to use to remove inhibitor.
Methvl iodide (Mel) was obtained from Aldrich Chemical Co.
10% Palladium on carbon (10%  Pd/C) was obtained from Engelhard 
Minerals and Chemical Corp.
Potassium carbonate (K2OO3) was obtained from Fisher Chemical Co. 
Potassium iodide (Kl) was obtained from Fisher Chemical Co.
Ranev nickel (W-21 was prepared by the method of Monzingo from 
Raney Nickel catalyst powder 2813 obtained from Grace Davison 
Chem ical.
Sea Sand was obtained from Fisher Chemical Co.
Sodium borohvdride (NaBHAl was obtained from Alfa Products Inc. 
Sodium carbonate fNaoQCM was obtained from Fisher Chemical Co. 
Sodium hydroxide (NaOH) was obtained from Fisher Chemical Co.
2 7 6
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Sodium tertaphenvlborate (NaBPh4 ) was obtained from J.T. Baker. 
Sulfuric acid (97% H2SO4 ) was obtained from J.T. Baker.
1 .4 .7 .1 0 -T e tra a z a c v c lo d o d e c a n e  (cyclen) was graciously prepared by 
Fagan. The tetra-p-toluenesulfonyl derivative was prepared by the 
Kellogg CS2OO3 m o d ific a tio n s ,76 of the cyclization procedure of 
Richman and Atkins.? 7 The detosylation procedure was based upon
that of Raymond.77.78
1 .4 .8 .1 1 -T e tra a z a c v c lo te tra d e c a n e  (cyclam) was obtained from 
Strem Chemical Co.
1 .4 .7 .1 1 -T e t r a a z a c v c lo t e t r a d e c a n e  (iso cyc lam ) w a s  grac ious ly  
p re p a re d  by F a g a n . T h e  te tra -p -to lu e n e s u lfo n y l d e riv a tiv e  w as  
p rep ared  by th e  Kellogg Cs2 0 0 3 m o d if ic a t io n s ,76 o f th e  cyc liza tio n  
p ro ced u re  of R ichm an an d  A tk in s .? 7 T h e  d etosy la tion  p ro ced u re  w as  
based  upon that of R aym o n d .77 .78
1 .4 .7 .1 0 -T e tra a z a c v c lo tr id e c a n e  was prepared as described in the 
experimental procedures section of this chapter.
1 .4 .8 .1 1 -T e tra a z a tr ic v c lo [9 .3 .1 .I^ Jflhexadecane was prepared 
previously by North .142 The product was purified by sublimation 
before use.
T h iira n e  (ethylene sulfide) was obtained from Aldrich Chemical Co.
2 7 7
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Thionvl chloride (SOCfe) was obtained from J.T. Baker. It was 
distilled prior to use.
T r ie th v la m in e  (EtsN)was obtained from Fisher Chemical Co. It was 
distilled from CaH2 and stored over 3A molecular sieves.
2 .4 .6 -T rim eth v lb en zo ic  acid (mesitoic acid) was recrystallized  
from CCI4  before use.
Tritvl chloride was obtained from Aldrich Chemical Co.
D. Column Chromatography Solid Supports.
A lum ina: Aluminum oxide powder (activated, basic, Brockmann 1,
150 mesh) “suitable for chromatography” was obtained from Aldrich 
Chemical Co.
F lo r is il:  Florisil (100 -200  mesh) “suitable for chrom atography” was 
obtained from Fisher Chemical Co.
E. Experimental Procedures
1 , 4 , 7 - T r i - p - t o l u e n e s u l f o n y l - 1 , 4 , 7 - t r i a z a c y c l o d e c a n e  
(212 ). 1 ,4 ,7 -T r i-p -to lu e n e s u lfo n y l-1 ,4 ,7 -tr ia z a c y c lo d e c a n e  w as
prepared by the Kellogg CS2 OO3 m o d ifica tio n s ,76 of the cyclization  
procedure of Richman and Atkins.?7 The crude product was
2 7 8
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recrystallized from CH2 Cfe/hexane to yield white powder (59% ): mp 
233-236 °C; (lit. mp 237 °C )2 .
1 , 4 , 7 - T r i a z a c y c l o d e c a n e  (2 0 8 ) .  Compound 2 0 8  was 
prepared by a detosylation procedure based upon that of 
Raymond.77.78 a  stirred solution of 1 ,4,7-tri-p-toluene-sulfonyl-
1 ,4,7-triazacyclodecane (9 .772  g, 16.10 mmoL) in 97%  H2 SO4 (50 mL) 
was heated to 100 °C under N2 atmosphere for 112 h. To the cooled
solution (0-5 °C), 80 mL of absolute EtOH was slowly added, and
followed by 120 mL of anhydrous Et2 0 . The precipitated product was 
filtered under nitrogen, dissolved in H20  (50 mL), adjusted to pH 14 
with solid KOH (with cooling), and extracted with CHCI3 ( 6  x 75 mL). 
The combined extracts were dried (Na2SC>4), and solvent was 
removed under reduced pressure. The crude product was kugelrohr 
distilled (0.25 mmHg, 120 °C  air bath temperature) to give an oil 
(1.95 g, 85%); 1H NMR (360 MHz, CDCI3) 5 1.60 (~p, 2H, J = 5.5 Hz,
CH2CH2CH2 ), 2.35 (br s, 3H, NH), 2 .68 -2 .77  (m, 4H ), 2 .78-2.86 (m, 4H),
2.91 (t, 4H, J =  5.4 Hz); 1 3C NMR (90.56 MHz, CDCI3) 6 26.16  
(CH2 CH2 CH2), 46.05, 47.40, 48.70. Compound 2 0 8  was prepared by
2 7 9
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Johnson. The trihydrobromide salt of 2 0 8  has previously been 
reported .
1 , 4 , 8 - T r i a z a - ( 1 1 - o x o ) - b i c y c l o [ 6 . 2 . 1 ] u n d e c a n e  ( 1 9 9 ) .  A
1 ,1-carbonyldiimidazole solution (2 .32  g, 14.31 mmoL in 50 mL TH F) 
was added dropwise over 2.5 h, under a nitrogen atmosphere, to a 
solution of 1,4,7-triazacyclononane (2.05 g, 14.3 mmoL) in THF (25  
mL) at 65 °C. The reaction mixture was then heated an additional
1.5 h at 65 °C. Solvent was removed under reduced pressure to give 
an oil which was flash chromatographed on basic alumina (2 % 
EtO H/CH2 C l2 ). The fractions containing primarily one spot by TLC  
(R f=0.59) were combined and flash chromatographed again on florisil 
(2% EtOH/CH2 C l2 , Ffy=0.63). Purified product was sublimed (0.02  
mmHg, 70 °C oil bath temperature) and then recrystallized from 
Et2 0 /Pentane (1:1) to give white crystals (0 .729  g, 30% ): mp 56- 
58°C; 1H NMR (360 MHz, C6 D6) 5 -0.15 (br s, 1H, NH), 0.78 (dtt, 1H, J = 
15.0, 4.0, 1.6 Hz, H6 -eq), 1.36 (dtdd, 1H, J = 15.0, 12.5, 4.3, 2.2 Hz, 
H6-ax), 2 .25 (ddd, 1H, J = 13.9, 9.6, 7.0 Hz), 2 .50-2.60 (m, 2H), 2.64  
(ddt, 1H, J =  14.3, 4.3, 1.6 Hz), 2.69 (ddd, 1 H, J = 13.6, 12.3, 1.4 Hz),
2 8 0
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2.86 (ddd, 1H, J = 9.8, 8.4, 4 .7  Hz), 2 .89-3.00 (m, 2H), 3 .08 (ddd, 1H, J 
= 11.2, 8.3, 7.0 Hz), 3 .24 (td, J =  9.5, 7.0 Hz), 3.58 (ddd, 1H, J  = 13.9, 
7.1, 1.6 Hz), 4.22 (ddd, 1H, J = 14.2, 12.8, 3.9 Hz); 13C NMR (90.56  
MHz, C6D6) 5 26.44 (CH2 CH2 CH2), 42 .34 , 45.90, 46.10, 48.76, 51.20, 
52.09, 171.05 (NCON); IR (KBr) 3360 (NH), 2950, 2925, 2905, 2840, 
1689 (C = 0 ), 1480, 1455, 1440, 1405, 1255, 1235, 1170, 1110, 775  
c m -1; MS, m j z  169 (M+); Anal Calcd for C8H15N30 : C, 56.78; H, 8.93; N, 
24.83. Found: C, 56.50; H, 9.13; N, 24.70.
4 - l m i d a z o l y l - 1 1 - o x o - 1 , 4 , 8 - t r i a z a b i c y c l o [ 6 . 2 . 1 ] -  
u n d e c a n e  (214 ). A solution of 1 ,1-carbonyldiimidazole (0.161 mg, 
0.990 mmol) in THF (3.0 mL) was added dropwise over 2.5 h, under a 
nitrogen atmosphere, to a solution of 1 ,4,7-triazacyclodecane (67.1 
mg, 0.469 mmol) in TH F (7.0 mL). The reaction mixture was then 
heated for 3 h at 65 °C. Solvent was removed under reduced 
pressure to give a solid which was chromatographed on 75 g basic 
alumina (2%  EtOH/CH2 C I2 , R^=0.35). The purified product was 
sublimed (0.15 mmHg, 80 °C oil bath temperature) to give white 
crystals (93.6  mg, 75% ): mp 147-148°C; 1H NMR (360 MHz, CDCI3) 5
2 81
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1.20-1.90 (m, 2H, CH2 CW2 CH2 ), 2.72-2.91 (dm, 1H, J =  14.6 Hz), 3.11- 
3.24 (m, 1H). 3.25-3.36 (m, 1H), 3 .37-3.46 (m, 2H), 3 .53 (dd, 1H, J = 
15.7, 11.0 Hz) 3.63-3.90 (m, 4H ), 4.01 (ddd, 1H, J =  14.7, 12.5, 3.7  
Hz), 4 .07-4.18 (ddm, 1H, J = 15.6, 6.0 Hz), 7 .10-7.20 (m, 1H), 7.31 (t, 
1H, J = 1.4 Hz), 7.87-8.01 (m, 1H, NCWN); 13C NMR (90.56 MHz, CDCI3)
5 23.98 (CH2 CH2 CH2), 42.86, 45 .85 , 46.98, 47.81, 51.55 (br), 53.29  
(br), 117.28 (NCHN), 130.11, 136.36, 152.07 (NCOIm), 168.75 (NCON); 
MS, m / z  263 (M+); IR (KBr) 3137, 3114, 3097, 2991, 1680 (CO), 1675 
(CO ), 1491, 1458, 1418, 1350, 1334, 1296, 1275, 1244, 764 cm-1; 
HRMS exact mass calcd for C ^ H ^ N sC ^  263 .1382, found 263.1381.
c / s - 1 3 - 1 , 4 , 7 , 1 0 - T e t r a a z a t e t r a c y c l o -  
[ 5 . 5 . 2 . 0 4 , 1  4. 0 1 0 , 1 3 ] te tra d e c a n e  (3 0 ). Aqueous glyoxal (1.64 mL 
40%  (w/w); 11.3 mmol) was added dropwise over 20 min under 
nitrogen to a stirred solution of 1,4,7,10-tetraazacyclododecane  
(1.50 g, 8 .70 mmoles) in MeCN (90 mL). The reaction mixture was 
then heated to 50 °C for 16 h. Solvent was removed to give a brown 
oil which crystallized upon the removal of residual solvent. The  
crude product was purified by sublimation (80 °C, 0 .02 mmHg) to 
give white powder (1.34 g, 79% ): mp 90-92 °C; 1H NMR (360 MHz,
2 8 2
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CDCI3) 5 2.52-2.60 (m, 4H), 2.70 (br s, 4H ), 2 .93-3 .02  (m, 8 H), 3 .14  
(s, 2H, CHCH); 13C NMR (90.56 MHz, CDCI3) 5 50.39, 51.18, 77.51 
(CHCH); IR (CCI4) 2940, 2890, 2830, 2800, 2760, 1315, 1270, 1185, 
1070, 850 cm -1; HRMS exact mass calcd for C10H18N4 194 .1522, 
found 194.1525.
( 1 R S , 7 R S , 1 3 S R , 1 4 S R ) - 1 , 7 - D i m e t h y l - 4 , 1  0 - d l a z a - 1 , 7 -  
d i a z o n i a t e t r a c y c l o [ 5 . 5 . 2 . 0 4 ,1 4 .0 1 0 , 1 3 ]te tra d e c a n e  d iio d id e  
( 3 1 ) .  To a stirred solution ofc/ 's-13 - 1 , 4 , 7 , 1 0 - t e t r a a z a t e t r a c y c l o -  
[5 .5 .2 .04 ,1 4.01 o,i3]tetradecane (1.45 g, 7 .47  mmol) in MeCN (20 mL) at 
room temperature, was added Mel (10.60 g, 74.69 mmol) all in one 
portion. The reaction flask was tightly stoppered, shielded from 
light, and the solution was stirred for 14 days. Precipitated product 
was collected by suction filtration and washed with M eCN ( 2 x 5  
mL), then CH2 C I2 ( 2  x 15 mL). Residual solvent was removed under 
high vacuum to give 3.23 g of white powder (90% ): mp 230-240 °C 
(dec); 1H NMR (360 MHz, D2O, MeCN secondary ref. set at 2.06 ppm) 5
3.02-3 .20  (m, 4H), 3 .31-3.45 (m, 2H + overlapping s, 6 H), 3.60 (td,
2H, J = 8 .6 , 4.2 Hz), 3.65 (dm, 2H, J = 10.8 Hz), 3.88 (ddd, 2H, J =
2 8 3
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12.2, 10.8, 4 .2  Hz), 3 .95-4.10 (m, 4H), 4 .49 (s, 2H, CHCH); 13CNMR 
(90.56 MHz, D2 0 ,  MeCN secondary ref. set at 1.7 ppm) 5 47.67, 51.10,
51 .34  (CH3), 63.73, 69.59, 82 .67  (CHCH); IR (KBr) 2995, 2950, 2920, 
2900, 2875, 1460, 1450, 1390 cm-1. Anal Calcd for C12H2 4N4 l 2 : C, 
30.14; H, 5.06; N, 11.72. Found: C, 30.43; H, 5.32; N, 12.02.
4 , 1 0 - D i m  e t h y l - 1 , 4 , 7 , 1 0 - t e t r a a z a b i c y  c l o [ 5 . 5 . 2 ] -  
te tra d e c a n e  (2 4 ). To a stirred solution of (1RS,7R S,13SR,14SR)-
1 , 7 -d im et hy l -4 , 10 - d i a z a - 1 , 7 - d i a z o n i a t e t r a c y c l o [ 5 . 5 . 2 . 0 4 . i 4 . o i o , i 3 ]  - 
tetradecane diiodide (1 .30 g, 2 .72  mmol) in 95% EtOH (50 mL) was 
added NaBH4 (1.40 g, 37 .00  mmol) in small portions over 20 minutes. 
The reaction mixture was stirred at room temperature for 4 days. 
Excess NaBH4 was then decomposed by slow addition of 30 mL 3 M 
HCI. Evaporation of solvent under reduced pressure gave a white 
solid which was dissolved in H20  (30 mL), adjusted to pH 14 with
solid KOH (with cooling), and extracted with benzene ( 6  x 15 mL).
The combined extracts were dried (Na2 S0 4 ), solvent was removed 
under reduced pressure, and crude product was kugelrohr distilled 
(80 °C  air bath temp, 0.04 mmHg) to give 0.60 g (96% ) of a clear oil:
2 8 4
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1H NMR (360 MHz, C6 D6) 5 2.27 (s, 6 H, CH3), 2 .3 6 -2 .4 8  (m, 4H), 2.65- 
2.85 (m, 12H), 3.05 (s, 4H, NCH2 CW2 N); 13C NM R (90.56 MHz, C6 D6) 5 
44.27  (CH3), 56.98 (NCH2 CH2 N), 57.35, 60.58; MS, m /z 226 (M+); IR 
(neat) 2951, 2910, 2848, 2812, 2793, 2747, 1445, 1366, 1105,
1062 cm -1; Anal Calcd for C12H2 6 N4 : C, 63.67; H, 11.58; N, 24.75. 
Found: C, 63.61; H, 11.85; N, 24.36.
1 , 4 , 7 , 1 0 - T e t r a - p - t o l u e n e s u l f o n y l - 1 , 4 , 7 , 1 0 -  
t e t r a z a c y c l o t r i d e c a n e  (5 3 ). 1 ,4 ,7 ,10 -T e tra -p -to lu en esu fo n y l-
1 ,4 ,7 ,10-tetrazacyclotridecane was prepared by the Kellogg Cs2 0 C>3 
m o d i f i c a t i o n s , 76 of the cyclization procedure of Richman and 
A t k i n s .77  The crude product was triturated with acetone twice to 
yield white powder (57% ): mp 208 -210°C  (lit. mp 194-197 °C); 1H 
NMR (360 MHz, CDCI3) 5 2.05 (~p, 2H, J = 6.5 Hz, CH2CW2CH2), 2.43 (s, 
6 H, ArCH3), 2.44 (s, 6 H, ArCW3) 3.16 (t, 4H, J =  6.5 Hz), 3 .28-3.42 (m, 
12H), 7 .27-7.40 (m, 8 H), 7 .40-7.55 (m, 8 H); 1 3C NMR (90.56 MHz, 
CDCI3) 5 21.50 (4C), 27 .04  (1C), 47.48 (2C), 48 .95  (2C), 51.60 (4C),
127.49 (1C), 127.77 (1C), 129.79 (1C), 129.85 (1C), 133.58 (1C), 
134.31 (1C), 143.74 (1C), 144.02 (1C).
2 8 5
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1 , 4 , 7 , 1 0 - T e t r a a z a c y c l o t r i d e c a n e  ( 46 ) .  Compound 4 3 was 
prepared by a detosylation procedure based upon that of Raymond.?7 
A stirred solution of 1 ,4 ,7 ,1 0 -te tra -p -to lu en esu lfo n y l-1 ,4 ,7 ,1 0 - 
tetrazacyclotridecane (20.25 g, 25.20 mmoL) in 97%  H2SO4 (150 mL) 
was heated to 100 °C  under N2 atmosphere for 96 h. To the cooled 
solution (0-5 °C), 180 mL of absolute EtOH was slowly added, and 
followed by 510 mL of anhydrous Et20 .  The precipitated product was 
filtered under nitrogen, dissolved in H20  (130 mL), adjusted to pH 14 
with solid KOH (with cooling), and extracted with CHCI3  (6  x 50 mL,
2 x 30 mL). The combined extracts were dried (Na2S0 4 ), and solvent 
was removed under reduced pressure. The crude product was 
purified by sublimation (0 .02 mmHg, 80 °C) to give hydroscopic 
needles (3.81 g, 81%): mp 36-38 °C (lit. mp 40 °C);77 1H NMR (360 
MHz, CDCI3) 5 1.67 (~p, 2H, J = 5.4 Hz, CH2 CW2 CH2), 1 .80-2.10 (br s, 
4H, NH), 2 .55-2 .85  (m, 16H); 13C NMR (90.56 MHz, CDCI3) 5 29.01 
(CH2 CH2 CH2), 47 .43 , 47 .64 , 48.90, 49.91.
c / s - 1 4 - 1 , 4 , 8 , 1 1 - t e t r a a z a t e t r a c y c l o -
2 8 6
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
[ 6 . 5 . 2 . 0 4 , 1 5 . 0 1 1 , i 4 ] p e n t a d e c a n e  (56 ). Aqueous glyoxal (3 .7 mL 
40%  (w/w); 25.1 mmol) was added dropwise over 1 h under nitrogen 
to a  stirred solution of 1 ,4 ,7 ,10-tetraazacyclotridecane (3 .42  g, 
18.36 mmoles) in MeCN (100 mL). The reaction mixture was then 
heated to 60 °C for 2.5 h. Solvent was removed to give a yellow oil, 
which was dissolved in CHCI3 and dried (Na2 9 0 4 ). After 
concentration of the solution, the crude product was purified by 
flash chromatography on basic alumnia (10%  EtOH/Et20 ,  fy 0.29) to 
give a clear oil which crystallized upon storage at -10 °C. (1.91 g, 
50%): mp 28-30°C; 1H NMR (360 MHz, CDCI3) 5 1.20-1.32 (dm, 1H, J = 
8.1 Hz) 1.90-3.70 (br m, 19H) 2.88 (d, J = 2.8 Hz, CH) 3.37 (d, J = 2.8 
Hz, CW)(Note: the 1H NM R spectrum exibited severe dynamic exchange 
broadening.); 13C NMR (22.5 MHz, CDCI3 , -39 °C) 5 19.79 (CH2 CH2 CH2),
(Note: the following three pairs of peaks (labelled A, B, and C) each 
broadened upon warming and coalesced to a singlet by 55 °C; see 
below) 45.51 and 53.18 (A), 49 .35  and 51.82 (B), 51.82 and 54.76 (C),
49.93 , 75.39 (CH), 77.74 (CH); 13C NMR (22.5 MHz, CDCI3 , 55 °C) 5
20.35, (Note: the following peaks (labelled A, B, and C) correspond to 
three pairs of coalesced resonances.) 49 .82  (br) (A), 50.97 (B), 53.83
2 8 7
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(C), 50.41, 76.13 (CH), 78.17 (CH); MS, m / z  208 (M+); IR (CCI4) 2930, 
2883, 2842, 2795, 2790, 1320, 1278, 1161,  1130, 1112, 1095 cm-1- 
Anal Calcd for C n H 2 oN4: C, 63.43; H, 9.68; N, 26.90. Found: C, 63.17;
H, 9.98; N, 27.02. A minor isomer was also isolated (0.20 g, 5%, Rf 
0.07 10% EtOH/Et20 ); 1H NMR (360 MHz, CDCI3) 5 1.40 (dtt, 1H, J =
15.0, 5.6, 2.0 Hz) 2.02 (dtt, 1H, J = 15.0, 10.7, 2.9 Hz) 2 .45-2.85 (m, 
8H) 2.92-3.08 (m, 3H) 3.13 (ddd, 2H, J = 13.7, 5.7, 2.6 Hz) 3.27-3.40  
(m, 2H) 3.59 (s, 2H, CHCH); 13C NMR (90.56 MHz, CDCI3) 5 25.11,
49.33, 51.31, 51.63, 52.31, 80.94.
( 1 R S , 8 S R , 1 4 S R , 1 5 S R ) - 1 , 8 - D i m e t h y l - 4 , 1 1  - d i a z a - 1 , 8 -  
d i a z o n i a t e t r a c y c l o [ 6 . 5 . 2 . 0 4 ,1 5. 0 1 1 . 1  4 ]p e n ta d e c a n e  d iio d id e  
( 6 2 ) .  To a stirred solution of c / s - 1 4 - 1 , 4 , 8 , 1 1 - t e t r a a z a t e t r a c y c i o -  
[6 .5 .2 .04,15.011 ,i4]pentadecane (0.358 g, 1.72 mmol) in MeCN (5 mL) at 
room temperature, was added Mel (5.7 g, 40  mmol) all in one portion. 
The reaction flask was tightly stoppered, shielded from light, and 
the solution was stirred for 13 days. Precipitated product was 
collected by suction filtration and washed with M eCN ( 2 x 5  mL). 
Residual solvent was removed under vacuum to give 0.74 g of white
2 8 8
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
powder (87% ): mp 220-224 °C (dec); m  NMR (360 MHz, D20 , MeCN 
secondary ref. set at 2 .06 ppm) 5 1.90-2.03 (dm, 1H, J  = 15.3 Hz, H12- 
eq), 2.37 (dtt, 1H, J = 15.3, 13.8, 4.6 Hz, H12.ax), 2.71 (td, 1H, J =  12.3, 
3.0 Hz), 3 .01-3.24 (m, 4H), 3.46 (tm, 2H, J = 11.8 Hz), 3.35 (s, 3H,
CH3), 3.42 (s, 3H, CW3), 3 .44-3.64 (m, 2H), 3.69 (td, 1H, J = 13.5, 3.8
Hz), 3.81-3.91 (m, 2H), 3 .95-4.12 (m, 2H), 4.41 (m, 1H), 4.65 and 4.69
(AB, 2H, J =  2.1 Hz, CHCH); 13C NMR (90.56 MHz, D20 ,  MeCN secondary 
ref. set at 1.7 ppm) 6 19.43, 42.71, 46.34, 46.74, 47.33, 49 .12 , 50.87, 
52.04, 56.95, 64.59, 65.53, 76.98, 78.49; IR (KBr) 2994, 2990, 2965, 
2950, 2927, 2909, 2862, 2852, 2843, 2831, 2826, 1418, 1121 cm-1. 
Anal Calcd for C i3H26N4I2: C, 31.73; H, 5.32; N, 11.38. Found: C, 31.66;
H, 5.50; N, 11.34. In a separate example when the reactiopn was run
for 3 days an 85% yield of pure 6 2 was isolated.
4 , 1 1 - D i m e t h y l - 1 , 4 , 8 , 1 1 - t e t r a a z a b i c y c l o [ 6 . 5 . 2 ] -  
p e n ta d e c a n e  (5 8 ). To a stirred solution of (1R S ,8S R ,14S R ,15S R )-
I , 8 -d im e t h y l - 4 , 1 1 - d ia z a - 1 , 8 - d i a z o n i a t e t r a c y c l o [ 6 . 5 . 2 . 0 4 . i 5 . o i  1 .14] - 
pentadecane diiodide (0.624 g, 1.27 mmol) in 95% EtOH (20 mL) was 
added NaBH4 (1.64 g, 43 .3  mmol) in small portions. The reaction was
2 8 9
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stirred at room temperature for 7 days. Excess NaBH4 was 
decomposed by slow addition of 3 M HCI (25 mL). Solvent removal 
gave a white solid which was dissolved in H2O (20 mL), adjusted to 
pH 14 with solid KOH (with cooling), and extracted with toluene ( 6  x 
15 mL). The combined extracts were dried (Na2S0 4), solvent was 
removed under reduced pressure, and crude product was kugelrohr 
distilled (100-130 °C air bath temp, 0 .03 mmHg) to give 0.291 g 
(96% ) of a clear viscous oil: 1H NMR (360 MHz, CeDe) 5 1.47 (tt, 2H, J 
= 6.7, 4.9 Hz, CH2CW2 CH2 ), 2  06 (dt, 1 H, J = 1 2 .1 , 4.9 Hz), 2.14 (s, 3H, 
CH3), 2.29 (s, 3H, CH3), 2 .23 -2 .37  (m, 2H), 2 .39-2 .53  (m, 2H), 2.54- 
2.93 (m, 12H), 2.96 (ddd, 1H, J  =  13.6, 5.6, 2.4 Hz), 3 .22-3.32 (m, 1H),
3.43 (dt, 1H, J = 12.1, 6 . 8  Hz); 1 3C NMR (90.56 MHz, C6D6) 5 27.91 
(CH2 CH2 CH2 ), 43.38, 43 .88 , 54 .00 , 54.05, 54.69, 55.33, 55.44, 56.78, 
57.52, 58.41, 60.57, 61.11; IR (neat) 2949, 2916, 2874, 2854, 2788, 
2784, 2745, 1447, 1363, 1117,  1053 cm-1; HRMS exact mass calcd 
for C13H2 9N* 241 .2392, found 241 .2383.
c i s - 1 5 - 1 , 4 , 8 , 1  2 - t e t r a a z a t e t r a c y c l o -  
[ 6 .6 .2 .O4 . 1 6. 0 1 2 >1 s]hexadecane (57 ). Aqueous glyoxal (0.63 mL
2 9 0
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40%  (w/w); 4 .34 mmol) was added dropwise over 20 minutes under 
nitrogen to a stirred solution of 1 ,4 ,7 ,1 1-tetraazacyclotetradecane  
(0.66 g, 2 .97 mmol) in MeCN (45 mL). The reaction mixture was then 
heated to 55 °C for 1.5 h. Solvent was removed under reduced 
pressure to give a yellow oil which was dissolved in CHCI3 and dried 
(Na2 S0 4). After concentration of the solution, the crude product was 
purified by flash chromatography on basic alumnia (10%  Et0 H/Et2 0 ,
Rf 0.32) to give a clear oil. This oil was kugelrohr distilled (100 °C  
air bath temperature, 0 .03 mmHg) to give pure product, which 
solidified upon standing (0.353 g, 49% ): mp 50-52°C; 1H NMR (360 
MHz, CDCI3) 5 1.32-1.42 (m, 1H), 1.58 (dddt, 1H, J = 13.6, 7.5, 5.1, 2.5  
Hz), 1 .87-2.18 (m, 3H), 2.27 (td, 1H, J = 11.7, 2.7 Hz), 2 .39-2.70 (m, 
6 H), 2 .77 (ddd, 1H, J =  12.0, 6 .8 , 1.8 Hz), 2.84 (ddd, 1H, J = 14.0, 7.1,
3.5 Hz), 2 .88-2.99 (m, 3H), 2.91 (d, 1H, J  = 3.8 Hz, CH), 3.06 (ddd, 1H, 
J = 10.3, 9.2, 6 . 8  Hz), 3.13 (ddd, 1H, J  = 12.0, 7.1, 2.3 Hz), 3.48 (d, 1H, 
J = 3.8 Hz, CH), 3.58 (td, 1H, J = 10.5, 6 . 8  Hz); 13C NMR (90.56 MHz, 
CDCI3) 5 23.93, 30.65, 47.96, 50.15, 52.33, 52.71, 53.00, 55.55,
55.89, 56.97, 81.90 (CH), 84.44 (CH); MS, m / z  222 (M+); IR (KBr)
2958, 2935, 2926, 2893, 2875, 2850, 2813, 2792, 2771, 2757,
2 9 1
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2749, 1439, 1377, 1299, 1177, 1141, 1123, 1097, 1035, 965 cm-1. 
Anal Calcd for C 12H2 2N4 : C, 64.83; H, 9.97; N, 25.20. Found: C, 65.13;
H, 10.23; N, 25.56.
( 1 R S , 7 R S , 1 3 S R , 1 4 S R ) - 1 , 7 - D i b e n z y l - 4 , 1 0 - d i a z a - 1 , 7 -  
d i a z o  n i a t e t  r a c y  cl  o [ 5 . 5 . 2 . 0 4 ,1 4 .0 1  0 ,1  3 ] t e t r a d e c a n e  d i b r o m i d e  
( 7 0 ) .  To a stirred solution of c / s - 1 3 - 1 , 4 , 7 , 1 0 - t e t r a a z a t e t r a c y c l o -  
[5 .5 .2 .04 .14 0 1 0 ,13]tetradecane (260 mg, 1.34 mmol) in MeCN (10 mL) 
at room temperature, was added benzyl bromide (1 .44 g, 8.41 mmol), 
all in one portion. The reaction mixture was stirrred for 3 days. 
Precipitate was collected by suction filtration, and washed with 
MeCN ( 3 x 5  mL). Residual solvent was removed under vacuum. This 
gave 640 mg of product as white powder (89% ): mp 208-212°C  (dec); 
1H NMR (360 MHz, D2O, MeCN secondary ref. set at 2 .06 ppm) 5 3 .10-
3.25, (m, 2H), 3 .40-3.55 (m, 4H) 3 .58-3.75 (m, 6H), 3 .80-3 .95  (m,
2H), 4 .25-4 .90  (m, 2H), 4.84 (s, 2H, CH), 4 .82 and 4.98 (AB, 2H, J = 
13.2 Hz, CH2Ph), 7 .50-7.75 (m, 10H, CH2Ph); 13C NMR (90.56 MHz, D20 ,
MeCN secondary ref. set at 1.70 ppm) 5 43 .55, 46.82, 55.55, 61.68,
61.83, 78 .37  (CH2Ar), 126.97, 130.52, 132.11, 133.21; IR (KBr) 3063,
2 9 2
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3039, 3006, 2956, 2941 , 2917, 2893, 2842, 1459, 1442, 1340,
1292, 1202, 941, 761, 704 cm-1- Anal Calcd for C24H33N4 Br2: C,
53.75; H, 6.01; N, 10.45. Found: C, 53.56; H, 6.20; N, 10.35.
4 , 1 0 - d i b e n z y l - 1 , 4 , 7 , 1 0 - t e t r a a z a b i c y  cl  o [ 5 . 5 . 2 ] -  
t e t r a d e c a n e  (7 1 ). To a stirred solution of (1RS,7R S,13SR,14SR)-
1 , 7 - d i b e n z y l - 4 , 1 0 - d i a z a - 1 , 7 - d i a z o n i a t e t r a c y c l o [ 5 . 5 . 2 . 0 4 . i 4 .Oio,i3] - 
tetradecane dibromide (3 .83 g, 7.14 mmol) in 95% EtOH (135 mL) was 
added NaBH4 (10.09 g, 0 .267  mol) in small portions over 20 minutes. 
The reaction was stirred at room temperature for 4 days. Excess 
NaBH4 was then decomposed by slow addition of 100 mL 3 M HCI. 
Evaporation of solvent under reduced pressure gave a white solid
which was dissolved in H20  (40 mL), adjusted to pH 14 with solid
KOH (with cooling), and extracted with benzene (6  x 50 mL). The
combined extracts were dried (Na2S04), and solvent was removed
under reduced pressure to yield 2.89 g (-1 0 0 % ) of a viscous oil; 1H 
NMR (360 MHz, C6D6) 5 2 .50-2 .90  (m, 16H), 3 .17 (s, 4H), 3.59 (s, 4H), 
7 .05 -7 .33  (m, 10H); 1 3C NMR (90.56 MHz, C6 D6) 5 57.00, 57.88, 58.75,
61.35, 126.97, 128.42, 129.17, 140.89; MS, m / z  378 (M+); IR (KBr)
2 9 3
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3080, 3055, 3025, 2915, 2865, 2820, 2800, 1493, 1450, 1365,
1093, 720, 690 cm -1; HRMS exact mass calcd for C10H18N4 379 .2862 , 
found 379.2849. The 13C and 1H NMR showed the material to be >99%  
purity. This material was debenzylated without further purification.
1 , 4 , 7 , 1 0 - T e t  r a a z a b i  e y e  I o [ 5 . 5 . 2 ]  t e t r a d e c a n e  ( 7 2 ) .
Hydrogenolysis of 4 ,1 0 -d ib e n z y l-1 ,4 ,7 ,1 0 -te tra a z a b ic y c lo [5 .5 .2 ]-  
tetradecane was carried out in a glass apparatus designed for the 
exclusion of O2 and for measurement of H2 uptake with maintainance 
of constant pressure. The catalyst (0.79 g, 10% Pd/C) and solvent 
(250 mL glacial acetic acid) were added to a 500 mL hydrogenation 
flask which was connected to the hydrogenator. The system was 
evacuated (by means of a water aspirator) and flushed with nitrogen 
four times. After another evacuation the system was filled with 
hydrogen. The mixture of 10% Pd/C and glacial acetic acid was 
equilibrated with stirring under H2 (766 mmHg) for 1.25 h. To this 
was added 4 ,1 0 -d ib e n zy l-1 ,4 ,7 ,1 0 -te tra a za b ic y c lo [5 .5 .2 ]te tra d e c a n e  
(2.89 g, 7.64 mmol) dissolved in glacial acetic acid (10 mL). The  
mixture was stirred for 40 minutes under H2 (759 mmHg). The 
theoretical H2 uptake for this reaction was 399 mL. The actual
2 9 4
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uptake was 460 mL, which is 115% of the theoretical value. The  
hydrogenation apparatus was evacuated and flushed with nitrogen 
four times. The reaction flask was removed from the apparatus, the 
contents were filtered through celite, and the catalyst and celite 
were washed with glacial acetic acid (3 x 10 mL). The filtrate and 
washings were combined and concentrated under reduced pressure to 
give a light yellow oil, which was dissolved in H20  (50 mL), adjusted 
to pH 14 with solid KOH (with cooling), and extracted with benzene  
( 6  x 40 mL). The combined extracts were dried (Na2S0 4 ) and solvent 
was removed under reduced pressure to give 1 . 6 8  g of crude solid 
product, which was kugelrohr distilled (100 °C air bath temperature, 
0.03 mmHg). The collection bulb for the distillation was changed 
after the first 20 minutes and the distillation was continued. The  
first fraction ( 1 . 1 0  g) was a white solid and the second fraction 
(0 .308 g) was a clear liquid. The distillation residue (0 .150 g), the 
sublimation residue (0 . 1 1 0  g), and the second fraction collected 
from the distillation (0 .308  g) contained 4 -b en zy l-1 ,4 ,7 ,10 - 
te traazab icyc lo [5 .5 .2 ]te trad ecan e  and 4 ,1 0 -d ib e n zy l-1 ,4 ,7 ,1 0 -  
tetraazabicyclo[5.5.2]tetradecane. An attempt to obtain more 
product by hydrogenolysis of these mixtures was unsuccessful. The
2 9 5
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first fraction collected from the distillation was further purified by 
sublimation (80 °C, 0.03 mmHg) to yield 0.91 g of white crystals 
(55% ): mp 102-104°C; 1H NMR (360 MHz, C6D6) 5 2.15 (s, 2H, Ntf), 
2.45-2 .75  (m, 20H), 2 .66 (s, NCH2 CH2N bridge); 13C NMR (90.56 MHz, 
CsDe) 6 50.58, 52.63, 55.40; MS (Cl, CH4), m / z  199 (M + 1 ); IR (KBr) 
3390, 2940, 2935, 2910, 2890, 2870, 2850, 2825, 2805 , 1580,
1462, 1365, 1340, 1155, 804 cm -1; Anal Calcd for C10H2 2 N4 :C ,
60.57; H, 11.18; N, 28.25. Found: C, 60.61; H, 11.31; N, 28.30. The 
crude product could also be purified by an alternate method. The 
crude solid product (2.00 g) was dissolved in absolute EtOH (4 mL) 
containing (2 mL) concentrated HCI. Mixing resulted in precipitation 
of the hydrochloride salt which was filtered, washed with cold (0 - 5  
°C) absolute EtOH ( 2 x 1  mL), and air-dried, th e  hydrochloride salt 
was recrystallized from CH3CN (10 mL) containing enough H20  to 
totally dissolve all of the solid. The recrystallized m aterial was 
dissolved in H20  (10 mL), adjusted to pH 14 with solid KOH (with 
cooling), and extracted with benzene (5 x 20 mL). The combined 
extracts were dried (Na2S04), and solvent was removed under 
reduced pressure to give crystalline material identical to that
2 9 6
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mentioned above. The yield for this purification method was 50%
(0.99 g).
( 1 R S , 8 S R , 1 4 S R , 1 5 S R ) - 1 , 8 - D i  b e n z y l - 4 , 1 1 - d i a z a - 1 , 8 - 
d i a z o n i a t e t r a c y c l o [ 6 . 5 . 2 . 0 4 , 1 5. 0 1 1 >1 4 ]p e n ta d e c a n e  d i b r o m i d e  
h y d r a t e  ( 6 8 ). To a stirred solution of c / s - 1 4 - 1 , 4 , 8 , 1 1 - t e t r a a z a -  
te tra c y c lo [6 .5 .2 .0 4 ,i5 .o n .i4 ]p e n ta d e c a n e  (1.49 g, 7.17 mmol) in MeCN  
(35 mL) at room temperature, was added benzyl bromide (12.40 g, 
72.50 mmol), all in one portion. The reaction mixture was stirrred 
at room temperature for 3 weeks. Precipitate was collected by 
suction filtration, washed with M eCN (2 x 30 mL), then CH2 C I2 (3 x 
15 mL). Residual solvent was removed under vacuum. This gave 3.60  
g of product as white powder (90% ): mp 222-225 °C (dec); 1HNMR  
(360 MHz, D2 0 ,  MeCN secondary ref. set at 2.06 ppm) 6  1 .86-1 .97  (dm, 
1 H, J  =  15.0 Hz, H6 -eq) 2.15-2.33 (m, 1 H, H6 . ax) 2.78 (td, 1 H, J = 1 2 .2 , 
2.9 Hz) 3 .09-3 .92  (m, 13H) 4.21-4.39 (m, 2H), 4.78 and 5.09 (AB, 2H, 
J =  13.3 Hz, CZ-fePh) 4 .87 and 5.18 (AB, 2H, J =  13.0 Hz, CH2 Ph), 4 .95  
and 5.12 (AB, 2H, J  = 1.1 Hz, CHCH), 7 .30-7.90 (m, 10H, Ph)\ 1 3CNMR  
(90.56 MHz, D2 O, MeCN secondary ref. set at 1.70 ppm) 6  19.40
2 9 7
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
(CH2 CH2 CH2 ), 43.37, 46.34, 47.68, 48.94, 51.25, 52 .84 , 61.05, 61.16, 
61.37, 63.34, 76.81 (CH), 78.82 (CH), 125.56 (1 carbon), 126.62 (1 
carbon), 130.28 (2 carbons), 130.52 (2 carbons), 132.18 (2 carbons), 
133.18 (2 carbons), 134.10 (2 carbons); IR (KBr) 3062, 3050, 3026, 
3018, 2996, 2957, 2915, 2886, 2864, 2844, 2821, 2807, 1480,
1456, 1437, 1283, 1212, 1146, 1110, 1055, 769, 711, 706 cm-1- 
Anal Calcd for C2 5H3 4N4 Br2 «0 .5 H2O: C, 53.68; H, 6.31; N, 10.02. Found: 
C, 53.94; H, 6.10; N, 9.97.
4 , 1 1 - d i b e n z y l - 1 , 4 , 8 , 1 1 - t e t r a a z a b i c y c l o [ 6 . 5 . 2 ] -  
p e n ta d e c a n e  (6 9 ). NaBH4 (13.10 g, 0 .340 mol) was added in small 
portions over 2 0  minutes to a stirred solution of 
(1 R S , 8 S R , 1 4 S R , 1 5 S R ) - 1 , 8 - d i b e n z y  1-4,11 - d i a z a - 1 , 8 -d ia z o n ia -  
t e t racyclo[6.5 .2 .04, i5 .oi  1 .i4]pentadecane dibromide (3.05 g, 5.55  
mmol) in 95%  EtOH (75 mL). The reaction mixture was stirred at 
room temperature for 10 days. Excess NaBH4 was then decomposed 
by slow addition of 150 mL 3 M HCI. Evaporation of solvent under 
reduced pressure gave a white solid which was dissolved in H20  (100  
mL), adjusted to pH 14 with solid KOH (with cooling), and extracted
2 9 8
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with benzene ( 6  x 50 mL). The combined extracts were dried 
(Na2 SC>4 ), and solvent was removed under reduced pressure to yield
1.44 g (-10 0% ) of a viscous oil; 1H NMR (360 MHz, CeD6) 5 1 .37 -1 .60  
(m, 2 H, CH2 CH2CH2), 2 .26-2 .49  (m, 5H), 2 .53-2 .73  (m, 7H), 2.78 (ddd, 
1H, J = 13.7, 4.3, 2.6 Hz), 2 .82-3.04 (m, 5H), 3.09-3.21 (m, 1H), 3.26  
and 3.64 (AB, 2H, J = 13.4 Hz, Ctf2Ph), 3.60 and 3.62 (AB, 2H, J = 14.4 
Hz, CH2 Ph), 3.88 (ddd, 1H, J =12.7, 8.2, 4 .9  Hz), 7.07-7.41 (m, 10H, 
CH2 P/7); 13C NMR (90.56 MHz, C6D6) 5 28.59 (CH2 CH2CH2), 52.39, 53.78,
55.43, 55.84, 56.36, 56.43, 57.04, 57.93, 59.04, 59 .48 , 60.82, 60.99,
126.93, 126.98, 128.41, 128.42, 129.08, 129.39, 140.92, 141.03; MS, 
m / z  392 (M +); IR (neat) 3077, 3053, 3020, 2919, 2863, 2800, 2784, 
2745, 2721, 2702, 1448, 1364, 1110, 1046, 1025, 729, 696 cm -H  
HRMS exact mass calcd for C2 5H37N4 393.3018, found 393.3012. The  
1 sc and 1H NMR showed the material to be >98%  purity. This material 
was debenzylated without further purification.
1 , 4 , 8 , 1 1 - T e t r a a z a b i c y c l o [ 6 . 5 . 2 ] p e n t a d e c a n e  (6 7 ) .
Hydrogenolysis of 4 ,1 1 -d ib e n zy l-1 ,4 ,8 ,1 1 -te tra a za b ic y c lo [6 .5 .2 ]- 
pentadecane was carried out in a glass apparatus designed for the
2 9 9
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exclusion of O2 and for measurement of H2 uptake with maintenance 
of constant pressure. 10% Pd/C (0.20 g) glacial HOAc (60 mL) were 
added to a 125 mL hydrogenation flask which was connected to the 
apparatus. The system was evacuated (by means of a water 
aspirator) and flushed with nitrogen four times. The system was 
then evacuated, filled with hydrogen, and catalyst was equilibrated  
under H2 (767 mmHg) for 1.5 h. To this was added a solution of 
4,11 -d ib en zy l-1 ,4,8 ,11 -te traazab icyc lo [6 .5 .2 ]pen tadecane  (1.11 g, 
2.83 mmol) in glacial HOAc (5 mL). The mixture was stirred for 19 h 
under H2 (767 mmHg). (The theoretical H2 uptake for this reaction 
was 138 mL. The actual uptake was 144 mL, which is 104%  of the 
theoretical value.) The apparatus was evacuated and flushed with 
nitrogen four times, the reaction flask was removed from the  
apparatus, the contents were filtered through celite, and the 
catalyst and celite were washed with glacial acetic acid ( 2 x 5  mL). 
The filtrate and washings were concentrated under reduced pressure 
to give a light yellow oil which was dissolved in H20  (50 mL),
adjusted to pH 14 with KOH, and extracted with benzene (5 x 50 mL). 
The combined extracts were dried (Na2 S0 4 ), and solvent was
3 0 0
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removed under reduced pressure to give an oil which was kugelrohr 
distilled (90-120  °C air bath tem perature, 0 .03  mmHg). This oil 
solidified upon standing to give 0 .494 g (82%  crude yield) of solid 
product. The material contained minor impurities and was further 
purified. This solid was dissolved in absolute EtOH (5 mL) 
containing (1 mL) concentrated HCI. Mixing resulted in precipitation 
of a hydrochloride salt which was filtered, washed with cold (0-5  
°C) absolute EtOH (2 x 1 mL), and air-dried. This solid was dissolved 
in H2 O (10 mL), adjusted to pH 14 with solid KOH (with cooling), and
extracted with benzene ( 6  x 15 mL). The combined extracts were 
dried (Na2 S0 4 ), and solvent was removed under reduced pressure to 
give an oil. This oil was kugelrohr distilled (100 °C  air bath 
temperature, 0.03 mmHg) and solidified upon standing to give 0.283  
g (47% ) of white solid: mp 28-30°C; 1H NMR (360 MHz, C6D6) 5 1.26- 
1.51 (m, 2 H CH2 CH2CH2 ), 2 .10-2.90 (m, 2 1 H), 3.30 (ddd, 1H, J = 1 2 .1 , 
7.5, 2.4 Hz); 13C NMR (90.56 MHz, C6 D6) 5 27.14 (CH2 CH2 CH2 ), 47.68,
48.56, 48.89, 49.02, 52.85, 53.27, 53.59, 54.20, 55.97, 59.41; MS, 
m / z  212 (M+); IR (KBr) 3474, 2948, 2929, 2907, 2894, 2845, 2699, 
1577, 1464, 1399, 1356, 1342, 812, 612, 523 cm-1: HRMS exact
3 01
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
mass calcd for C11H2 5 N4 213.2079, found 213 .2078.
( 1  R S , 8 R S , 1 5 R S , 1 6 R S ) - 1 , 8 - D i b e n z y l - 4 , 1 1 - d i a z a - 1 , 8 -  
d i a z o n i a t e t  r a c y  cl  0  [ 6 . 6 . 2 . 0 4 , 1  6. 0 1 1 , 1  s jh e x a d e c a n e  d i b r o m i d e  
m o n o h y d r a t e  (27 ). Benzyl bromide (100 g, 0.585 mol) was added 
in one portion to a stirred solution of c / s - 1 5 - 1 , 4 , 8 , 1 1  - t e t r a a z a -  
te tra c y c lo [6 .6 .2 .0 4 ,i6 .o n ,i5 ]h e x a d e c a n e  (9.04 g, 40 .60  mmol) in MeCN  
(200 mL) at room temperature under nitrogen. The reaction mixture 
was stirrred for 14 days. Precipitate was collected by suction 
filtration and washed with M eCN (2 x 20 mL), followed by CH2 C I2 (2 
x 50 mL). Residual solvent was removed under vacuum. This gave
21.35  g of product as white powder (93%): mp 147-151 °C (dec); 1H 
NMR (360 MHz, D2O, MeCN secondary ref. set at 2 .06 ppm) 5 1 .86 -1 .96  
(dm, 2 H, J = 15.2 Hz, H6i13-eq) 2.20-2.39 (qm, 2 H, J =  15.2 Hz, He, 13-ax) 
2.81 (td, 2H, J = 12.3, 2.8 Hz) 3.17-3.30 (dm, 4H, J =  12.3), 3 .39-3 .65  
(m, 6 H) 3.74 (td, 2H, J = 13.2, 3.4 Hz), 4.43 (td, 2H, J =  13.1, 4 .0  Hz),
4 .75 and 5.27 (AB, 4H, J = 13.0 Hz, CW2 Ph) 5.08 (s, 2 H, CH), 7 .4 0 -7 .8 0  
(m, 10H CH2 P/7); 13C NMR (90.56 MHz, D20 ,  MeCN secondary ref. set at 
1.70) 5 18.77, 46.66, 47.52, 51.89, 61.14, 63.07, 77 .49 , 125.45,
3 0 2
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130.24, 132.15, 134.02; IR (KBr) 3051, 3030, 3003, 2995, 2960,
2943, 2869, 2853, 2844, 2812, 1456, 1356, 1137, 1056, 871, 722, 
706 cm-1- Anal Calcd for C ^ e r ^ B r ^ O :  C, 54.36; H, 6.67; N, 9.75. 
Found: C, 54.71; H, 6.79; N, 9.40.
4 , 1 1 - D i b e n z y  1 - 1 , 4 , 8 , 1 1  - t e t r a a z a b i c y c l o [ 6 . 6 . 2 ] -  
h e x a d e c a n e  (28). NaBH4 (66.70 g, 1.76 mol) was added in small 
portions over 1 h to a stirred solution of (1R S ,8R S ,15R S ,16R S )-1 ,8- 
d i b e n z y l - 4 , 1 1 - d i a z a - 1 , 8 - d i a z o n i a t e t r a c y c l o [ 6 . 6 . 2 . 0 4 . i 6 .o i i . i 5 ]  - 
hexadecane dibromide monohydrate (20.25 g, 35 .90  mmol) in 95%  
EtOH (900 mL). The reaction mixture was stirred at room 
temperature for 16 days. Excess NaBH4 was then decomposed by 
slow addition of 700 mL 3 M HCI (with cooling). Evaporation of 
solvent under reduced pressure gave a white solid which was 
dissolved in H20  (400 mL), adjusted to pH 14 with solid KOH (with 
cooling), and extracted with benzene ( 6  x 250 mL). The combined 
extracts were dried (Na2 S04) and solvent was removed under reduced 
pressure to yield 12.44 g (8 8 %) of solid product: mp 89-91 °C; 1H 
NMR (360 MHz, CDCI3) 5 1.31-1.45 (m, 2H, CH2 CH2 CH2), 1 .50-1 .65  (m,
3 0 3
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2 H, CH2 CW2CH2), 2 .26-2 .53  (m, 1 2 H), 2 .38-2 .54  (X X ’ of AA’XX’, 2 H, 
NCH2 CH2N bridge), 2.85 (ddd, 2H, J = 13.0, 11.2, 4 .0  Hz), 3.11-3.29  
(AA’ of AA’XX ’, 2H, NCH2 CH2N bridge), 3.17 and 3.78 (AX, 4H, J = 13.5 
Hz, CH2 Ph), 3.96 (ddd, 2H, J  = 12.1, 10.8, 4.3 Hz), 7.15-7.45 (m, 10H, 
CH2 P/7); 13C NMR (90.56 MHz, CDCI3) 5 28.06 (CH2 CH2 CH2), 52.00,
54 .29 , 56.57, 57.22, 57 .61 , 59.98, 126.49, 127.99, 128.94, 141.01; 
MS, m / z  406 (M+); IR (KBr) 3050, 3025, 3000, 2960, 2945, 2915, 
2900, 2860, 2800, 2770, 2720 , 2860, 2655, 1445, 1435, 1345,
1093, 710, 660 cm-1. Anal Calcd for C2 6 H3 8N4 : C, 76.80; H, 9.42; N,
13.78. Found: C, 76.72; H, 9.82; N, 13.82. The 13C and 1H NMR showed 
the material to be >99%  purity. This material was debenzylated 
without further purification.
1,4,8,11-Tetraazabicylo[6.6.2]hexadecane (29).
Hydrogenolysis of 4,11 -d ib e n zy l-1 ,4 ,8 ,11  -te traaza b ic yc lo [6 .6 .2 ]- 
hexadecane was carried out in a glass apparatus designed for 
exclusion of O2 and for measurement of H2 uptake with maintenance 
of constant pressure. 10% Pd/C (0.80 g) and glacial HOAc (125 mL) 
were added to a 500 mL hydrogenation flask which was connected to
3 0 4
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the apparatus. The system was evacuated (by means of a water 
aspirator) and flushed with nitrogen four times. The system was 
then evacuated, filled with hydrogen, and catalyst was equilibrated 
under H2 (759 mmHg) for 1 h. To this was added a solution of 4,11- 
d ib enzy l-1 ,4 ,8 ,11 -te traazab icyc lo [6 .6 .2 ]-hexadecane (4 .54  g, 11.17  
mmol) in glacial HOAc (5 mL). The mixture was stirred for 21 h 
under H2 atmosphere (759 mmHg). (The theoretical H2 uptake for 
this reaction was 542 mL. The actual uptake was 525 mL, which is 
97%  of the theoretical value.) The apparatus was evacuated and 
flushed with nitrogen four times, the reaction flask was removed 
from the apparatus, the contents were filtered through celite, and 
the catalyst and celite were washed with glacial acetic acid ( 3  x 10  
mL). The filtrate and washings were concentrated under reduced 
pressure to give a light yellow oil which was dissolved in H20  (20
mL), adjusted to pH 14 with solid KOH (with cooling), and extracted 
with benzene ( 6  x 25 mL). The combined extracts were dried 
(Na2 S0 4 ), and solvent was removed under reduced pressure to give an 
oil (2 .35 g, 93%  crude yield). This oil was dissolved in Et20  (17 mL) 
and then crystallized at -78  °C  (acetone/dry ice bath) in a fritted
3 0 5
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Schlenck tube to give 2.02 g (80% ) of white solid: mp 48-49°C; 1H 
NMR (360 MHz, C6 D6) 6  1.16 (dtt, 2H, J = 15.1, 6 .8 , 2 .7  Hz, H 6 , i 3 . e q ) ,  
1.53 (dtt, 2H , J = 15.0, 9.0, 2.7 Hz, H 6 i i 3 - a x ) ,  2.07-2 .26  (m, 6 H), 2.31 
(ddd, 2H, J = 13.0, 6.7, 2.6 Hz), 2 .42-2.64 (m, 6 H), 2 .74-2 .86  (m, 4H), 
3.21 (ddd, 2H, J = 12.6, 8 .8 , 2 .7  Hz), 3.59 (br s, 2H, NW); 13NMR (90.56  
MHz, C6D6) 6  24.89 (CH2CH2 CH2 ), 47.37, 50.73, 52 .40 , 56.13, 59.04; 
MS, m / z  226; IR (CHCI3 ) 3260, 2955, 2925, 2890, 2870, 2825, 1490, 
1352, 1248, 1135, 1090, 652 cm -1; HRMS exact mass calcd for 
C12H2 6 N4 226 .2157, found 226.2151.
(1 R S , 1 3 S R , 1 4 R S ) - 1  - B e n z y l - 4 , 7 , 1 0 - t r i a z a - 1  - 
a z on ia te t ra c y c lo [5 .5 .2 .0 4 , 1 4.010 , 13]tetradecane bromide
( 8  5 ) .  To a stirred solution of c / s - 1 3 - 1 , 4 , 7 , 1 0 - t e t r a a z a t e t r a c y c l o -  
[5 .5 .2 .04.14 01 o,i 3]tetradecane (0 .373 g, 2 .17 mmol) in toluene (30  
mL) at room temperature, was added benzyl bromide (0 .360 g, 2 .10  
mmol) all in one portion. The reaction mixture was stirred for 18 h. 
Precipitated product was collected by suction filtration and washed  
with toluene (3 x 15 mL). Residual solvent was removed under 
vacuum to give 0.63 g of white powder (84%): mp 215-225 °C (dec);
3 0 6
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1H NMR (360 MHz, D2 O, MeCN secondary ref. set at 2.06 ppm) 6  2 .43- 
2.58 (m, 2H), 2 .74-2 .96  (m, 4H), 3 .05-3.35 (m, 5H), 3 .41 -3 .63  (m,
4H), 3.74 (d, 1H, J = 2.5 Hz, CH), 4.02 (d, 2H, J = 2.5 Hz, CH), 4 .14- 
4.24 (m, 2H), 4.69 and 4.85 (AB, 2H, J =  13.3 Hz, CH2Ar),  7 .5 0 -7 .7 0  
(m, 5H); 13C NMR (90.56 MHz, D2O, MeCN secondary ref. set at 1.7 
ppm) 44.53, 48.32, 48.36, 48.93, 49.09, 52.06, 57.90, 62.05, 62.24,
72.43, 83.43, 127.67, 130.40, 131.85, 133.31; IR (KBr) 3059, 3050, 
3034, 3024, 2980, 2955, 2946, 2905, 2880, 2848, 2838, 2817,
2803, 1443, 1185 cm-1; Anal. Calcd for C i 7H2 5 N4 Br: C, 55.89; H, 6.90; 
N, 15.34. Found: C, 55.63; H, 7.08; N, 15.21.
( 1 R S , 7 R S , 1 3 S R , 1 4 S R ) - 1 - B e n z y l - 7 - m e t h y  1 - 4 , 1 0 - d i a z a -
1 , 7 - d i a z o n i a t e t r a c y c l o [ 5 . 5 . 2 . 0 4 , i 4 . 0 1 0 , 1 3] te t  r a d  e c a n e  
d i h a l i d e  ( 8 6 ). To a stirred solution of (1R S ,13SR ,14R S)-1-benzyl-
4 , 7 , 1 0 - t r i az a- 1  - a z o n i a t e t r a c y c l o [ 5 . 5 . 2 . 0 4>14.010-13] te tra d e c a n e  
bromide (0.125 g, 0 .342 mmol) in MeCN (5 mL) at room temperature, 
was added M el (0.460 g, 3.24 mmol), all in one portion. The reaction 
flask was tightly stoppered, shielded from light, and the solution 
was stirred for 5 days. Precipitated product was collected by 
suction filtration and washed with MeCN (2. x 2 mL). Residual
3 0 7
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solvent was removed under vacuum to give 144 mg of white powder: 
mp 195-200°C  (dec); 1H NMR (360 MHz, D20 ,  MeCN secondary ref. set
at 2.06 ppm) 6  3 .00-3 .23  (m, 3H), 3.33-3.51 (m, 3H), 3.43 (s, 3H,
CH3), 3 .52-3 .72  (m, 5H), 3 .79-3 .99  (m, 2H), 4 .01-4 .16  (m, 2H), 4 .28  
(td, 1H, J = 10.9, 3.5 Hz), 4 .62 and 4.68 (AB, 2H, J =  2.7 Hz, CHCH) ,
4.75 and 4.94 (AB, 2H, J =  13.7 Hz, CH2 Ph), 7 .50-7.70 (m, 5H, CH2 P/7);
13C NMR (90.56 MHz, D2 0 ,  MeCN secondary ref. set at 1.7 ppm) 5
43.54, 43 .80 , 46 .87 , 47 .17 , 47 .24 , 55.61, 59.86, 61.67, 61.94, 65.70,
78.19, 79.01, 126.92, 130.50, 132.11, 133.20; IR (KBr) 3042, 3024, 
3012, 2999, 2948, 2906, 2843, 2837, 1463, 1454, 1283, 1200, 770, 
707 cm-1. This salt was carried on without further characterization  
because of its mixed halide nature.
1 - B e n z y l - 7 - m e t h y l - 1 , 4 , 7 , 1 0 - t e t r a a z a b i c y c l o [ 5 . 5 . 2 ] -  
t e t r a d e c a n e  (8 7 ). NaBH4 (2.91 g, 76.92 mmol) was added in small 
portions over 2 0  minutes to a stirred solution of 
(1 R S , 7 R S , 1 3 R S , 1 4 R S ) - 1 - b e n z y l - 7 - m e t h y l - 4 , 1 0 - d i a z a - 1 ,7-  
d ia z o n ia te tra c y c lo [5 .5 .2 .0 4 .i4.01 o,i3]tetradecane dihalide (0 .86 g) in 
95%  EtOH (80 mL). The reaction mixture was stirred at room
3 0 8
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temperature for 5 days. Excess NaBH4 was then decomposed by slow 
addition of 50 mL 3 M HCI. Evaporation of solvent under reduced 
pressure gave a white solid which was dissolved in H2O (30 mL), 
adjusted to pH 14 with solid KOH (with cooling), and extracted with 
benzene ( 6  x 25 mL). The combined extracts were dried (Na2 S0 4 ), 
and solvent was removed under reduced pressure to give an oil. The 
crude product was kugelrohr distilled (100 °C  air bath temperature, 
0.04 mm Hg) to give pure product as a clear oil (0.415 g). The yield 
was 85%  for two steps from (1 R S ,13S R ,14R S )-1 -benzy l-4 ,7 ,10 - 
t r i aza-1 -azon i ate t racyc l o[5 . 5 .2 .04 , i 4 . o io , i 3 ] te t radecane  bromide; 1H 
NMR (360 MHz, C6D6) 5 2.26 (s, 3H, CH3), 2 .36 -2 .48  (m, 2H), 2 .58-2.85  
(m, 14H), 3 .02-3.22 (AB part of ABXY, 4H), 3.58 (s, 2H, CW2 Ph), 7.07- 
7.33 (m, 5H, CH2Ph)\ 13C NMR (90.56 MHz, C6D6) 5 44 .14 , 56.97, 57.28, 
57.88, 58.71, 60.46, 61.45, 126.96, 128.42, 129.17, 140.97; MS m / z  
302 (M+); IR (neat) 3106, 3085, 3061, 3026, 2958, 2921, 2805,
2747, 1676, 1493, 1452, 1372, 1108, 729, 697 cm -1; HRMS exact 
mass calcd for C18H3 0N4 303.2549, found 303 .2550 .
1- M e t h y l - 1 ,4 ,7 ,1 0 - te t r a a za b  icy cl o [ 5 . 5 . 2 ] t e t  rad ecane
3 0 9
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
( 8 4 ) .  The hydrogenolysis was carried out in a glass apparatus 
designed for the exclusion of O2 and for measurement of H2 uptake 
with maintainance of constant pressure. Catalyst (25 mg, 1 0 % Pd/C) 
and solvent (10 mL glacial acetic acid) were added to a 50 mL 
hydrogenation flask which was connected to the apparatus. The  
system was evacuated (by means of a water aspirator) and flushed 
with nitrogen four times. After another evacuation the system was 
filled with hydrogen. The mixture of 10%  Pd/C and glacial acetic 
acid was equilibrated under H2 (744 mmHg) for 40 minutes. A 
solution of 4 - benz y l -10 - met hy l - 1 , 4 , 7 ,10 - te t raazab icyc lo [5 . 5 . 2 ] -  
tetradecane (99.3 mg, 0.328 mmol) in glacial acetic acid (2 mL) was 
then added and the mixture was stirred for 21  minutes under H2 ( 2 2  
°C, 744 mmHg). The hydrogenolysis was stopped because no 
noticeable H2 uptake was observed after the first five minutes. (The 
theoretical H2 uptake for this reaction was 8.1 mL. The actual 
uptake was 5.8 mL, which is 71%  of the theoretical value.) The  
apparatus was evacuated and flushed with nitrogen four times, the 
reaction flask was removed from the apparatus, the contents were 
filtered through celite, and the catalyst and celite were washed 
with glacial acetic acid ( 3 x 2  mL). The filtrate and washings were
3 1 0
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concentrated under reduced pressure to give a light yellow oil which 
was dissolved in H2O (2 mL), adjusted to pH 14 with solid KOH (with
cooling), and extracted with benzene ( 6  x 10 mL). The combined 
extracts were dried (NaaSO,*), solvent was removed under reduced 
pressure, and the crude product was kugelrohr distilled (100 °C  air 
bath temperature, 0.04 mmHg) to give 65.1 mg of an oil which 
solidified upon standing (93%  crude yield, >85%  pure by 1 3C NMR).
An attempt to sublime the material was unsuccessful. This material 
could not be purified by conversion to the hydrochlorde salt using 
the sam e procedure described for the purification of 1 ,4 ,7 ,10- 
tetraazabicyclo[5.5.2]tetradecane; mp 53-61 °C; 1H NMR (360 MHz, 
Q A )  5 2 .21-2 .66  (m, 17H), 2.27 (s, CH3), 2 .68-2 .85  (m, 4H), 4 .07  (s, 
1H, NH)] 13C NMR (90.56 MHz, C6 D6) 5 44.05, 47 .55 , 51.39, 51.80,
51.93, 56.21; MS, m / z  2 1 2  (M+); IR (CCI4) 3213, 3037, 2963, 2933, 
2914, 2890, 2841, 2803, 1675, 1550, 1448, 1372, 1164, 1131,  793, 
784, 761 cm -1.
(1 RS,  1 5 R S , 1 6 S R ) - 1 - B e n z y l - 4 , 8 , 1 1 - t r i a z a - 1 -  
azoniatet racyclo[6.6.2.04>i  6.0 11 -1 sjhexadecane bromide
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h y d r a t e  (8 0 ). Benzyl bromide (0.79 g, 4 .62 mmol) was added in one 
portion to a stirred solution of c / s - 1 5 - 1 , 4 , 8 , 1 1  - t e t r a a z a -  
te tra c y c lo [6 .6 .2 .0 4 ,i6 .o ii.i5 ]h e x a d e c a n e  (0.75 g, 3.37 mmol) in 
toluene (25 mL) at room tem perature. The reaction mixture was 
stirred for 11 days. Precipitated product was collected by suction 
filtration and washed with toluene (3 x 15 mL). Residual solvent 
was removed under vacuum to give 0 .82 g of white powder (62%): mp 
137-140 °C (dec); 1H NMR (360 MHz, D20 ,  MeCN secondary ref. set at
2.06 ppm) 6 1.40-1.51 (dm, 1H, J = 14.1 Hz, H6 0r 13-eq). 1.70-1 .83  
(dm, 1H, J = 14.9 Hz, H6 0r 13-eq), 2 .09-2 .34  (m, 3H), 2 .41-2.53 (m,
2H), 2.65 (td, 1H, J = 12.2, 2.8 Hz), 2 .92-3.18 (m, 7H), 3 .20-3.27 (dm, 
1H, J = 13.6 Hz), 3 .28-3.36 (dm, 1H, J = 13.7 Hz), 3.43-3.61 (m, 2H),
3.68 (s, 1H, CH slightly broadened by small gauche coupling), 4 .19  
(td, 1H, J = 13.1, 3.5 Hz), 4 .36 (s, 1H, CH slightly broadened by small 
gauche coupling), 4 .77 and 5.05 (AB, 2H, J =  13.3 Hz, CH2Ar), 7 .45-
7.68 (m, 5H); 13C NMR (90.56 MHz, D20 ,  MeCN secondary ref. set at 1.7 
ppm) 5 18.77 (CH2CH2 CH2), 19.14 (CH2 CH2CH2), 42.73, 47.37, 49.31, 
52.09, 52.72, 54.05, 54 .70 , 60 .56 , 63.31, 70.29, 82.64, 126.45, 
130.11, 131.84, 134.08; IR (KBr) 3063, 3034, 3025, 3006, 2947,
3 1 2
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2931, 2901, 2861, 2838, 2793, 2772, 1651, 1457, 1357, 1142,
1110, 891, 707 cm -1. Anal. Calcd for C, 9H2 9 N4 B M  .5H 20 : C, 54.28; H, 
7.67; N, 13.32. Found: C, 53.95; H, 7.81; N, 13.13.
(1  R S , 8 R S , 1 5 R S , 1  6 R S ) - 1 - B e n z y l - 8 - m e t h y  1 - 4 , 1 1 - d  i a z a -
1 , 8 - d i a z o n i a t e t r a c y c l o [ 6 . 6 . 2 . 0 4 . i 6 . o n  .1 s j h e x a d e c a n e  
d ih a lid e  (8 2 ). To a stirred solution of (1R S ,15R S,16SR )-1-benzyl- 
4,8', 1 1 - t r i a za - 1 - a zo n i a te t ra c yc l o [ 6 .6 . 2 . 0 4 . i 6 . o i  i.i5 ]hexadecane  
bromide hydrate (0.59 g, 1.51 mmol) in M eCN (15 mL) at room 
temperature, was added Mel (1.07 g, 7 .54 mmol), all in one portion. 
The reaction flask was tightly stoppered, shielded from light, and 
the solution was stirred for 7 days. Precipitated product was 
collected by suction filtration and washed with M eCN ( 2 x 2  mL). 
Residual solvent was removed under vacuum to give 0.753 g of white 
powder: mp 150-155 °C (dec); 1H NMR (360 MHz, D2O, MeCN secondary
ref. set at 2.06 ppm) 5  1.80-1.90 (dm, 1H, J =  15.4 Hz, H6 0 r 1 3 -e q ) .
1.93-2.02 (dm, 1H, J =  15.2 Hz, H6 or 13 -eq ) .  2.12-2.30 (m, 1H, H6 or 13. 
ax), 2 .37-2.53 (m, 1H, H6 0 r 13 -ax ) ,  2.72  (td, 1H, J = 12.4, 3.3 Hz), 2.93  
(td, 1H, J =  12.5, 3.4 Hz), 3 .07-3.48 (m, 9H), 3.44 (s, 3H, CH3), 3.54
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(td, 1H, J = 13.2, 3.6 Hz), 3 .67 (td, 1H, J = 13.3, 3.9 Hz), 3 .73-3.87 (m, 
2H), 4 .37 (td, 1H, J = 13.2, 4 .6  Hz), 4 .44-4 .58  (m, 1H), 4.71 and 5.21 
(AB, 2H, J = 13.2 Hz, CW2 Ph), 4:84 (br s, 1H, CH), 5 .03 (br s, 1H, CH), 
7.50-7 .68  (m, 5H, CH2Ph)', 13C NMR (90.56 MHz, D20 ,  MeCN secondary 
ref. set at 1.7 ppm) 5 18.74, 19.13, 47 .15 , 47 .20 , 47 .22 , 48 .99 , 50.32, 
51.82, 51.91, 60.10, 63.22, 65.94, 77.31 , 77.50 , 125.43, 130.27,
132.19, 134.02; IR (KBr) 3059, 3029, 2996, 2956, 2940, 2912, 2869, 
2842, 2807, 1443, 1277, 1152, 1125, 1049, 881, 704 cm-1. This 
salt was carried on without further characterization because of its 
mixed halide nature.
4 - B e n z y l - 1 1 - m e t h y l - 1 , 4 , 8 , 1 1 - t e t r a a z a b i c y c l o [ 6 . 6 . 2 ]  
h e x a d e c a n e  (83 ). NaBH4 (3 .00 g, 79 .32  mmol) was added in small 
portions over 2 0  minutes to a stirred solution of 
(1 R S , 8  R S , 1 5 R S , 1 6 R S ) - 1 - b e n z y l - 8 - m  e t h y l - 4 , 1 1 - d i a z a - 1 ,8 - 
d ia zo n ia te tra c y c lo -[6 .6 .2 .0 4 ,i6 .o n .i5 ]h e x a d e c a n e  dihalide (0 .753 g) 
in 95%  EtOH (45 mL). The reaction mixture was stirred at room 
temperature for 7 days under nitrogen. Excess NaBH4 was then 
decomposed by slow addition of 60 mL 3 M HCI. Evaporation of 
solvent under reduced pressure gave a white solid which was
3 1 4
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dissolved in H2O (75 mL), adjusted to pH 14 with solid KOH (with 
cooling), and extracted with benzene (5 x 30 mL). The combined 
extracts were dried ( ^ 2 8 0 4 ), and solvent was removed under 
reduced pressure. The crude product was kugelrohr distilled (120° C 
air bath temperature, 0 .03  mmHg) to give a clear oil (340 mg, 6 8 % 
for two steps from (1 R S ,1 5 R S ,1 6 S R )-1 -b e n zy l-4 ,8 ,1 1 -tr ia za -1 -  
a z o n ia te tra c y c lo [6 .6 .2 .0 4 .i6 .o n  .i5]hexadecane bromide hydrate); 1H 
NMR (360 MHz, C6D6) 5 1 .26-1.59 (m, 4H, CH2 CH2CH2), 2.12 (s, 3H,
CH3), 2 .15-2.63 (m, 13H), 2 .67-2.82 (m, 2H), 2 .97 (td, 1H, J =  12.1,
4.0 Hz), 3 .07 (X of AX, 1H, J =  13.5 Hz, CW2Ph), 3.20 (td, 1H, J = 12.2, 
3.8 Hz), 3.34 (td, 1H, J  = 12.2, 3.8 Hz), 3 .66 (td, 1H, J = 11.5, 4.6 Hz),
3.77 (A of AX, 1H, J =  13.5 Hz, CW2 Ph), 4 .09 (td, 1H, J = 11.7, 3.8 Hz),
7.09-7.25 (m, 3H, CH2Ph), 7 .35-7.40 (m, 2H, CH2 P/j); 13C NMR (90.56  
MHz, C6 D6) 5 28.29 (CH2 CH2 CH2). 28.81 (CH2 CH2 CH2), 42.28, 51.71, 
51.93, 54.82, 56.43, 57 .16 , 57.41, 57.59, 57.89, 60.34, 61.66,
126.94, 128.39, 129.26, 141.34; MS, m l z  330 (M+); IR (neat) 3080, 
3060, 3025, 2960, 2915 , 2880, 2835, 2745, 1455, 1365, 1125,
1 1 1 0 , 728, 690 cm -1; HRM S exact mass calcd for C 20H 35N4 331 .2862 , 
found 331 .2851 .
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1 - M e t h y l - 1 , 4 , 8 , 1 1 - t e t r a a z a b i c y l o  [ 6 . 6 . 2 ]  h e x a d e c a n e  
( 8 1 ) .  Hydrogenolysis of 1 -b e n zy l-4 -m e th y l-1 ,4 ,8 ,1 1 -te traaza-  
bicyclo[6 .6 .2 ]hexadecane was carried out in a glass apparatus 
designed for the exclusion of O2 and for measurement of H2 uptake 
with maintenance of constant pressure. 10%  Pd/C (35 mg) and 
glacial HOAc (15 mL) were added to a 50 mL hydrogenation flask 
which was connected to the apparatus. The system was evacuated 
(by means of a water aspirator) and flushed with nitrogen four 
times. The system was then evacuated and filled with hydrogen.
The catalyst was equilibrated under H2 (26 °C, 752 mmHg) for 1.5 h.
1 - B e n z y l - 4 - m e t h y l - 1 , 4 , 8 , 1 1 - te t r a a z a b i c y c l o [ 6 . 6 . 2 ] h e x a d e c a n e  
(0.158 g, 0 .478 mmol) in glacial acetic acid (2 mL) was added and 
the mixture was stirred for 21 h under H2 (752 mmHg). (The  
theoretical H2 uptake for this reaction was 11.9 mL. The actual 
uptake was 12.3 mL, 103% of the theoretical value.) The apparatus 
was evacuated and flushed with nitrogen four times. The reaction 
flask was removed from the apparatus, the contents were filtered 
through celite, and the catalyst and celite were washed with glacial 
acetic acid ( 2 x 4  mL). The filtrate and washings were concentrated
3 1 6
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under reduced pressure to give a light yellow oil which was 
dissolved in H2O (4 mL), adjusted to pH 14 with solid KOH (with 
cooling), and extracted with benzene (6  x 10 mL). The combined 
extracts were dried (N a2 S0 4 ), and solvent was removed under 
reduced pressure. The crude product was kugelrohr distilled (100 °C  
air bath temperature 0.04 mmHg) to give 114 mg (99% ) of product as 
an oil; 1H NMR (360 MHz, C6D6) 5 1.21-1.37 (m, 2 H, CH2 C/72 CH2). 1.42- 
1.58 (m, 2H, CH2CH2CH2), 1.93 (ddd, 1 H, J = 13.5, 10.0, 1.9 Hz), 2.02  
(s, 3H, CH3), 2 .05-2 .85  (m, 15H), 2 .97-3 .12  (m, 3H) 3 .41-3 .52  (m,
1H), 4 .67 -4 .82  (m, 1H, NH)\ 13C NMR (90.56 MHz, C6D6) 5 25.81, 28.07, 
41.26, 49 .17 , 49.38, 49 .47 , 49 .75 , 55.21, 56.40, 56.63, 57.59, 59.41, 
62.13; MS m l z  240 (M+); IR (neat) 3232, 2918 (br), 2792 (br), 1487, 
1452, 1355, 1112 cm-1 ; HRMS exact mass calcd for C13H2 9 N4 
241 .2392 , found 241 .2390 .
4 , 1 1 - B i s - ( c a r b o  e t h o x y  m e t  h y  I ) - 1 , 4 , 8 , 1 1  - t e t  r a a z a -  
b i c y c l o [ 6 . 6 . 2 ] h e x a d e c a n e  (1 2 9 ) .  To a solution of 1,4,8,11- 
tetraaza-bicyclo[6.6.2]hexadecane (0.831 g, 3 .67 mmol) in 
acetonitrile (30 mL) was added anhydrous sodium carbonate (0 .78 g,
3 1 7
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7.3 mmol) and ethyl bromoacetate (1.23 g, 7.39 mmol). The mixture 
was stirred under N2 and heated to 50°C for 22.5 h. Solvent was 
then removed under reduced pressure and residual material was 
dissolved in 20% aq NaOH (30 mL) at ice bath temperature (0-5 °C). 
This aqueous solution was extracted with cold (0 -5  °C) CHCI3 (6  x 
50 mL), combined extracts were dried (Na2S0 4 ), and solvent was 
removed under reduced pressure to give a solid (1 .520 g, essentially 
quantitative): mp 57-59°C ; 1H NMR (360 MHz, C6 D6) 5 0.97 (t, X3 of 
ABX3i 6 H, J = 7.1 Hz, CH2 CW3), 1.19-1.41 (m, 4H, CH2CH2 CH2), 2.17  
(ddd, 2H, J = 13.4, 3.7, 1.8 Hz), 2.29 (ddd, 2H, J =  13.0, 4.7, 2.5 Hz),
2.43-2.57 (XX’ of AA’XX’, 2H, NCH2 Ctf2N bridge), 3 .08 and 3.20 (AB,
4H, J = 16.7 Hz, NCH2 COOEt), 3 .21-3 .35  (AA’ of AA’XX’, 2H, NCtf2CH2N 
bridge), 3 .69 (td, 2H, J = 11.9, 4 .4  Hz), 3.96 and 3.97 (AB of ABX3, J =
7.1 Hz, CH2 CH3); 13C NMR (90.56 MHz, C6D6) 5 14.36 (CH2 CH3), 28.23  
(CH2 CH2CH2), 50.91, 53.26, 54.71, 56.37, 57 .32 , 59 .84 , 60.23, 171.60  
(COOEt); IR (KBr) 2969, 2945, 2926, 2907, 2851, 2833, 2819, 2784, 
1743 (CO), 1461, 1444, 1379, 1365, 1301, 1184, 1162, 1137, 1124  
cm-1; MS, m / z  398 (M+); HRMS exact mass calcd for C2 0 H39N4O4 
399 .2971 , found 399 .2963 .
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4 . 1 0 - B i s - ( c a r b o e t h o x y m e t h y l ) - 1 , 4 , 7 , 1 0 - t e t r a a z a -  
b i c y c l o [ 5 . 5 . 2 ] t e t r a d e c a n e  ( 1 3 0 ) .  To a solution of 1,4,7,10- 
tetraaza-bicyclo[5.5.2]tetradecane (53.7  mg, 0.271 mmol) in 
acetonitrile (4 mL) was added anhydrous sodium carbonate (54.7  mg, 
0.516 mmol) and ethyl bromoacetate (90.4 mg, 0.541 mmol). The  
mixture was stirred under N2 and heated to 55°C for 3 h. Solvent 
was then removed under reduced pressure and residual material was 
dissolved in 40%  aq KOH (3 mL) at ice bath temperature (0-5 °C).
This aqueous solution was immediately extracted with cold (0-5  °C) 
CHCI3 ( 5 x 5  mL), combined extracts were dried (NaaSC^), and 
solvent was removed under reduced pressure to give an oil (69.3 mg, 
69% ): 1H NMR (360 MHz, CDCI3) 5 1.27 (t, X3 of A2X3 , 6 H, J =  7.1 Hz, 
CH2 CW3), 2 .70-2.86 (m, 1 2 H), 2.97 (s, 4H, NCH2CH2N bridge), 2 .93- 
3.05 (m, 4H .) 3.39 (A2, 4H, NCH2COOEt), 4 .17 (q, A2 of A2X 3, J = 7.1 
Hz, CW2CH3 ); 13C NMR (90.56 MHz, CDCI3 ) 5 14.23 (CH2 CH3), 56.31,
56.50, 56 .84 , 57.79, 60.02, 172.59 (COOEt); IR (neat) 1736 (CO) cm-1.
4 . 1 1 - B i s - ( c a r b o x y m e t h y l ) - 1 , 4 , 8 , 1 1 - t e t r a a z a -
3 1 9
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b ic y c lo [6 .6 .2 ]h e x a d e c a n e  te tra h y d ro c h lo r id e  h ydra te  (131).
4.11  - B i s - ( c a r b o e t h o x y m e t h y l ) - 1 , 4 , 8 , 1 1 - te t r a a z a b i c y c l o -
[6.6.2]hexadecane (0.635 g, 1.593 mmol) was dissolved in 6  N HCI (30 
mL), and heated to 100 °C  with stirring under N2 for 48 h. Solvent 
was removed under reduced pressure to give an oil which 
crystallized after removal of residual solvent under vacuum (0.777  
g, 95%): mp 155-160°C; 1H NMR (360 MHz, D2O, CH3 CN as reference 
set at 2.06 ppm) 6  1 .63-1.89 (dm, 2H, J = 16.6 Hz, H 6 i 1 3 . e q ) ,  2 .23 -2 .53  
(m, 2H, H6,1 3 - a x ) ,  2.93-3 .05  (tm, 4H, J = 13.4 Hz), 3 .04-3 .10  (m, 4H),
3 .24-3.43 (m, 4H), 3 .45-3.73 (m, 8 H), 3.50 and 3.90 (AB, 4H, J = 17.8 
Hz, NCW2 COO H);13C NMR (90.56 MHz, CH3CN as reference set at 1 .7 
ppm) 5 19.69 (CH2CH2CH2 ), 47.36, 47.60, 53.33, 55 .21 , 57.70, 60.04, 
172.92 (COOH); IR (KBr) 3411, 3291, 3177, 2936, 2860, 2714, 2600, 
2528, 1709 (CO), 1461, 1429, 1232, 989, 664 cm -1 ; Anal Calcd for 
C i6H3 oN4 0 4 *4 H C M . 5 H2 0 : C, 37.29; H, 7.24; N, 10.87. Found: C, 37.20; 
H, 7.41; N, 11.21.
Attempted preparation of 4,1 l -bis-(acetamido)-
1.4.8.11 - te t r a a z a b i c y c lo [ 6 . 6 . 2 ]h e x a d e c a n e /A c t u a l
3 2 0
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p r e p a r a t i o n  of  4 , 1 1 - b i s - ( c a r b o x y m e t h y l ) - 1 , 4 , 8 , 1 1 -  
t e t r a a z a b i c y c l o [ 6 . 6 . 2 ] h e x a d e c a n e  (131 ) .  4 ,11-B is-
(carboethoxymethy l ) - l  , 4 , 8 , 1 1 - te t raazab i cyc l o[6 .6 .2 ]hexadecane  
(69.8 mg, 0 .175 mmol) was dissolved in conc. aq NH3 (2 mL). The 
mixture was heated to 100 °C for 3 days in a pressure tube. The 
mixture was cooled for 15 minutes (0-5 °C), and solvent was 
removed under reduced pressure to give an oil which crystallized 
after removal of residual solvent (37.2  mg, 62% ): mp 270-275°C  
(dec); 1H NMR (360 MHz, D2O, CH3CN as reference set at 2.06 ppm) 5 
1.70-1.77 (dm, 2H, J  =  16.7 Hz, H6, i 3-eq). 2 .20 -2 .45  (dtt, 2H, J = 16.0, 
12.9, 3.2 Hz, H6 ii 3.ax ). 2.56 (dd, 2H, J = 13.6, 2.2 Hz), 2 .80-3.79 (m, 
17H), 3.31 (XX’ of AA’XX’, 2H, NCW2CH2 N), 4 .14  (AA’ of AA’XX’, 2H, 
NCH2 CH2 N), 3.69 (td, 2H, J  =  14.5, 3.5 Hz); 13C NMR (90.56 MHz, D20 , 
CH3CN as reference set at 1.7 ppm) 5 20.51 (CH2 CH2 CH2), 49.14, 
49.62, 52.60, 57.76, 58.77, 59.11, 171.51; MS (Cl, NH3), m / z  343  
(M +1); IR (KBr) 3409, 2999, 2991, 2957, 2898, 2838, 2810, 1629, 
1485, 1404, 1392, 1101, 1062, 791, 740 cm-1- HRMS exact mass 
calcd for C16H3 1 N4O4 343.2345, found 343.2349. This molecular ion 
is consistent with 4 , 1 1-bis- (carboxymethyl ) -1 , 4 , 8 , 1 1- tet raaza-
321
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
bicyclo[6.6.2]hexadecane.
4 , 1 1  - B i s - ( 2 - h y d r o x y e t h y l ) - 1 , 4 , 8 , 1 1  - t e t r a a z a b i c y c l o -
[ 6 . 6 . 2 ] h e x a d e c a n e  (1 3 3 ). NaBH4 (0.50 g, 13.30 mol) was added in 
small portions over 20 minutes to a stirred solution of 4 ,11-b is- 
(c a rb o e th o x y m e th y l)-l , 4 , 8 , 1 1 - te t raazab i cyc l o[ 6 .6 .2 ] hexadecane  
(0.110 g, 0 .276 mmol) in 95%  EtOH (10 mL). The reaction mixture 
was heated to 100 °C  and stirred for 4 h. Excess NaBH4 was then 
decomposed by the slow addition of 6.0 mL 3 M HCI (with cooling). 
Evaporation of solvent under reduced pressure gave a white solid 
which was dissolved in H2O (20 mL), adjusted to pH 14 with solid 
KOH (with cooling), and extracted with PhCH3 ( 6 x 1 5  mL). The  
combined extracts w ere dried (Na2 S0 4), and solvent was removed 
under reduced pressure to give an oil. This oil was kugelrohr 
distilled (0 .02 mmHg, 110 °C air bath temperature) yielding 19.4 mg 
(2 2 %) of a clear viscous oil; 1H NMR (360 MHz, CDCI3) 5 1 .38 -1 .68  
(m, 4H, CH2 CH2CH2 ), 2 .25-2.78 (m, 2 0 H), 2 .80-3 .02  (m, 2 H, OH + 
overlapping AA’ of AA’XX’, 2H, NCH2 CH2 N bridge), 3 .41-3 .65  (m, 4H, 
CH2CH2OH), 3.97 (ddd, 2H, J = 13.4, 9.0, 5.1 Hz); 13C NMR (90.56 MHz,
3 2 2
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CDCI3) 5 27.64 (CH2 CH2 CH2 ), 52.87, 53.50, 56.15, 56.28, 57.79, 58.93, 
59.20; IR (neat) 3342, 2948, 2914, 2902, 2842, 2820, 2800, 1652, 
1461, 1363, 1289, 1124, 1058, 1038 cm -1; MS (Cl, NH3), m /z  315  
(M+1); HRMS exact mass calcd for C i 6H3 5N4 0 fe 315 .2760 found 
3 1 4 . 2 7 5 7 .
4 , 1 1 - ( 2 - C a r b o m e t h o x y e t h y l ) - 1 , 4 , 8 , 1 1 - t e t r a a z a -  
b i c y c l o [ 6 . 6 . 2 ] h e x a d e c a n e  ( 1 3 4 ) .  1 ,4 ,8 ,1 1-Tetraazabicyclo-
[6.6.2]hexadecane (0.331 g, 1.46 mmoL) was dissolved in 35 mL 
freshly distilled methyl acrylate (33 g, 0 .39 moL) under a nitrogen 
atmosphere. The reaction mixture was shielded from light and 
stirred at room temperature for 24 h. Removal of excess methyl 
acrylate under reduced pressure gave an oil (0 .644 g, essentially 
quantitative); 1H NMR (360 MHz, C6D6) 5 1.18-1.31 (m, 2H, 
CH2 CH2CH2), 1.46-1.58 (m, 2 H, CH2 CW2CH2 bridge), 2 .10-2 .40  (m,
16H), 2.35-2.46 (XX’ of AA’XX ’, 2H, NCH2 CW2 N), 2 .64-2 .82  (m, 4H), 
2.86-2 .97  (m, 2H), 3 .05 -3 .17  (AA’ of AA’XX', 2H, NCH2CW2N bridge), 
3.41 (s, 6 H, COOCH3), 3 .64 (td, 2H, J = 12.1, 3.7 Hz); 13C NMR (90.56  
MHz, C6D6) 6  28.50 (CH2 CH2CH2), 33.68 (NCH2 CH2 COOMe), 50.83,
3 2 3
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50.97, 51.28, 55.00, 57.33, 57.82, 59.39, 172.74 (C O O M e ); MS, m / z  
398 (M +); IR (n e a t  N a C I p la te s ) 2970, 2945, 2904, 2831, 2805, 2797, 
2716, 1736 (C O ) ,  1455, 1432, 1359, 1190, 1171, 1119,  692 c m -1 ;  
H R M S  e x a c t m a s s  c a lc d  fo r C 20H 39N4O 4 399.2971, fo u n d  399 .2956 . 
T r a c e  im p u r it ie s  (<2%) a re  e v id e n t b y  c lo s e  e x a m in a tio n  o f th e  1H 
and  1 3C  N M R  s p e c tra . A tte m p ts  to  d istill a n d  c ry s ta lliz e  th e  p ro d u c t  
w e r e  u n s u c c e s s fu l.
4 , 1 1 - B i s - ( 2 - c a r b o x y e t h y l ) - 1 , 4 , 8 , 1 1 - t e t  r a a z a -  
b i c y c l o [ 6 .6 .2 ] h e x a d e c a n e  h y d r o c h l o r i d e  (1 3 6 ). 4 ,11 -B is -(2 -
car bo me tho xye t hy l ) - 1 , 4 , 8 , 1 1 - te t raazab i cyc l o[6 .6 .2 ]hexadecane  
(0.132 g, 0.331 mmol) was dissolved in 2 mL 20% aq HCI. The  
mixture was stirred at room temperature under N2 for 4 days.
Solvent was removed under reduced pressure to give a solid (0 .096  g, 
56%): mp 155-160 °C; 1H NMR (360 MHz, D20 ,  HOD set at 4.80 ppm) 5
1.78 (dm, 2H, J  = 15.0 Hz, H 6 i 1 3 . e q ) ,  2.22-2.45 (m, 2H), 2 .50 -2 .72  (m, 
2H), 2 .75-3 .42  (m, 10H), 3.54 (td, 2H, J = 12.5, 4.1 Hz), 3 .63-3 .94  (m, 
4H); 13C NMR (90.56 MHz, D20 ,C H 3CN as ref. set at 1.7 ppm) 5 19.71, 
27.91, 49 .14 , 49.51, 54.63, 54.45, 57.78, 175.08 (CO). Material
3 2 4
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appears to be >90% pure by 13C NMR. Attempts to recrystallize this 
material (C H 3 C N , EtOH) were unsuccessful (oiling out occured).
4 , 1 1 - B i s - ( 2 - c y a n o e t h y l ) - 1 , 4 , 8 , 1 1 - t e t r a z a b i c y c l o -
[ 6 .6 .2 ] h e x a d e c a n e  (1 3 5 ) .  1 ,4 ,8 ,1 1-Tetraazab icyclo [6 .6 .2]-
hexadecane (0.170 g, 0.751 mmoL) was dissolved in 2.0 mL 
acrylonitrile (1.6 g, 30 mmoL) under a  nitrogen atmosphere. The  
reaction mixture was shielded from light and stirred at room 
temperature for 24 h. Removal of excess acrylonitrile under reduced 
pressure gave an oil which was dissolved in toluene (15 mL), dried 
(Na2 S0 4), and filtered. Evaporation of solvent under reduced 
pressure gave an oil which crystallized upon storage at -10 °C to a 
pale yellow solid (0.196 g, 79% ): mp 62-64°C; 1H NMR (360 MHz,
CeDe) 51 .05 -1 .35  (m, 4H, CH2 Ctf2 CH2), 1 .45-1 .68  (m, 4H), 1 .81-1.98  
(m, 4H ), 2 .10-2.35 (m, 12H), 2 .39-2 .57  (XX' of AA’XX ’, 2H, NCH2 CH2 N), 
2.53 (ddd, 2H, J = 13.2, 11.0, 3 .2  Hz), 2.77 (td, 2H, J = 12.0, 4 .2  Hz), 
3.01-3.19 (AA’ of AA’XX’, 4H, NCW2CH2 N), 3.51 (td, 2H, J = 12.0, 4.2
Hz); 13C NMR (90.56 MHz, C6D6) 5 16.44 (CH2 CH2 CN), 28.31 
(CH2 CH2CH2), 50.28, 51.15, 53.90, 57 .20 , 57.76, 58.98, 119.10
3 2 5
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(CH2CH2 CN); MS, m /z  332 (M+); IR (KBr) 2946, 2901, 2889, 2825,
2797, 2786, 2704, 2238 (CN), 1455, 1358, 1117 cm -1. Anal Calcd 
for C i8H3 2N6 : C, 65.02; H, 9.70; N, 25.28. Found: C, 65.14; H, 10.01; N, 
25.54 .
H y d r o g e n a t i o n  of  4 , 1 1 - B i s - ( 2 - c y a n o e t h y l ) - 1 , 4 , 8 , 1 1 -  
t e t r a a z a b i c y c l o [ 6 . 6 . 2 ] h e x a d e c a n e .  The hydrogenation was 
carried out using a Parr shaker equipped with a 250 mL 
hydrogenation flask (tested to 120 psig). To 50 mL of a 1.4 M 
solution of NaOH in EtOH/H20  (95:5), was added 4,11 -bis-(2- 
cyan o eth y l)-1 ,4 ,8 ,1 1-te traazab icyclo [6 .6 .2]hexadecane (0 .2 0 7  g, 
0.623 mmoL), followed by W -2 Raney nickel (1.25 g slurry in 2.5 mL 
H20 ) .  The system was evacuated (by means of a water aspirator) and 
flushed with nitrogen twice, then evacuated and filled with hydrogen 
twice. The mixture was hydrogenated with constant agitation at 2.4  
barr H2 pressure for 1 week at 25 °C. The system was evacuated (by 
means of a water aspirator) and flushed with nitrogen twice. The  
mixture was filtered through celite, and washed with 95%  EtOH (2 x 
10 mL). The catalyst was deactivated with 25 mL 6 M aq HCI (H2 
effervescence). Filtrate and washings were concentrated under
3 2 6
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reduced pressure to give an oil which was dissolved in H2O (25 mL) 
and extracted with CHCI3 ( 6 x 1 5  mL). The combined extracts were 
dried (Na2 S0 4 ) and solvent was removed under reduced pressure to 
give 0 .208 g of crude product, which was kugelrohr distilled (160°C  
air bath temperature, 0 .03  mmHg) to yield 0 .145 g of a clear viscous 
oil. The 1 3C NMR spectrum and the mass spectrum (El, CH4) are 
consistent with a m ixture of 4 -(3 -am in o p ro p y l)-1 ,4 ,8 ,11 - 
tetraazabicyclo[6.6.2]hexadecane (0 .0 650  g, 37% ) and 4,11 -bis-(3- 
am inopropyl)-1 ,4 ,8 ,1 1-te traazab icyc lo [6 .6 .2 ]hexadecane  (0 .0 7 9 2  g, 
37% ) contaminated with 10% of unidentified material. The relative 
proportions of the two major products are based upon 1 3C NMR line 
intensities; 1H NMR (360 MHz, CDCI3) 5 1 .25 -1 .72  (m), 2 .05-2 .92  (m),
2.93 (dt, J = 12.2, 4.4 Hz), 3 .02-3.14 (m), 3 .20 (td, J =  12.5, 3.9 Hz), 
3.26-3 .33  (m), 3.76 (ddd, J = 12.0, 10.8, 4 .6  Hz), 5.01 (m, NH)\ 13C 
NMR (90.56 MHz, CDCI3) 5 2 5 .7 2  (4,11 -b is -(3 -a m in o p ro p y l)-1 ,4 ,8 ,11  -
te traazab icyc lo [6 .6 .2 ]hexadecane), 2 7 .3 7  (4 -(3-am inopropyl)-
1 ,4 ,8 ,1 1 -te traazab icyc lo [6 .6 .2 ]h exad ecan e ), 2 7 .7 5  (4 -(3 -  
am inopropy l)-1 ,4 ,8 ,1 1 -te traa zab icyc lo [6 .6 .2 ]h ex ad eca n e ), 32 .30 , 
32.43, 40.66, 48.53, 48 .67 , 49 .01 , 49 .15 , 51.68, 52.49, 52.86, 54.14,
3 2 7
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54.50, 54 .72 , 56.40, 57.14, 57.73, 57.91, 58.07, 58.56, 58.98, 59.75; 
MS, m / z  340 (M+), 283 (M+); IR (neat NaCI plates) 3370, 3237, 2949, 
2928, 2914, 2854, 2810, 2798, 2722, 2145, 1672, 1598, 1459,
1364, 1117 cm -1.
M e t h o x y a c e t y l  ch l o r i de .  The acid chloride was prepared by 
the method of Rothstein in 85% yield, bp 113-115 °C; (lit. bp 112- 
113 °C) .209
4 , 1 1 - B i s ( m e t h o x y a c e t y l ) - 1 , 4 , 8 , 1 1 - t e t r a a z a b i c y c l o -
[ 6 . 6 . 2 ] h e x a d e c a n e  (1 3 9 ). 1 ,4 ,8 ,1 1-Tetraazab icyclo [6 .6 .2]-
hexadecane (0.582 g, 2 .57  mmoL) and 8.0 mL triethylamine (distilled 
from CaH 2 ) were dissolved in dry THF (40 mL). A solution of 
methoxyacetyl chloride (0.590 g, 5 .47 mmoL) in 10 mL of dry THF  
was added dropwise over a period of 40 minutes. The solution was 
stirred under nitrogen at room temperature for 2 days. The mixture 
was filtered, the solids were washed with TH F, and filtrate and 
washings were combined and evaporated under reduced pressure to 
give an oil. The crude product was chromatographed on 50 g of basic 
alumina (20%  EtOH/Et2 0 , Rf 0 .27) to yield 0 .849 g (essentially
3 2 8
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quantitative, purity >96% ) of a yellow viscous oil: 1H NMR (360 MHz, 
C6D6 ; Note: the 1H NMR spectrum exhibits multiple resonances 
consistant with slow amide rotation, therefore the 1 H integrations 
are not given.) 6 1 .27-1.64 (m), 1 .65-1 .90  (m), 2 .00 -2 .77  (m ), 2.96- 
3.15 (m), 3.25 (s, CH3), 3.39 (d, J =  4.5 Hz), 3 .54-3 .73  (m), 3 .75-4.09  
(m), 4 .10-4 .20  (m); 13C NMR (90.56 MHz, C6 D6; Note: t h e i 3 C N M R  
exhibits multiple resonances which are grouped according to their 
intensities. The four resonances observed in the upfield region of 
the 13C NMR spectrum are consistant with three confomational 
isomers, one Ci rotamer and two different C2 rotamers. 5 29.13 (B 
or C)(CH2 CH2CH2), 29.25 (B or C)(CH2 CH2 CH2), 29.39 (A)(CH2 CH2 CH2) , 
29.60 (B or C)(CH2 CH2CH2), 43.54 (B or C), 44.20 (B or C), 45.94 (A), 
46.24 (B or C), 46.41 (B or C), 50.09 (B or C), 50.38 (A), 52.09 (A), 
52.42 (B or C), 52.79 (B or C), 53.13 (A), 53.23 (B or C), 57.65 (B or 
C), 57.83 (B or C), 57.89 (B or C), 58.50 (B or C), 58.91 (A), 59.27 (B 
or C), 71.91 (B or C), 71.97 (B or C), 72.98 (A), 73.04 (B or C), 169.26  
(B or C)(CO), 169.44 (A)(CO), 169.62 (B or C)(CO); IR (neat) 2955, 
2910, 2880, 2860, 2790, 2770, 1630, 1455, 1405, 1350, 1300,
1275, 1255, 1180, 1055, 1045, 985, 915 cm -1; MS, m / z  370 (M+) ;
3 2 9
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HRMS exact mass calcd for C 18H39N4O4 371 .2658, found 371.2655. 
T h e i H a n d i s c  NMR suggest minor impurities are present. The  
resulting yellow oil was reduced without further purification.
4 , 1 1 - B i s - ( 2 - m e t h o x y e t h y l ) - 1 , 4 , 8 , 1 1 - t e t r a z a b i c y c l o -
[6 .6 .2 ]h e x a d e c a n e  (1 4 0 ). A borane solution (22 mL of 1.0 M 
BH3- TH F complex in THF) was added dropwise over 30 minutes, under 
a nitrogen atmosphere, to a cooled solution (0-5  °C) of 4,11 -bis-(2- 
m ethoxyacety l)-1 ,4 ,8 ,1 1-te trazab icyc lo [6 .6 .2 ]hexadecan e  (0 .6 0 8  g,
1.641 mmoL) in THF (75 mL). The reaction mixture was warmed to 
room temperature and refluxed for 3 h. Excess borane was 
decomposed by the addition of H20  (10 mL). THF was removed under 
reduced pressure to give a white solid which was dissolved in 90 mL 
H C I-H 2 0 -MeOH (6:9:30) and refluxed for 4 h. MeOH removal gave a 
solid which was dissolved in H20 ,  adjusted to pH 14 with NaOH, and 
extracted with CHCI3 (5 x 20 mL). Combined extracts were dried 
(Na2 9 0 4 ) and evaporated to afford an oil which was kugelrohr 
distilled (120 °C air bath temp, 0.04 mmHg) to give 0 .337 g (60% ) of 
solid crude product. A solution of NaBPh4 (0 .025 g, 0 .730 mmoL) in
3 3 0
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M eOH (1 mL) and a solution of crude 4 ,1 1-bis(2-methoxyethyl)-
1,4,8,11-tetrazabicyclo[6.6.2]hexadecane (0 .025  g, 0 .730  mmoL) in 
MeOH (1 mL) were mixed to give a white precipitate which was 
isolated by filtration. The precipitate was dissolved in H2O, 
basified to pH 14 with NaOH, and extracted with benzene ( 5 x 2  mL). 
The combined extracts were dried (Na2S0 4) and solvent was removed 
under reduced pressure to give an oil. This oil was kugelrohr 
distilled (120 °C air bath temp, 0.04 mmHg) to give 0 .014 g (56%  
recovery) of product, which solidified on standing. The overall yield 
for this reaction was 34%  (0.189 g): mp 47-49 °C; 1H NMR (360 MHz, 
C6 D6) 5 1.22-1.38 (m, 2H), 1 .41-1.58 (m, 2H), 2 .25 -2 .42  (m, 6 H),
2 .44-2 .65  (m, 8 H), 2 .68-2 .85  (m, 4H), 2 .92 (td, 2H, J =12.6, 4.0 Hz), 
3.14 (s, 3H, CH3), 3 .22-3.46 (m, 6 H), 3.68 (td, 2H, J =11.9, 4.0 Hz);
13C NMR (90.56 MHz, C6 D6) 6  28.77 (CH2 CH2CH2), 51.12, 54.62, 55.48, 
57.45, 57.90, 58.46, 60.90, 72.51 (CH2 CH2OCH3); MS, m / z  342 (M+); IR 
(neat) 2950, 2897, 2861, 2841, 2780, 2760, 1441, 1346, 1182,
1145, 1111 cm-1. Anal Calcd for CT8H36N4Q?: C, 63.12; H, 11.18; N, 
16.36. Found: C, 63.13; H, 11.54; N, 16.29.
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2 - ( M e t h y l ) p h e n y l  a c e ta t e .  The ester 1 4 6  was prepared by 
the method of K a r l in ^ ,  a modification of the procedure published by 
Ranges. The crude product was purified by reduced pressure 
distillation to give a colorless liquid (81% ): bp 8 8  °C  /  11 mmHg (lit. 
83 °C I  20 mmHg).
2 - ( B r o m o m e t h y l ) p h e n y l  a c e ta t e .  Compound 1 4 4 was 
prepared in 56%  yield by the method described by K a r l i n i 2 7  and 
coworkers. The crude product was fractionally distilled in vigreux 
column twice to obtain pure material: bp 77 °C  /  0 .005 mmHg (lit. 8 8  
°C /  0.03 mmHg); 1H NMR (360 MHz, CDCI3) 5 2.29 (s, 3H, CH3), 4.73  
(s, 2H, CH2 Br), 7 .06-7 .10  (dm, 1H, J = 8.2 Hz, ArH), 7 .11-7 .18  (tm, 1H, 
J = 7.5 Hz, ArH), 7.28 (td, 1H, J =  7.7, 1.6 Hz, ArH), 7.34 (dd, 1H, J = 
7.6, 1.5 Hz, ArH)\ 13C NMR (90.56 MHz, CDCI3) 5 20.65 (COCH3), 27.49  
(CCH2 Br), 122.84, 125.97, 129.30 (CCH2 Br), 129 .57 , 130.55, 148.69  
(COAc), 168.55 (OCOCH3); MS m / z  229 (M+). The authors did not 
mention that a minor dibrominated side product (o-dibromomethyl- 
phenyl acetate) is formed. This higher boiling component was 
isolated (>85%  pure) in -1 4 %  yield: bp 82 °C I 0.005 mmHg; 1HNMR
3 3 2
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(360 MHz, CDCI3) 6  2.29 (s, 3H, COCH3), 6.83 (s, 1 H, CCHBr2), 7.06 (dd,
1H, J = 7.9 , 1.1 Hz, ArH), 7.22 (td, 1H, J = 7.7, 1.1 Hz, ArH), 7.29 (td,
IH , J = 7.5, 1.5 Hz, ArW), 7.79 (dd, 1H, J = 7.7, 1.6 Hz, ArH)\ 13CNMR 
(90.56 MHz, CDCI3) 8  20.78 (COCH3), 34.19 (CCHBr2), 122.64, 126.19, 
129.30, 130.55, 132.68 (CCHBr2), 145.19 (COAc), 168.12 (OCOCH3 );
MS m / z  308 (M -).
( 1 R S , 8 R S , 1 5 R S , 1 6 R S ) - 1 , 8 - B i s - ( 2 - a c e t o x y b e n z y l ) -
4 , 1 1 - d i a z a - 1 , 8 - d i a z o n i a t e t r a c y c l o [ 6 . 6 . 2 . 0 4 , i 6 . 011 . 15] .
h e x a d e c a n e  d ib ro m id e  m o n o h y d ra te  (148 ). To a stirred 
solution of c / s - 1 5 - 1 , 4 , 8 , 1 1 - t e t r a a z a t e t r a c y c l o [ 6 . 6 .2 .0 4 ,16.0 1 1 .15] - 
hexadecane (0.268 g, 1.21 mmol) in MeCN (8  mL) at room 
tem perature, was added 2 -(brom om ethyl)-phenyl acetate (2 .60 g,
I I . 3  mmol), all in one portion. The reaction mixture was stirrred 
for 18 days. Precipitated product was collected by suction 
filtration, washed with M eCN (2 mL), then Et20  (2 x 10 mL). Residual 
solvent was removed under vacuum. This gave 0.59 g of product as 
white powder (70%): mp 135-140 °C  (dec); 1H NMR (360 MHz, D20 ,  
MeCN secondary ref. set at 2.06 ppm) 5 1.84-1.94 (dm, 2H, J =  14.9
3 3 3
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Hz, H6, i 3 -eq), 2 .14 -2 .34  (qm, 2H , J =  14.3 Hz, H6 ,13-ax), 2 .50  (s, 6H,
COCH3), 2.95 (td, 2H, J =  12.1, 2.8 Hz), 3 .16-3 .27  (m, 4H), 3 .37-3.66  
(m, 6 H), 3.74 (td, 2H, J =  13.1, 3.3 Hz), 4 .36 (td, 2H, J = 12.7, 3.4 Hz), 
4.71 (A of AX, 2H, J =  13.2 Hz, CH2Ar), 5.42 (X of AX, 2H, J = 13.2 Hz, 
CH2Ar), 5.46 (s, 2H, CH), 7.36 (d, 2H, J =  8.3 Hz), 7.43 (t, 2H, J = 7.6  
Hz), 7 .61-7.66 (m, 4H); 13C NMR (90.56 MHz, D20 ,  MeCN secondary ref. 
set at 1.7 ppm) 5 18.81, 22.12, 46.52, 47 .83 , 51.84, 57.92, 60.83, 
78.29, 118.10, 124.79, 127.98, 133.97, 135.61, 151.44, 172.97; IR 
(KBr) 3423, 3067, 3057, 3053, 3045, 3024, 2 9 9 5 ,2 9 5 5 , 2938, 2902, 
2855, 2851, 2811, 1764 (0 0 ), 1454, 1370, 1181,  903 cm-1. Anal. 
Calcd for CsoHUoNABfe* H2 0 : C, 51.59; H, 6.06; N, 8.02. Found: C, 
51.97; H, 6.22; N, 7.95.
A t t e m p t e d  r e d u c t i o n  of ( 1 R S , 8 R S , 1 5 R S , 1 6 R S ) - 1 , 8 - b i s -  
( 2 - a c e t o x y b e n z y l ) - 4 , 1 1 - d i a z a - 1 , 8 - d i a z o n i a t e t r a c y c l o -  
[ 6 . 6 . 2 . 0 4 . 1  6.o i  1 , 1 5 ]h e x a d e c a n e  d i b r o m i d e  m o n o h y d ra te  (148 ) 
w ith  NaBH4 . To a stirred solution of (1R S ,8R S ,15R S,16R S)-1 ,8- 
b i s - ( 2 - a c e t o x y b e n z y l ) - 4 , 1 1 - d i a z a - 1 , 8 - d ia z on i a t e t r a c y c l o -  
[6 .6 .2 .04 .i6 .o n .i5 ]h exad ecan e  dibromide monohydrate (0.105 g, 0 .150
3 3 4
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
mmol) in 95%  EtOH (6.0 mL), was added NaBH4 (0.26 g, 6 .87 mol) in 
small portions over 10 minutes. The reaction mixture* was stirred at 
room temperature for 8  days. Excess NaBH4 was decomposed by the 
slow addition of 3 M HCI (3.0 mL). Evaporation of solvent under 
reduced pressure gave a white solid which was dissolved in H2O (2 .0  
mL), adjusted to pH 14 with solid KOH (with cooling), and extracted 
with CHCI3 ( 4 x 5  mL). The combined extracts were dried (Na2 S0 4) 
and solvent was removed under reduced pressure to yield 0 .092 g of 
an oil. The 13C NMR spectrum of this oil clearly indicates that the 
ester had been reduced (peak at 172.97 ppm absent). The aromatic 
region of the is c  NMR spectrum is consistent with two o - hydroxy  
phenyl rings resulting from two products. A multiplet in the 1HNMR  
at 4 .5  ppm is very characteristic of functionaiized cross-bridged  
cyciam derivatives. The mass spectrum (El, CH4) identifies two 
molecular ions at 332 and 438. The spectra suggest the product of 
this reaction is most likely a mixture of 4-(2-hydroxybenzyl)-
1 ,4 ,8 ,1 1-te traazab icyc lo [6 .6 .2 ]hexadecane  and 4,11 -b is -(2 -  
h yd ro xyben zyl)-1 ,4 ,8 ,11  -te traazab icyc lo [6 .6 .2 ]h exad ecan e; 1H NMR 
(360 MHz, CDCI3) 5 1 .15-1 .30  (m), 1 .50-1 .85  (m), 2 .00 -3 .20  (m),
3 3 5
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3.41-3 .65  (m), 3 .85-4.00 (d, J = 1*3.9 Hz), 4 .45 (dt, J  =  13.0, 6.3 Hz) 
6.65-6 .84  (m), 6.96 (tm, J = 5.6 Hz), 7 .10-7.20 (m); 13C NMR (90.56  
MHz, CDCI3) 5 19.57, 22 .52 , 25 .54  (br), 29.65, 44.76, 47.60, 49.22, 
49.71, 51.84, 52.48, 52 .80 , 53 .23 , 53.61, 54.00, 54.37, 56.05, 56.28, 
56.90, 58.04, 60.12, 115.83, 116.87, 118.23, 118.81, 122.24, 123.21,
128.40, 128.58, 128.64, 129.74, 158.12, 158.20; MS, m / z  438 (228), 
332 (1405).
2 - C h l o r o e t h y l  t r i t y l  s u l f i d e .  Compound 1 5 1 was prepared 
by the method of Trujilloi 28 and coworkers (75-95%  yield). The 1H 
a n d 1 sc NMR spectra are consistent with the literature report.
4 - ( S - t r i t y l - 2 - m e r c a p t o e t h y l ) - 1 , 4 , 8 , 1 1 - t e t r a a z a -  
b ic y c lo [6 .6 .2 ]h e x a d e c a n e  (154 ) .  To a solution of 1,4,8,11- 
tetraaza-bicyclo[6.6.2]hexadecane (0 .270  g, 1 .192 mmol) in 
anhydrous DMF (7.0 mL) was added anhydrous potassium carbonate 
(0 .67 g, 4.85 mmol), potassium iodide (0.80 g, 4.83 mmoL), and 2- 
chloroethyl trityl sulfide (0 .809  g, 2 .387  mmol). The mixture was 
stirred under N2 and heated to 80°C for 2 h, then stirred for 16 h at
3 3 6
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room tem perature. Crystallized material was collected by filtration 
and residual DMF was removed under vacuum. Solid was dissolved in 
H20  (5 mL), adjusted to pH 14 with solid KOH (with cooling), and 
extracted with PhCH3 ( 6 x 5  mL). The combined extracts were dried 
(Na2 S 04) and solvent was removed under reduced pressure to give an 
oil which crystallized after removal of residual solvent (0 .134  g, 
21%): mp 124-126°C; 1H NMR (360 MHz, C6D6) 5 1.15-1.33 (m, 2H, 
CH2CH2CH2), 1.35-1.53 (m, 2H, CH2 CW2 CH2), 1.80 (br s, H2O), 1.94 (dm, 
1H, J = 13.6 Hz), 2 .02-2 .60  (m, 17H), 2.11 (s, residual PhCtf3), 2 .69- 
2.82 (m, 2H), 2.98 (td, 1H, J =  10.3, 5.7 Hz), 3.04 (td, 1H, J =  12.1, 4.0  
Hz), 3 .14 (td, 1H, J = 12.5, 3.8 Hz), 3 .37-3 .47  (m, 1H), 4 .58-4 .72  (m, 
1H, NH), 6 .90-7.40 (m, 9H), 7 .51-7.68 (m, 6 H); 1 3C NMR (90.56 MHz, 
CeD6) 5 25.89 (CH2 CH2 CH2), 28.32 (CH2 CH2CH2), 31.10 (NCH2 CH2S), 
48.81, 48 .90 , 48.92, 50.11, 54.03, 54.51, 55.46, 57.70, 59.04, 59.41, 
60.39, 67 .23  (SCPh3), 126.79, 128.13, 130.11, 145.76; MS (Cl, CH4) 
m/z 529 (M +1 ), 557 (M+C2 H5); IR (KBr) 3240, 3088, 3057, 3030,
2991, 2956, 2940, 2921, 2862, 2804, 2722, 1491, 1464, 1444,
1363, 1117, 763, 743, 700 cm -1 - Anal Calcd for C33H4 4 N4 S -0 .5 H2Q  
C, 73.69; H, 10.42; N, 8.43. Found: C, 73.41; H, 8.36; N, 10.33.
3 3 7
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4 , 1 1 - B i s - ( S - t r i t y l - 2 - m e r c a p t o e t h y I ) - 1 , 4 , 8 , 1 1 -  
t e t r a a z a b i c y c l o [ 6 . 6 . 2 ] h e x a d e c a n e  ( 1 5 0 )  . To a solution of
1 ,4 ,8 ,1 1-tetraazabicyclo[6.6.2]hexadecane (79 .7  mg, 0 .352 mmol) in 
anhydrous DMF (4.0 mL) was added anhydrous potassium carbonate 
(0.202 g, 1.46 mmol), potassium iodide (0 .250 g, 1.51 mmoL), and 2- 
chloroethyl trityl sulfide (0 .483 g, 1.43 mmol). The mixture was 
stirred under N2 and heated to 80 °C for 3 h. The solvent was 
evaporated under reduced pressure and the residue extracted with 
benzene (25 mL). Insoluble solids were removed by filtration and 
the benzene solution was evaporated under reduced pressure to give 
a yellow oil. Trituration of this oil with Et20  (35 mL) caused 
precipitation of a light yellow solid, which was filtered and washed  
with Et20  ( 2 x 3  mL). This solid was dissolved in H20  (1.0 mL). The 
resulting solution was adjusted to pH 14 with solid KOH (with 
cooling) and extracted with PhCH3 . The combined extracts were 
dried ( I^ S C ^ )  and solvent was removed under reduced pressure to 
give an oil which solidified under vacuum (0.172 g, 60% crude), is c  
NMR indicated that the material was 91-93%  desired product, 
( contaminated with 4 - (S - t r i t y l - 2 -m er ca pt oe t hy l ) - 1 , 4 , 8 ,11 -
3 3 8
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tetraazabicyclo[6 .6 .2 ]hexadecane (1 5 4 ) ) :  mp 135-140 °C (dec); 1H 
NMR (360 MHz, C6 D6) 5 1.11-1.27 (tm, 2H, J = 10.6 Hz, CH2CH2CH2) 
1.30-1.45 (tm, 2H, J =  10.6 Hz, CH2 CH2CH2 ), 2 .03 -2 .55  (m, 2 0 H), 2.64  
(td, 2H, J =  12.5, 3.8 Hz), 2 .80 (td, 2H, J =  12.1, 3 .3  Hz), 3.13-3.27  
(AA’ of AA’XX ’, 2H, NCH2 CH2N bridge), 3.56 (td, 2H, J = 11.6, 3.2 Hz),
6.93-7.02 (m, 6 H, CP/73), 7 .03-7 .13  (m, 12H, CP/73), 7.57-7 .65  (m, 
12H, CP/73); 13C NMR (90.56 MHz, C6 D6) 5 28.45 ( CH2 CH2CH2), 31.29  
(CH2 CH2 S), 51.33, 54.02, 54.40, 57 .10 , 57.78, 59 .14 , 66.98  
(CH2SCPh3), 126.61, 127.99, 130.00, 145.69; IR (KBr) 3085, 3057, 
3052, 3026, 2940, 2930, 2923, 2880, 2850, 2838, 2827, 2820, 
2809, 2776, 1670, 1487, 1444, 1133, 1118, 1080, 1034, 743, 701 
cm-1; MS (Cl, NH3), m / z  831 (M+); HRMS exact mass calcd for 
C54H6 3N4 S2 831.4494, found 831 .4506. The low resolution mass 
spectrum (Cl, NH3) indicates that minor impurities other than 4-(S - 
t r i t y l - 2 - m e r ca p t o e t h y l ) - 1 , 4 , 8 , 1 1 - t e t r aa z a b i c y c l o [ 6 .6 .2] h ex a de ca n e  
are also present. Attempted chromatography on alumina (20%  
M eO H/Et2 0 ) resulted in partial deprotection (removal of trityl 
groups) of the ligand as indicated by 1H NMR of the eluted fractions. 
Several two solvent recrystallization systems (C H 2 C ^ /H exan e;
3 3 9
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C6H6/E t 2 0 ;C H 3C N /E t2 0 ; Et0 H/Et2 0 ) were tried without success 
(oiling out occured).
( 1 R S , 8 S R ) - 1 , 8 - D i b e n z y l - 4 , 1 1 - d i a z a - 1 , 8 -  
d ia z o n i a t r i c y c l o [ 9 . 3 .1 .14,8]hexadecane dibromide (176).
Benzyl bromide (388 mg, 2.268 mmol) was added in one portion to a 
stirred solution of 1 ,4 ,8 ,1 1 -te traaza tricyc lo [9 .3 .1 .14 .8]hexadecane 
(131 mg, 0.580 mmol) in MeCN (12 mL) at room temperature, and the 
reaction mixture was stirred for 17 h. Precipitate was collected by 
suction filtration, washed with M eCN ( 2 x 2  mL), and residual 
solvent was removed under vacuum to give 288 mg of product as 
white powder (87%): mp 200-206°C  (dec); 1H NMR (360 MHz, D20 , 
M eCN secondary ref. set at 2.06 ppm) 5 1.80-1.95 (dm, 2H, J = 13.9 
Hz, H6i1 3 -ax), 2 .30-2.49 (m, 2 H, H 6 , i 3 - e q ) ,  2.57 (td, 2 H, J = 1 2 .1 , 3.4  
Hz), 2 .85-3.05 (dm, 4H, J  = 12.9 Hz), 3.17 (dd, 2H, J = 11.2, 4 .8  Hz),
3.25-3.40 (m, 2H), 3 .42 (td, 2H, J = 12.8, 4 .0  Hz), 3.59 (d, 2H, J =  9.6 
Hz.NCW 2 N), 3 .57-3 .70  (tm, 2H, J = 13.8 Hz), 4 .36-4.49 (tm, 2H, J =
13.1 Hz), 4.55 (B of AB, 2H, J = 13.4 Hz, NCW2 Ph), 4.75 (A of AB, 2H, J 
= 13.4 Hz, NCH2 Ph (Note: The A part of AB is obscured by the HDO
3 4 0
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signal. An analysis of the signal intensities of the B part was used 
to calculate 5A)), 5.51 (d, 2H, J =  9.6 Hz, NCH2 N), 7 .40-7.68 (m, 10H, 
P/7); 13C NMR (90.56 MHz, D2O, MeCN as secondary ref. set at 1.7 ppm)
6 19.99 (CH2CH2CH2). 47.92, 48.17, 51.78, 60.10, 63.45, 77.22,
126.44, 129.78, 131 .39 , 133.44; IR (KBr) 3042, 3028, 3014, 2977, 
2963, 2942, 2902, 2813 , 2766, 1487, 1459, 1442, 1184, 1132,
1006, 769, 717 cm-1: Anal Calcd for C2 6 H38N4 Br2: C, 55.13; H, 6.76;
N, 9.89. Found: C, 54.75; H, 6 .8 6 ; N, 10.17.
1 , 8 - D i b e n z y l - 1 , 4 , 8 , 1 1 - t e t r a a z a c y c l o t e t r a d e c a n e  
( 1 7 8 ) .  ( 1 R S , 8 R S ) - 1 , 8 -D ib en zy  1-4,11 -d ia z a -1 ,8 -d iazon ia -
tricyc lo [9 .3 .1 .14 ,8 ]hexadecane  dibromide (101 mg, 0.178 mmoL) was 
dissolved in 20 mL 3 M KOH. The solution was heated to 50°C and 
stirred for 2 0  minutes under N2 , after which it was extracted with 
CHCI3 (6  x 15 mL). The combined extracts were dried (Na2S0 4 ) and 
solvent was removed under reduced pressure to yield an oil (59.6 mg, 
8 8 % ) which was kugelrohr distilled (150-170  °C  air bath 
temperature, 0 .04  mmHg); 1H NMR (360 MHz, C6 D6) 5 1.75-2.95 m(~p), 
4H, J = 5.5 Hz, CH2CH2 CH2 ), 2.52 (t, 4H, J = 5.3 Hz) 2.55-2.60 (m, 4H),
341
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2.67-2 .76  (m, 8 H), 2 .70-3.00 (br s, 2H, HH), 3.73 (s, 4H, NCtf2 Ph),
7 .11-7 .38  (m, 10H, Ph); 13C NMR (90.56 MHz, C6D6) 5 26.55, 48.19, 
49.76, 51.70, 54.33, 58.37, 127.11, 128.53, 129.71, 138.76; IR (neat) 
3301, 3083, 3060, 3027, 3002, 2949, 2924, 2869, 2859, 2829,
2809, 2799, 2660, 1496, 1456, 1333, 1265, 1126, 1076, 759, 729, 
699, 631 cm -i. HRMS exact mass calcd for C24H37N4 381 .3018 , found 
3 8 1 .3 0 0 8 .
1 - B e n z y l - 8 - m e t h y l - 1 , 4 , 8 , 1 1 - t e t r a a z a c y c l o -  
te t r a d e c a n e  (1 8 0 ). (1 R S ,8R S ,15R S ,16R S )-1 -B en zy l-8 -m eth y l-
4.11 -d ia z a -1 ,8 -d ia z o n ia te tra c y c lo [6 .6 .2 .0 .4 ,i6 0 i u s jh e x a d e c a n e  
dihalide (0.488 g) was dissolved in 10 mL 20%  aq KOH. The solution 
was heated to 60 °C and stirred for 4 h under N2, after which it was 
cooled to 0 °C and extracted with benzene ( 6  x 20 mL). The combined 
extracts were dried (Na2 S0 4 ), and solvent was removed under 
reduced pressure to give an oil. This oil was kugelrohr distilled 
(100-130°C  air bath temperature, 0 .04 mmHg) to yield 0.211 g of 
product. The yield for two steps from (1R S ,15R S ,16SR )-1-benzyl-
4 . 8 . 1 1 - tr ia z a -1 -a z o n ia te tra c y c lo [6 .6 .2 .0 4 .i6 .o i1 .isjhexadecane was
3 4 2
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73%; 1H NMR (360 MHz, C6D6) 5 1.55-1.65 (~p, 2H, J = 6.3 Hz, 
CH2 CW2CH2), 1.66-1.75 (~p, 2H, J = 6.3 Hz, CH2CH2CH2), 2.17 (s, 3H, 
CW3), 2.29 (t, 2H, J = 5 .5  Hz) 2.32-2.43 (m, 6 H), 2 .44-2.70 (m, 8 H), 
2.74 (br s, 2 H, NH), 3 .39 (s, 2 H, CW2 Ph), 7 .09-7.18 (m, 1 H, CH2Ph), 
7.19-7.27 (m, 2H, CH2Ph), 7 .36-7.43 (m, 2H, CH2Ph)\ 13C NMR (90.56  
M H z,C 6 D6) 5 26.70 (CH2 CH2 CH2), 26.76 (CH2 CH2CH2), 42.84, 47.91, 
48.11 , 50.05, 51.13, 53 .39 , 54.41, 57.71, 58.22, 58.83, 127.00,
128.41, 129.42, 139.86; M S (Cl, NH3), m / z  305 (M+1); IR (neat) 3295, 
3081, 3056, 3022, 2930 , 2915, 2868, 2820, 2798, 2726, 2652,
1455, 1130, 1058, 726 , 696 cm -1; HRMS exact mass calcd for 
C18H33N4 305 .2705, found 305 .2717.
1 ,7 -D lb enzy l -1 ,4 ,7 ,10 - te traazacy clod odecane (179).
(1 R S ,7 R S ,1 3 S R ,1 4 S R )-1 ,7 -D ib e n z y l-4 ,1 0 -d ia z a -1 ,7 -d ia z o n ia -  
te tra c y c lo [5 .5 .2 .0 .4 .i4 0 io .i3 ]te tra d e c a n e  dibromide (1 .54  g, 2 .87  
mmol) was dissolved in 45 mL 20%  aq KOH. The solution was heated 
to 50°C  and stirred for 5 h under N2 . The reaction mixture was then 
cooled to 0°C, extracted with benzene ( 6  x 50 mL), and the combined 
extracts were dried (N a 2 SC>4 ). Solvent was removed under reduced
3 4 3
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pressure to yield 0 .780 g (80% ) of solid product which was kugelrohr 
distilled (130-150°C  air bath tem perature, 0.03 mmHg); m.p. 8 8 - 
89°C; 1H NMR (360 MHz, C6 D6) 5 2.10-2.80 (m, 18H), 3 .39 (s, 4H,
CH2Ar); 7 .06-7.43 (m, 10H); 1 3C NMR (90.56 MHz, C6D6) 6  45.73,
52.20, 60.01, 127.24, 128.54, 129.30, 139.95; MS, m / z  352 (M+); IR 
(KBr) 3304, 3061, 3017, 3001, 2933, 2921, 2873, 2857, 2822, 2794, 
2726, 2718, 2698, 1447, 1260, 1112, 1045, 925, 770, 726, 694  
cm-1: Anal Calcd for C2 2H3 2 N4 : C, 74.96; H, 9.15; N, 15.89. Found: C, 
74.79; H, 9.40; N, 15.88; HRMS exact mass calcd for C2 2H3 2 N4 
353 .2705 , found 353 .2704 .
1 - B e n z y l - 7 - m e t h y l - 1 , 4 , 7 , 1 0 - t e t r a a z a c y c l o d o d e c a n e  
( 1 8 1 ) .  (1 R S ,7 R S ,1 3 S R ,1 4 S R )-1 -B e n z y l-7 -m e th y l-4 ,1 0 -d ia z a -1 ,7-
d ia z o n ia -te tra c y c lo [5 .5 .2 .0 .4 .140 10-13]tetradecane dihalide (73.2 mg) 
was dissolved in 10 mL 20%  aq KOH. The mixture was heated to 50 
°C and stirred for 4 h under N2. The reaction mixture was cooled to 
0 °C, and extracted with benzene ( 6  x 15 mL). The combined extracts 
were dried (Na2 S0 4), and solvent was removed under reduced 
pressure to give an oil, which was kugelrohr distilled (100-130 °C
3 4 4
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air bath temperature, 0 .02 mmHg). The yield was 6 8 % (39.3 mg) for 
two steps from (1 R S ,1 3 S R ,1 4 R S )-1 -b e n z y l-4 ,7 ,1 0 -tr ia z a -1 -
azoniatetracyclo[5.5.2.0.4.i40io,i3]tetradecane bromide; 1H NMR (360
M H z,C 6 D6) 6  2.10 (s, 3H, CH3), 2 .26 -2 .34  (m, 4H ), 2 .37-2.42 (m, 4H), 
2.48-2.57 (m, 10H), 3.39 (s, 2H, CH2 Ph), 7 .02-7.09 (m, 1H, CH2Ph),
7.12-7.19 (m, 2H, CH2Ph), 7 .24-7.29 (m, 2H, CHzPh)\ 13C NMR (90.56  
MHz, C6 D6) 5 44.16, 45 .74 , 45.81, 52.22, 54.85, 60.09, 127.14,
128.49, 129.34, 139.61; MS (Cl, NH3), m / z  277 (M+1); IR (neat) 3308, 
3085, 3061, 3029, 2938, 2919, 2879, 2835, 2816, 2802, 1495,
1354, 1341, 1120, 1053, 929, 731, 699  cm -1 : HRMS exact mass 
calcd for C i 6H39N4 277 .2392 , found 277 .2381.
F. Experimental Procedures for Ion. Ligand, and Proton Competition 
Experim ents.
1. Competitions (G eneral Procedurel-Liaand/Liaand for Metal 
C ations
Equal molar amounts (-2 5 -4 0  mg each) of the two ligands used 
for each study were weighed out into separate 1 dram vials and 
transferred into a 5 mm Wilmad 528 NM R tube with the aide of 0.50-
3 4 5
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1.00 mL CD3CN. The volume of the solution in the NMR tube was 
determined by comparison to an identical tube containing acetone.
The volume of the acetone was determined using a Hamilton syringe. 
The sample tube was sealed with a teflon cap and parafilm. The 
concentration of a single amine component was typically between
0.09 and 0.27 M. The 1H (360.13 MHz) and 13C (90.56 MHz) NMR 
spectra were recorded on an AM -360A Bruker NMR Spectrometer.
One equivalent of the desired metal salt was added directly to the 
NMR tube with the aid of a glassine paper funnel. The solution was 
agitated until all solids had dissolved. The 1 H a n d l e  NMR spectra 
were recorded and the appropriate resonances were integrated. No 
account was taken for slight differences in NOE.
2. Competitions (G eneral Procedurel-Liaand/Liaand  
Competition for Trifluoroacetic acid fTFA I.
Equal molar amounts (-2 5 -4 0  mg each) of the two ligands used 
for each study were weighed out in separate 1 dram vials and 
transferred into a 5 mm Wilmad 528 NMR tube with the aide of 0 .50-
1.00 mL CD3CN. The volume of the solution in the NMR tube was 
determined by comparison to an identical tube containing acetone.
3 4 6
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The volume of the acetone was determined using a Hamilton syringe. 
The sample tube was sealed with a teflon cap and parafilm. The 1H 
(360.13 MHz) and 13C (90.56 MHz) NMR spectra were recorded on an 
AM -360A Bruker NMR Spectrometer. One equivalent of TFA  
(trifluoroacetic acid) was added to the NMR tube via a pL syringe and 
the solution was agitated. The 1H and 1 3C NMR spectra were 
recorded and the appropriate resonances were integrated. No
account was taken for slight differences in NOE.
3. Pka Determinations of 5 8  Relative to DBU.
Into a 1 dram vial was weighed DBU (22.5  mg, 0.148 mmol)
which was transferred to a Wilmad 528 NM R tube with the aide of 
-0 .5  mL CD3CN. The sample tube was sealed with a teflon cap and 
parafilm. The 1H (360.13 MHz) and 13C (90.56 MHz) NMR spectra were 
aquired on an AM -360A Bruker NM R Spectrometer. Trifluoroacetic 
acid (TFA, 11.3 pL, 0.148 mmol) was added via a Hamilton 20 pL 
syringe. The solution was mixed and the 1H (360.13 MHz) and 13C 
(90.56 MHz) NMR spectra were recorded on an AM -360A Bruker NMR  
Spectrometer. Ligand 5 8  (35.5 mg, 0.148 mmol) was weighed out in 
a 1 dram vial and added to the NMR tube with the aide of -0 .5  mL
3 4 7
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CD3 CN. The tube was resealed as described above. The solution was 
mixed and the 1H (360.13 MHz) and 13C (90.56 MHz) NMR spectra were 
acquired on an AM -360A Bruker NMR Spectrometer.
4. Li+/Na+ Ion Selectivity Determination of Liaand 5 8 .
Equal molar amounts NaBPh4 (29.2 mg, 8.53 x 10- 5 mol), and 
LiC I0 4 (9 .1  mg, 8.55 x 10-5 mol) used for this study were transferred 
into a 5 mm Wilmad 528 NMR tube with the aide of a glassine paper 
funnel. Ligand 5 8  ( 20.5 mg, 8.54 x 10-5 mol) was weighed out in a 1 
dram vial and transferred to the NMR tube with the aide of -0 .5  mL 
of CD3CN. The volume of the solution in the NMR tube was 
determined by comparison to an identical tube containing acetone. 
The volume of the acetone was determined using a Hamilton syringe. 
The sample tube was sealed with a teflon cap and parafilm. The 1H 
(360.13 M Hz) and 13C (90.56 MHz) NMR spectra were aquired on an 
AM -360A Bruker NMR Spectrometer. The 1H a n d 1 3C NMR spectra 
were recorded and the appropriate resonances were integrated. No 
account was taken for slight differences in NOE.
3 4 8
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I I . D u p o n t / M e r c k
A. HPLC Instrumentation Used for Liaand Radiolabellina Experiments.
The analytical reverse phase HPLC work was performed on a 
Hewlett Packard 1050 HPLC in conjunction with a Hewlett Packard 
integrator recorder-model 3392A unless otherwise noted. A Ludlum 
survey meter (model 177 or equivalent) equipped with a Nal probe 
(model 44-2 or equivalent) was used for radiodetection (99mTc is a 
y-emmiter with a half of 6.01 h). The column (4.6 x 250 mm) was a 
C isV ydac reverse phase column, manufactured by West (part # 2 1 8  
TP 54). A mixture of the ligand, reducing agent, and Na9 9 mTcC>4 in a 
buffered solution was put into a sealed vial. The vial was put into a 
lead container and heated using a water bath. The contents were 
analyzed by reverse phase analytical HPLC. Aliquats of the reaction 
mixture (10 -25  pL) were removed using a leaded-glass syringe, 
injected onto the HPLC column, and eluted with a solvent gradient 
that started very polar (75-90%  aqueous buffer) and was ramped to a 
higher percentage of CH3 CN (70-85% ) over time. Most of the 
labelling attempts resulted in the formation of very polar
3 4 9
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components that eluted at or near the void volume (void volume = 
volume of the sample loop + volume of the column + volume of the 
connecting tubing).
Buffered solutions were prepared and adjusted to the correct 
pH (with 1.0 M HCI or 1.0 M NaOH) by measurement with an Orion 
Ross® electrode combination (model 81-02) in conjunction with a 
Corning pH ion analyzer (model 335).
B. Reagents:
Ammonium Acetate (NHdOAc) was obtained from Aldrich Chemical 
Co.
E thvlened iam ine te traaceta te  (disodium salt) was obtained from 
Fisher Scientific.
Glucoscan® (gluceptate) was obtained from Dupont/Merck 
P h arm aceu tica l.
Sodium Pertechnitate (Na9 9 mTcC>4 ) was obtained from a DuPont Merck 
T ec h n e lite®  99mTechnetium generator by elution with saline.
Sodium phosphate-m onobasic (HNaoPQi) was obtained from Fisher 
Sc ien t i f i c .
Sodium phosphate-dibasic (HoNaPO^I was obtained from Fisher
3 5 0
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Sc ient i f i c .
Sodium thiosulfate (NaoSoQa) was obtained from Aldrich Chemical 
Co.
S ta n n o u s  (\\) chloride (SnCbl was, obtained from Aldrich Chemical 
Co.
T r i c i n e  (N-[tris(Hydroxym ethyl)m ethyl]glycine) was obtained from  
Sigma Chemical Co.
T r ie th v l s i l a n e  (EtsSiH) was obtained from Aldrich Chemical Co. 
Trifluoroacetic  acid (TFA) was obtained from Aldrich Chemical Co. 
Triphenvlphosphine- r o - t r i su l fon a t e  (TPPTS) was prepared previously 
by the method of Bartiki 1 at Dupont/Merck (sample # DMP 112994- 
DEMO).
Tween 80® (polyoxyethyiene (20) sorbitan m onooleate) was obtained  
from Aldrich Chemical Co.
C. Solvents:
A c e t o n i t r i l e  fCHqCNI was obtained from Fisher Scientific (HPLC  
grade).
Saline Solution was manufactured for Dupont/Merck for use with 
99mTc generators (5.8 mL crimp top bottles, 9 mg/mL NaCI solution).
351
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D. Experimental Procedures:
1. Preparative HPLC of 1 5 0 .
The reverse phase HPLC analysis for compound 1 5  0 was 
performed on a Ci g Vydac column (22.1 x 250 mm). The instrument 
consisted of a Rainin Rabbit solvent delivery system in conjunction 
with Knauer variable wavelength monitor set at 254 nm. A Dynamax 
HPLC method manager installed in a Macintosh llsi was used to 
control the instrument and printout data. A sample of 1 5 0 (20.0 mg) 
was dissolved in 2.0 mL of 1:1 solution of 0.05 M NH4OAc (pH 7.0) and 
CH3CN. This solution was then injected into the HPLC and four 
fractions were collected. The gradient and solvents are summarized 
below.
HPLC Conditions
Column: 22.1 x 250 mm C1 8 Vydac
Flow: 12.0  mL/min
Solvents: A-0.05 M NH4OAC, pH 7.0
B-9:1 CH3CN:H20
Ramp: 30 sec




4 0  35%
3 5 2
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Table 2.1 shows the amounts of each fraction collected after 
l yophi l i za t ion.
Tab le 2.1
Fraction # Collection tim e  
(m in u tes )




to■CO D M P -4701 1 . 0  mg
2 1 6 - 2 1 D M P -4 7 0 2 1 .0  mg
3 2 2 - 2 6 D M P -4 7 0 3 1 .0  mg
4 2 6 - 3 2 D M P -4 7 0 4 2 . 0  mg
The total weight of fractions #1-4  after lyophilization was 5.0  mg 
giving a weight recovery of 25%.
E .aamTc Labelling of 1 8 9  and 1 9 0 .
1. Preparation of 1 9 0  bv Deprotection of Tritvlated Monothiol 
Liaand 1 5  0.
The ligand precursor (1 5 0) used in this procedure was -9 3 %  
pure according to 1 3C NMR. A solution of 1 5 0 (0 .4 -4 .0  mg) in 
CF3 OO2 H (0.5 mL) was stirred at room temperature in a stoppered 
flask for 10 minutes. To this solution was added EtsSiH (0.5 mL) all
3 5 3
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in one portion and the stoppered flask was stirred for 1 0  minutes. 
CF3OO2 H and EtsSiH were removed under reduced pressure to give an 
oil which was dissolved in saline. This solution was used directly in 
labelling studies without purification.
2. Preparation of 1 8 9  bv Deprotection of Tritvlated Precursor 
1 5  4. The (1 5 4) used in this procedure was >98%  pure according to 
13C NMR. A solution of 1 5 4  (4.0 mg) in CF3CD2 H (0.5 mL) was stirred 
at room temperature in a  stoppered flask for 10 minutes. To this 
was added triethylsilane (0.5 mL) all in one portion. The stoppered 
flask was stirred for 10 minutes. CF3OO2 H and triethylsilane were 
removed under reduced pressure to give an oil which was dissolved 
in saline. This solution was used directly in labelling studies 
w ithout purification .
3. Labelling Procedure 1: Liaand Exchange with aamTcfVK) 
Glucoheptonate (G enerali.
Into a 10 cc crimped vial was injected 0.2 mL of a glucoscan® 
kit (reconstituted with 2 .0  mL distilled H2O ) and 20 -50  millicuries 
(mCi) Na99mTc04 in saline. In some cases a phosphate buffer was
3 5 4
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added at this point to control pH. Deprotected ligand 1 9  0 dissolved 
in saline (0.5 mL), was added to the mixture which was heated at 80 
°C (water bath temperature) for 20 minutes and analyzed by HPLC. 
The total volume of the reaction mixture ranged from 1.0 mL to 2.3  
mL. The presence of labelled 99mjc glucoheptonate was checked by 
TLC and HPLC prior to the addition of ligand.
HPLC Conditions
4. Labelling Procedure 2: Liaand Exchange Using Tricine and 
S n C b .
A 10 cc vial was charged with 22.2  mg of Tricine and sealed 
with a crimp top. To this was added 4 .0  mg of deprotected ligand 
1 9  0 (weight before deprotection step) dissolved in 0.2 mL saline. 
The solution was adjusted to pH 10 using 0.03 mL of phosphate 
buffer (0.05 M, pH 12.5). A 10.0 pL solution of SnCl2 (20 .0  mg/mL in
Column: 4 .6  x 250 mm Ci 8 Vydac
Flow: 1.0 mL/min
Solvents: A-0.1%  TFA in H2O
B-9:1 CH3CN:H20  (0.1%  TFA) 
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0.1 M HCI) was added to the mixture followed by 1.00 mL Na9 9 mTcC>4
solution (60 mCi/mL, Generator # 9438-6D -19). The mixture was 
left for 30 minutes at room temperature, then heated to 50 °C 
(water bath). The mixture was analyzed by HPLC at 20-30 minute 
intervals after addition of deprotected ligand. The total volume of 
the reaction mixture was 1.5 mL and the pH was 10.
HPLC Conditions
Column: 4.6 x 250 mm C-ia Vydac
Flow: 1.0 mL/min
S o lvents: A-0.1%  TFA in H2O
B-9:1 CH3CN:H20  (0.1% TFA)
G radient: T im e (minutes) %B
0 5%
2 0  85%
3 0 85%
3 5  5%
5. Labelling Procedure 3: SnCb and EDTA at pH 7.0.
A 10 cc vial was charged with 15.3 mg of EDTA and sealed 
with a crimp top. To this was added 0.4 mg of deprotected ligand 
1 9  0 (weight before deprotection step) dissolved in 0 .2  mL saline. 
The solution was adjusted to pH 7.0 using 0.02 mL of phosphate 
buffer (0.05 M, pH 10.5). A 10.0 pL solution of SnCI2 (20.0 mg/mL in 
0.1 M HCI) was added to the mixture, followed by 1.00 mL Na99mTc04
3 5 6
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solution (55 mCi/mL, Generator # 9439-6D -17). The mixture was 
left for 30 minutes at room temperature, then heated to 50 °C  
(water bath). The mixture was analyzed by HPLC at 20-30 minute 
intervals after addtion of deprotected ligand. The total volume of 
the reaction mixture was 1.4 mL and the pH was 7.
HPLC Conditions
6 .Labellina Procedure 4: Reduction with TPPTS on a Small 
Scale .
A 10 cc vial was charged with 2.5 mg of sodium 
triphenylphosphine-m -trisulfonate (TPP TS) and sealed with a crimp 
top. To this was added 0.5  mg of deprotected ligand 1 9 0  (weight 
before deprotection step) dissolved in 0.2 mL saline. A 0.50 mL 
Na9 9 mTc0 4  solution (198 mCi/mL, Generator #9443-6D -21) was
Column: 4.6 x 250 mm C-is Vydac
Flow: 1.0 mL/min
Solvents: A-0.1%  TFA in H2O
B-9:1 CH3CN:H20  (0.1%  TFA) 
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added to the mixture which was then heated to 80 °C  (water bath). 
The mixture was analyzed by HPLC at 20-30 minute intervals. The 
total volume of the reaction mixture was 0.7  mL and the pH was 7. 
HPLC Conditions
Column: 4.6 x 250 mm Ci 8 Vydac
Flow: 1.0 mL/min
Solvents: A -0.05 M Phosphate, pH=7.0
£3-9:1 CH3CN:H20  




7. Labelling Procedure 5: Liaand Exchange with asmTcOOQ 
G lucoheptonate.
Into a 10 cc crimped vial was injected 0.2 mL of a glucoscan® 
kit (reconstituted with 2 .0  mL distilled H20 )  and 0.5 mL Na9 9 mTc0 4  
(100 mCi/mL) solution in saline. Ligand 1 8 9  dissolved in phosphate 
buffer (0.6 mL, 0.05 M, pH 10.5), was added to the mixture which was 
heated at 80 °C (water bath) for 20 minutes and analyzed by HPLC. 
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Column: 4.6 x 250 mm C is  Vydac
Flow: 1.0 mL/min
Solvents: A-0.1%  TFA in H2O
B-9:1 CH3 CN:H20  (0.1% TFA)





8 . Labelling Procedure 6 : Reduction with TPPTS for Bio­
distribution Scaleup.
A 10 cc vial was charged with 3.0 mg of sodium 
triphenylphosphine-m -trisulfonate (TPPTS) and sealed with a crimp 
top. To this was added 0.6  mg of deprotected ligand 1 9 0  (weight 
before deprotection step) dissolved in 0.2 mL saline. A  1.00 mL 
Na9 9 mTcC>4 solution (366 mCi/mL, Generator # 9447-6D -18) was 
added to the mixture which was then heated to 80 °C (water bath) 
for 20 minutes. A  500 jliL portion of the reaction mixture was
injected into the HPLC. The method used for HPLC analysis and 
isolation of the 15.56 (elution time) minute component was the 
same as that used in labelling procedure 4. It was necessary to have 
excess ligand present in the collection flask for the isolation
3 5 9
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procedure. Excess ligand often helps improve the stability of the 
complex.
F. Analytical HPLC of 1 8  9
The reverse phase HPLC analysis for compound 1 8  9 was 
performed on a C-is Vydac column (4.6 x 250 mm). The instrument 
consisted of a Hewlett Packard 1050 HPLC equipped with an 
autoinjector and UV wavelength monitor set at 254 nm. The Hewlett 
Packard 3D  Software installed on a Hewlett Packard Vectra  
486/66XM  was used to control the instrument and printout data. A 
sample of 1 8  9 (1 .0 mg) was dissolved in 0.5 mL of a 1 :1 solution of
0.05 M NH4OAC (pH 7.0) and CH3CN. A portion of this solution (20 juL)






4.6  x 250 mm C  ^q Vydac
1.0 mL/min 
A-0.05 M NH4OAc, pH 7.0 
B-9:1 CH3 CN:H20  
1 minuteRamp:












G. Unsuccessful Labelling Attempts of 2 9. 7  2. and 1 3 1 .
1. Ligand 7 2.
A 10 cc vial was charged with 5.0 mg of 7 2 and 3.0 mg Na2S2Q 3 
and then sealed with a crimp top. To this was added 1.0 mL of 
phosphate buffer (0.10 M, pH 11.0) and 1.0 mL Na99mTc04 solution 
(100 mCi/mL, Generator # 9418-D -19). The mixture was then 
heated to 80 °C (water bath). The mixture was analyzed by HPLC at 
20 -30  minute intervals after addition of ligand 7 2. The total 
volume of the reaction mixture was 2.0 mL and the pH was 11.0.
HPLC Conditions
2. Ligand 2 9.
A 5 cc vial was charged with 3.0 mg of 2 9 and 3.0 mg Na2 S2Q 3
361
Column: 4 .6  x 250 mm C 18 Vydac
Flow: 1.0 mL/min
Solvents: A-0.1%  TFA in H2O
B-9:1 CH3CN:H20  (0.1% TFA) 
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and then sealed with a crimp top. To this was added 1.0 mL of
phosphate buffer (0.10 M, pH 7.0) and 0.5  mL Na9 9 mTcC>4 solution (50
mCi/mL, Generator # 2). The mixture was then heated to 100 °C  
(boiling water). The mixture was analyzed by HPLC at 20-30 minute 
intervals after addition of ligand 2 9. The total volume of the 
reaction mixture was 1.5 mL and the pH was 7.0.
HPLC Conditions
Column: 4.6 x 250 mm C is  Vydac
Flow: 1 .0  mL/min
Solvents: A-0.1%  TFA in H2 O
B-9:1 CH 3CN:H20  (0.1%  TFA)
G radient: T im e (m inutes) %B
0 5%
2 0  85%
3 0 85%
3 5 5%
3. Liaand 1 3 1 .
A 5 cc vial was charged with 10.0 mg of 1 3 1 and 3.0 mg 
Na2 S2Qs and then sealed with a crimp top. To this was added 1.0 mL 
of phosphate buffer (0.10 M, pH 11.0). A 1.0 mL Na9 9 mTc0 4  solution 
(100  mCi/mL, Generator # 9418-D -19) was injected into the 
mixture which was analyzed by HPLC at 20-30  minute intervals 
(Note: no heat). The total volume of the reaction mixture was 2.0 mL
3 6 2
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and the pH was 11.0.
HPLC Conditions
Column: 4 .6  x 250 mm C-ie Vydac
Flow: 1 .0  mL/min
Solvents: A-0.1%  TFA in H2O
B-9:1 CH3CN:H20  (0.1% TFA)
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